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The research presented in this thesis aimed at investigating psychosocial functioning in people 
with diabetes mellitus in Zambia. The sample in the thesis included urban adolescents and 
adults with both type 1 and type 2 diabetes mellitus. The thesis addressed the following 
questions: 
1. What is the prevalence of diabetes in children in Sub-Saharan Africa (SSA), 
what are the consequences and risk factors for diabetes and what does diabetes 
care look like in SSA? (Chapter 2) 
2. What are the sources of stress, the ways of coping with stress, the perceived 
quality of care and the quality of life as experienced by Zambian adolescents 
living with type 1 diabetes? (Chapter 3) 
3. Does the Zambian version of the Problem Areas in Diabetes (PAID) have sound 
psychometric properties and what are the levels of diabetes-specific emotional 
distress in people with type 1 and 2 diabetes in Zambia? (Chapter 4) 
4. How common is co-morbid depression in individuals with type 1 and 2 diabetes 
in Zambia? (Chapter 5) 
5. What is the association between symptoms of depression with diabetes self-care 
in individuals with type 1 or 2 diabetes? (Chapter 6) 
 
To place this thesis into context, this introduction provides background information about 
psychosocial issues among people living in diabetes both globally and within the Zambian 








Psychosocial issues common in diabetes  
In 1994, the psychological well-being working group of the World Health 
Organization/International Diabetes Federation St Vincent Declaration Action Program for 
Diabetes published guidelines for encouraging psychological well-being in people with 
diabetes [1]. The guidelines included: improving communication between diabetes health-care 
teams and the person with diabetes; protecting self-esteem of people with diabetes; responding 
to individuals’ differing needs; helping patients learn about their own individual responses; 
helping to motivate self-care; monitoring of psychological well-being and proposing 
organizational changes aimed at optimizing psychological aspects of diabetes care [1]. 20 years 
down the line, psychosocial aspects of diabetes are almost never taken care of in the Zambian 
health care system and there is a dearth of research on the subject in Sub-Saharan Africa.  
 
Diabetes is a chronic metabolic disease characterized by hyperglycemia resulting from defects 
in insulin secretion, insulin action or both [2]. According to the World Health Organization 
(WHO), diabetes mellitus can be classified into four types: type 1 diabetes, type 2 diabetes, 
other specific types of diabetes and gestational diabetes mellitus [3]. Type 1 diabetes results 
from autoimmune destruction of the pancreatic beta cells, causing the loss of insulin production 
while type 2 diabetes is characterized by insulin resistance and abnormal insulin secretion [2]. 
Other specific type of diabetes are caused by genetic disorders, infections, diseases of the 
exocrine pancreases, endocrinopathies and drugs while gestational diabetes is due to glucose 
intolerance with onset or first recognition during pregnancy [2]. Diabetes can be managed 
through primary and secondary care. Primary care refers to medical care that a walk-in patient 
is given by a health care provider who often serves as the contact person and focal point person 
for further care within a health system, whereas secondary care refers to health care services 





recommendation or referral from a primary health care provider. Diabetes self-care consists of 
proper use of medication (insulin or oral medication, correct timing/correct doses especially 
for type 1 diabetes), counting of carbohydrates, a healthy diet (e.g., low in saturated fat, low in 
salt, high in vegetables/fruits and moderate in alcohol intake especially for type 2 diabetes), 
being physically active, monitoring of blood glucose levels, proper foot care and refraining 
from smoking among others [4]. If not properly cared for, diabetes can lead to microvascular 
and macrovascular complications. Microvascular complications include diabetes retinopathy, 
nephropathy and neuropathy. Macrovascular complications include heart attack, stroke and 
peripheral arterial disease [5]. 
 
The importance of addressing psychosocial issues has long been recognized in chronic 
conditions such as diabetes including the evidence that psychological issues, such as depression 
and stress, are linked with an increased risk for the onset of diabetes mellitus [6]. In addition, 
diabetes increases the risk of depression [7, 8], stress [9], diabetes-specific emotions such as 
fear of hypoglycemia and worrying about (future) complications. These psychological factors, 
in turn, negatively influence diabetes self-care behavior which in turn can hamper glycemic 
control. Therefore, psychological wellbeing is itself an important goal of medical care and 
psychosocial factors are relevant to nearly all aspects of diabetes care [10]. This is particularly 
true for conditions such as diabetes, since most of the treatment consists of self-care by the 
patient, such as injecting insulin, checking the blood glucose, counting carbohydrates, eating 
healthy, balancing carbohydrates with exercise and visit the health care provider(s). Each of 






One of the biggest behavioral problems among patients with diabetes is suboptimal diabetes 
self-care. Health behaviors such as eating unhealthy diet, physical inactivity, but also emotional 
factors such as depression and anxiety can hamper glycemic control [11]. In addition to a 
healthy diet and sufficient exercise, people with diabetes should also quit or refrain from 
smoking. Non-adherence to treatment recommendations is often attributed to inadequate 
knowledge about proper diabetes care, but lack of resources can also play a role. In addition to 
that, psychosocial challenges may explain suboptimal self-care behaviors, such as lack of social 
support, chronic stress, time pressure, poverty and traditional beliefs about health or diabetes 
that are not in line with treatment recommendations [12]. The ultimate goal of adhering to 
optimal health behaviors is to control blood glucose levels. Self-care behaviors and 
psychological state of patients, such as dieting, exercising and depression, contribute to 
diabetes health indicators such as glycemic control [11]. Non-adherence is often attributed to 
inadequate knowledge about proper diabetes care. However, other psychosocial factors 
mentioned above may contribute to non-adherent behaviors, such as lack of social support, 
stress, time pressure and health beliefs and practices that are not in line with the recommended 
treatment regimens [12]. Other than the aforementioned factors, in adolescents, non-adherence 
problems can be a result of the increase in counter-regulatory hormones (e.g., growth 
hormones, cortisol, epinephrine and glucagon) responsible for insulin resistance, a situation 
also known as “dawn phenomenon” [13]. Dawn phenomenon is the night-to-morning elevation 
of blood glucose before and after breakfast in subjects with both type 1 and 2 diabetes mellitus. 
In people without diabetes mellitus, physiology of glucose homeostasis indicates that blood 
glucose and plasma insulin concentrations remain remarkably flat and constant overnight, with 





production and prevent hyperglycemia [53]. People without diabetes mellitus do not show 
symptoms of the dawn phenomenon. 
 
Several other psychosocial issues can affect people with diabetes including psychiatric 
disorders and behavioral problems. In adolescents with type 1 diabetes for example, 
internalizing behaviors (such as depression and anxiety) or externalizing behaviors (such as 
impulsivity, hyperactivity and aggression) are often reported [14-16]. Further, during diagnosis 
children just like adults, present feelings of anxiety, sadness and withdrawal. A study in Nigeria 
showed that children with diabetes were 42% more likely to experience emotional disorder 
(such as separation anxiety disorder, social phobia, dysthymic disorder, major depression 
disorder and generalized anxiety disorder) than children with sickle cell disease (38%) and a 
healthy group (11%) [17]. 
 
Diabetes can cause enormous pressure on how the family functions which either can strengthen 
or break family ties, depending on the characteristics of a family. During adolescence there is 
increasing independence and adolescents often challenge parents’ supervision of their diabetes 
care for example. This may lead to conflicts within a family. Type 1 diabetes is demanding and 
affects everyday lives of not only patients with diabetes but also their families and significant 
others. Advice given by parents or family members (e.g., “Shouldn’t you check your blood 
glucose? I think you are low!”) can be perceived as offensive or intrusive behaviors into 
diabetes management, especially in adolescents who want to be or become independent. On 
the other hand, constant respectful and unconditional support to patients’ diabetes management 
may improve diabetes treatment outcomes. In low-income homes, apportioning resources to 





to take certain diets that have low saturated fat composition and rich in vegetables, part of a 
healthy diet, which may not be liked by other family members. This underscores the importance 
of family and friends in diabetes management. Moreover, there is literature suggesting that 
friends’ support for blood glucose testing is related to patients’ disease adaptation and quality 
of life [14]. 
 
Chronic illnesses are daunting not only to patients but also to others surrounding the patient. It 
is therefore not surprising that people with chronic illness such as diabetes may potentially find 
it difficult to have romantic relationships. There are several factors other than diabetes that are 
implicated to include medical costs, psychological pressure [14], discrimination and traditional 
beliefs. For instance, in Japan 90% of men and women felt medical expenditure was a factor 
which affects their marriage rate because of the bills attached to their health status, 30% felt 
diabetes restricted their school and work attendance, which are useful avenues for meeting a 
potential romantic partner and 30% felt diabetes restricted them from having an intimate 
partner relationship [18]. 
 
Both type 1 and 2 diabetes have been associated with deteriorating cognitive functioning [19-
22]. A study in Sweden revealed that children who developed type 1 diabetes during 1977-
2000 had poorer school performance compared to non-diabetes peers (means = 3.14 vs. 3.23, 
p < 0.001) [23]. Common cognitive problems in people with type 1 and 2 diabetes include 
attention, processing speed and concentration problem [14, 24]. Hypoglycemia seems to be 
associated with impaired intellectual abilities, memory, attention, perceptual and motor skill 
problems in people with type 1 and 2 diabetes [14, 24]. Contrary to what was initially thought, 





impact of recurrent hypoglycemia (RH) on brain functioning but evidence shows that RH 
causes brain adaptation which enhances cognitive performance when euglycemic, but poses 
significant threat during future hypoglycemic episodes [25]. 
 
Quality of Life (QoL) in people with diabetes is another issue that has received considerable 
attention of researchers. Age, gender, increased psychiatric and behavioral disorders, 
socioeconomic status, emotions, co-morbid conditions and instrumental support all seem to be 
factors that are linked with health-related QoL in people with diabetes across studies [26-28]. 
However, a systematic review showed that self-reported generic QoL was not impaired in 
young people with type 1 diabetes, compared to healthy controls; however, parents reported 
that QoL was lower and disease-specific QoL was also lower [29]. There is also a link between 
QoL and metabolic control since poor metabolic control burdens the family. For most people 
with diabetes, having diabetes also has negative financial consequences. In 2009, the World 
Health Organization reported that the 7.02 million cases of diabetes recorded by the WHO in 
African countries resulted in a total economic loss of US$ 25.51 billion, a figure which has 
since increased [30]. Moreover, high income has been positively associated with diabetes 
ketoacidosis at type I diabetes onset among children in wealthy nations [31]. Common 































Diabetes in Zambia 
As of 2012, it was estimated that there were about 268,000 people aged 20-79 years with 
diabetes (types not specified) in Zambia [32]. The prevalence rate of diabetes in Zambia is 
5.13% [32]. A figure of 221,390 was estimated to be the number of people with undiagnosed 
diabetes for those aged between 20-79 years old [32]. In addition, it is estimated that there were 
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was only 11.2 years for those aged 0-14 years and 16.7 years for those aged 15 years and above 
[33]. In Western countries, life expectancies for people with type 2 diabetes is estimated at 55 
years, 5 years after diagnosis [34] and about 68.8 years for those with type 1 diabetes diagnosed 
aged less than 17 years of age regardless of sex and puberty status [35]. Diabetes is a drain on 
household resources as a result of chronic and expensive treatment, distance to heath facilities 
and loss of family members, often breadwinners. The International Diabetes Federation (IDF) 
estimates that the mean diabetes-related expenditure per person with diabetes in Zambia was 
approximately US$ 125 per month compared to annual income of an average person in Zambia 
of US$ 1,490 [36]. 
 
Although there is a non-communicable diseases (NCDs) unit at the Ministry of Health (MOH), 
the country’s capacity to provide adequate medical care for persons with diabetes cases and 
also the prevention of type 2 diabetes is way below expected standards. For instance referral 
pathways are poorly used and sometimes non-extent [37]. The Diabetes Foundation and 
International Insulin Foundation (IIF) found that three main problems were related to referrals 
in Zambia: 
1. Lack of information given to users about their diagnosis in general and specifically 
about the reason for the referral; 
2. Many of the patients referred were not given a letter which should have facilitated their 
entry into the hospital system; 
3. Lack of linkage from the hospital, back to the urban health centers for follow-up. 
 
A survey by IIF showed that healthcare workers where often (no figures reported) unfamiliar 





cerebral malaria; 21 out of 199 patients in Tanzania who were diagnosed as having cerebral 
malaria actually had diabetes mellitus [37]. To counter this lack of knowledge on the 
management of diabetes, education initiatives for health workers and for patients are at times 
organized by the MOH and Diabetes Association of Zambia (DAZ). For instance, DAZ 
organizes educational camps for children annually and children are given the opportunity to 
interact with other children with diabetes and also learn about different aspects of their diabetes 
care [37]. Similarly, workshops are often organized for health care workers on diabetes 
management. DAZ has an advocacy and support role which is important for engaging the 
communities and the MOH to take a leading role in diabetes care. 
 
Diabetes care and management in Zambia is faced with a lot of challenges. A survey conducted 
by IDF and IIF, found that availability of diagnostic and care tools was below expected 
standards [37]. For instance, only in 61% of surveyed health facilities urine glucose strips were 
found, 49% of ketone strips and 54% of glucometers. The availability of other essential tools 
used for diagnosis, treatment and management of diabetes included sphygmomanometer 
(99%), stadiometer (49%), weighing scales (71%), body mass index charts (19%), Snellen 
charts (53%) and tendon reflex hammer (48%). Insulin was mostly acquired by tender 
procedures and tenders accounted for 79% of the total quantity compared to 21% for insulin 
acquired from private local wholesalers. Tenders accounted for 68% of the total cost of insulin 
expenditure in Zambia compared to 32% insulin expenditure from wholesalers [37]. It was 
estimated that purchasing insulin from a tender process could save around 15% of total insulin 
costs [37]. Consequently, the cost of insulin in Zambia was high. Over 13 years ago, Beran and 
colleagues found that the average cost per insulin vial was US$ 2.00 and patients paid US$ 





vial is US$ 20.00. Although patients often receive free insulin and syringes from government 
health care facilities, these commodities are sometimes unavailable and patients have to buy 
insulin on their own. Psychosocial support for people with diabetes is almost nonexistent. Our 
research observed that there are no health workers who have been trained to deal with patients’ 
psychosocial problems especially among adolescents [38]. 
 
About Zambia: Socioeconomic Situation 
Zambia is a landlocked country situated in the southern part of Africa with neighboring 
countries including Democratic Republic of Congo, Tanzania, Malawi, Mozambique, 



















Figure 2: Zambia and its neighboring countries 
 
Source: Commonwealth Health. Health in Zambia [39]  
 
As of 2012, the population of Zambia stood at 13,817,479 and has a median age of 16.5 years. 
The urban population accounts for 36% of the total population and the annual rate of urban 
population growth is estimated at 3.2%. The major cities in Zambia are Lusaka with a 
population of 1,742,979, Kitwe (522,092), Ndola (455,194), Chipata (452,428) and 
Livingstone (142,034). Others include Mongu, Solwezi, Kasama, Mansa and Kabwe. Life 
expectancy at birth in the total population as of 2012 stood at 52.6 years, 51.4 years for males 





(99.5%) with about 10 ethnic groups and languages including: Bemba, Tonga, Chewa, Lozi, 
Nsenga, Tumbuka, Ngoni, Lala, Kaonde, Lunda and other African groups), other 0.5% 
(includes Europeans, Asians and Americans) [40]. In 2012, the Human Development Index for 
Zambia was 0.448, a low score positioning the country at 163 out of 187 countries and 
territories [41]. The gross domestic annual income per capita was US$ 1490 [42]. 80.6% of the 
total population are literate, based on the definition that those aged 15 and above can read and 
write [40]. School life expectancy (primary to tertiary education) is 7 years for the total 
population, 8 years for males and 7 years for females. The 2014 education expenditure was 
20.2% of the total budget allocation [43]. 
 
The health sector expenditure has seen an increase from 4.8% of the GDP in 2009 to 9.9% in 
the 2013 expenditure allocation [43]. Despite the increase in expenditure in the health sector, 
there is a dearth of manpower in the health sector mainly because skilled manpower leave for 
greener pastures to other countries. The physician density a few years ago was 0.055/ 1000 
population [44]. WHO estimates that there were 7.8 nursing and midwifery persons per 10,000 
population and 31 community health workers per 10,000 population between the years 2005-
2012 [42]. In 2010 there were 0.5 hospitals per 100,000 individuals and 20 hospital beds per 
10,000 individuals between the years 2005-2012 [45]. 
 
There are very few published studies on diabetes in Zambia. Most of these are epidemiological 
studies focusing on the prevalence of diabetes and access of insulin among people with diabetes 
[33, 46-50], a clinical study focusing on glycemic control in people with diabetes [51] and a 
psychosocial study focusing on the relationship between compliance and quality of life [52]. 





diabetes mellitus in Zambia. Therefore, the general aim of this thesis was to examine 
psychosocial factors associated with diabetes mellitus in Zambia. 
 
Thesis Outline 
The thesis consists of 7 chapters, including a narrative literature review and four empirical 
papers using cross-sectional data which form the core components of the thesis. The first part 
presents a general introduction which explores the current situation of diabetes and associated 
psychosocial issues in Zambia and an examination of demographic characteristics of Zambia. 
Chapter 2 and 3 focus on understanding diabetes and its implications in Sub-Saharan Africa 
including Zambia. Specifically Chapter 2 explores literature on diabetes in Sub-Saharan 
African children: consequences and risks, care and challenges. Chapter 3 of the thesis explores 
experiences of adolescents living with diabetes in Zambia.  
 
In part 2, Chapters 4–6 focus on data regarding psychosocial functioning associated with 
diabetes in Zambia. Many self-report measures have been developed to assess diabetes 
specific-distress, but there are currently no validated self-report measures for researchers and 
clinicians in Zambia. Therefore, Chapter 4 examines the psychometric properties of the 
Problem Areas in Diabetes scale, a measure assessing diabetes-specific distress. Equally, many 
studies have been conducted in the USA and Europe, focusing on diabetes and depression. 
However, data from Zambia are currently lacking. Depression is a burdensome condition that 
can also hamper adequate self-care and increase the risk for diabetes complications. Depression 
is also associated with higher mortality rates. Consequently, Chapter 5 examines comorbid 
depression and diabetes in Zambia and factors associated with depression. Chapter 6 examines 





Chapter 2 through to Chapter 6 are collated, summarized and discussed in Chapter 7. In 
addition, current developments in literature and recommendations are discussed in chapter 7. 























































1. General  Introduction 
Part 1: Understanding Diabetes in SSA and Zambia 
2. Diabetes in SSA children: Risks, care and challenges 
3. Experiences of adolescents living with diabetes in Zambia 
Part 2: Psychosocial issues in diabetes 
4. Diabetes specific distress 
5. Comorbid depression and diabetes 
6. Depressive symptoms and diabetes self-care 
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As of 2012, there were 15 million adults and 36,000 children living with diabetes mellitus in 
Sub-Saharan Africa (SSA). It is estimated that 12 million people in SSA live with undiagnosed 
diabetes. The incidence of diabetes vary from country to country; 0.3 per 1000 in Nigeria to 10 
per 100,000 in Sudan. These epidemiological data may not reflect a true picture of the 
prevalence of diabetes especially among children since such data are often non-existent in most 
countries due to lack of research and resources. Common acute complications of diabetes in 
SSA include ketoacidosis, hyperosmolar non-ketotic coma and hypoglycemia. Chronic 
complications include retinopathy, glaucoma, nephropathy and neuropathy. In addition, many 
children suffer from neuro-cognitive and psychosocial problems. Early onset and duration of 
the illness and recurrent hypoglycemia episodes are major factors leading to neuro-cognitive 
and psychosocial problems in children. Children with diabetes tend to show adjustment 
problems, report depression, anxiety and poor quality of life. Apart from suffering from 
diabetes, some children have comorbid HIV and AIDS and eye diseases, among others. Few 
studies document mortality rates of children in SSA, however, life expectancy of children with 
diabetes is on average five years. In WHO member African countries, millions of dollars were 
spent on diabetes costs and it is estimated that US$ 1,154.15 per diabetes patient was spent per 
year. Despite the huge costs associated with diabetes, most essential diabetes commodities, 
equipment and personnel are still lacking in most countries. In conclusion, diabetes among 
children in SSA is still a big challenge. More effort by different stakeholders is required to 
make prevention programs, management and care of diabetes better by improving resources 
and implementation of health services. In all these processes, traditional healers and 








The aim of this chapter was to increase our understanding of the prevalence and consequences 
of diabetes in SSA and Zambia by summarizing the literature. The questions that are addressed 
in this chapter include: What is the prevalence of diabetes in children, in SSA? What are the 
consequences and risk factors for diabetes and what is the quality of diabetes care in SSA? This 
chapter will also act as a basis for comparison with the current status of diabetes in Zambia. To 
place this chapter into context, a general synopsis of the etiology of diabetes will be discussed 
followed by the prevalence of diabetes in African children. Consequences or risks (acute and 
chronic, psychological and social) of diabetes in patients with diabetes will be discussed. This 
will be followed by implications in terms of preventative measures and care in Africa and future 
directions that can be taken into account for diabetes management. 
The World Health Organization (WHO) [1] defines diabetes mellitus as a metabolic disorder 
of multiple etiologies that is characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin 
action or both. Our bodies require glucose which mainly comes from food we eat. Through the 
small intestine, glucose is absorbed by the capillaries into the bloodstream and it is then ready 
as a source of energy for body cells. In order for glucose to be transferred from the blood into 
the body cells, the hormone insulin is a requisite, which is produced by the beta cells in the 
pancreas. In individuals with diabetes, this process is impaired. This disorder can be inherited 
and/or acquired [2].  
Diabetes mellitus can be classified into different types [1]. These include type 1 diabetes, type 
2 diabetes, gestational diabetes mellitus and other specific types of diabetes such as latent 





Mbanya and Ramiaya [3] distinguished the different types of diabetes; the onset of type 1 
diabetes mellitus (T1DM) can occur at any age, but is generally before the age of 40 and results 
from autoimmune destruction of the pancreatic beta cells, causing a complete loss of insulin 
production. Patients with this type of diabetes require insulin therapy (i.e. insulin injections or 
insulin pump therapy) for survival [1]. 
Type 2 diabetes mellitus (T2DM) is the most common type of diabetes, affecting 
approximately 90% of the diabetes patients. This type of diabetes often has its onset after the 
age of 50 (but can also develop before the age of 50) and is characterized by a relative lack of 
insulin, caused by insulin resistance (cells are less sensitive for insulin) and insufficient insulin 
secretion (beta cell dysfunction), either of which may predominate but both of which are 
usually present. The specific reasons for the development of these abnormalities are not yet 
fully known [3] although obesity, inactivity, composition of diet and heredity seem to play an 
important role. T2DM can remain unrecognized for many years, as the first symptoms are often 
ignored: frequent urination, increased thirst, fatigue and weight loss. Many people seem to 
attribute these symptoms to “old age”. Still the diagnosis of type 2 diabetes is often made when 
microvascular or macrovascular diabetes complications are diagnosed and the patient is 
checked for diabetes. 
 
Pregnant women can develop gestational diabetes mellitus (GDM). GDM is defined as any 
degree of glucose intolerance with onset or first recognition during pregnancy [3]. Other 
specific types of diabetes include MODY and LADA. MODY is a rare type of diabetes 





type 1 diabetes that can occur in adults with the autoimmune process that destroys cells in the 
pancreas. These last types of diabetes are very uncommon and often misdiagnosed. 
Diabetes was less common centuries ago. However, in 1552 BCE the Egyptian physician Hesy-
Ra of the 3rd Dynasty was the first known person to describe a patient with diabetes on the 
Ebers Papyrus. In 250 BC, diabetes was described as the ‘melting down’ of flesh and limbs 
into urine [4]. Sattley, points that in the first century AD a Greek, Aretaeus, from Cappadocia, 
described the destructive nature of the affliction which he named “diabetes” from the Greek 
word for “Siphon” [5]. In the 17th century, a physician from London Dr. Thomas Willis 
determined whether his patients had diabetes or not by sampling their urine. If it had a sweet 
taste he would diagnose them with diabetes mellitus “honeyed” diabetes. In 1889, the German 
physiologist Oskar Minkowski and the physician Joseph von Mering, showed that if a dog's 
pancreas was removed, the animal got diabetes. In 1921 in Ontario, Canada, a surgeon Fredrick 
Banting and his assistants Charles Best and John McLeod, biochemist/physiologist, made a 
major discovery. They isolated insulin from dogs or cattle and used it to keep a diabetic dog 
alive for 70 days by injecting the insulin [5]. In 1923, Banting and McLeod won the Nobel 
Prize in Physiology or Medicine for the discovery of insulin.  
 
Etiology of Diabetes 
Type 1 Diabetes Mellitus 
There is growing literature on genetic susceptibility to diabetes. Alleles or genetic variants 
associated with T1DM provide either susceptibility or protection from acquiring the disease 
[6]. Evidence for hereditary influence can be deduced from twin studies. The concordance for 
T1DM is approximately 50% for monozygotic twins and the risk to a first degree relative is 





susceptible to developing diabetes mellitus. For instance, Bennett and Todd (1996) argued that 
more than 90% of patients who develop T1DM have DR3, DQ2 or DQ8 haplotypes [8]. They 
further argued that DR3-DR4 heterozygosity is highest in children who develop diabetes before 
age 5(50%) and lowest in adults presenting with type I diabetes accounting for about 20-30%. 
Equally one non-human leukocyte antigen (HLA) gene has been identified on chromosomes to 
contribute about 10% of the familial aggregation on T1DM [8]. This locus is a polymorphic 
region that maps to a variable number of tandem nucleotide repeats (VNTR) 5’ of the insulin 
gene and different sizes of this VNTR 5’ of the insulin gene is associated with risk of type I 
diabetes. On the contrary, a long form of the VNTR (≥ 100 repeats, class III) is associated with 
protection from diabetes [9]. 
 
T1DM is considered a multi-factorial disease in which the environmental risk factors trigger 
an immune-mediated destruction of the pancreatic beta cell in genetically susceptible 
individuals [10]. Environmental agents such as viruses may play a role in the development of 
T1DM [6]. Studies suggest that certain viruses and some aspects of early childhood diet may 
influence T1DM and even T2DM for the later. Enterovirus, mumps, rubella, rotavirus, 
chickenpox, cow milk, some common child vaccine and nitrates have been associated with 
T1DM [6]. Further, environmental factors can inhibit the development of autoimmunity. The 
environments for young infants are far too clean, leading to a deficiency in immunoregulation 
such as the “Th2” diseases e.g., asthma and the “Th1” diseases, e.g., T1DM are increasing 








Figure 1: Some possible causes of type 1diabetes mellitus 
 
Source: Ma & Chan, 2009 (reprinted with permission) 
Type 2 Diabetes Mellitus 
T2DM is considered by diabetes physicians as a complex and heterogeneous disease with a 
poorly understood etiology, apart from the fact that there is a strong genetic propensity that 
becomes overt when exposed to a typical westernized diet [13-14]. A meta-analysis found that 
there is a 26% risk of developing T2DM for those who consume 1-2 servings per day of sugar-
sweetened beverages [15]. Santé diabètes, a Non-Governmental Organization working in the 
area of diabetes in Africa, points out that in recent years, there has been an overweight problem 
in Africa especially with the sharp increase in the consumption of food that contains more 
saturated fat and an increasing number of people with a sedentary lifestyle, as a result of rising 
income and urbanization in Africa [16]. Urban life style in Africa is characterized by changes 
in dietary habits involving an increase in consumption of refined sugars and saturated fat and 
a reduction in fiber intake [17]. These changes will probably further increase the risk of obesity 





[13]. Among the environmental factors that are hypothesized in the etiology of diabetes is the 
gut microbiota which may play a critical role in development of T2DM [11]. 
 
Data on the levels of obesity in Sub-Saharan Africa is scarce, but it varies between 3 - 44% of 
the population, depending on ethnicity and urban or rural location [18]. Autoimmunity, 
physical inactivity, obesity and genetic factors may all contribute to the increasing young age 
onset of T2DM [19]. Emerging risk factors in Africa include age and ethnicity as confirmed by 
increasing prevalence in age and in the differences between people from India, blacks and 
Caucasians in South Africa. The greatest prevalence was found in Indian community of Durban 
(13%) and elderly colored community of Cape Town (29%) [20].  
 
Epidemiology of Diabetes 
The 2012 International Diabetes Federation (IDF) diabetes atlas estimated that there were about 
15 million people living with diabetes in Sub-Saharan Africa (SSA) a sharp increase from 12.1 
million in 2010 [21]. In 2011, the number of people with diabetes in Africa was expected to 
increase to 28 million people by 2030 [22]. This figure is enormous for a continent with a 
population of approximately 876.8 million [23]. 
 
Data by the IDF, indicates that there are approximately 36,000 children with diabetes in Africa 
and that nearly 5,900 children are diagnosed every year [24]. TIDM is more prevalent in girls 
than boys as documented by studies in Ethiopia, Nigeria, Liberia and Sudan [25]. Type 2 
diabetes accounts for over 90% diabetes cases in SSA, although estimates for children are not 
yet known, there is growing evidence that it is now also affecting African children [16]. Type 





condition in many parts of Africa and the mortality rates are high, this is probably an 
underestimation of the true prevalence and potential care needed [26]. Surveillance and proper 
records are lacking in most cases in many African countries to document the prevalence and 
incidence of diabetes in children and adults. The International Diabetes Federation (IDF) 
estimated that about 12 million people in Africa live with undiagnosed diabetes, accounting for 
81% of cases [27].  
 
The incidence of T1DM and T2DM in children and adults varies greatly from country to 
country and many estimates so far have excluded children, because comprehensive statistics 
for children are still lacking. Estimated prevalence of diabetes in SSA are described in Table 1 
below. In SSA, the highest prevalence estimate for diabetes is in the Islands of Reunion with 
16% prevalence, followed by the Seychelles with approximately 3,056 (12%) people with 
diabetes [27]. SSA countries with relatively large populations also seem to have large numbers 
of people with diabetes with Nigeria at approximately 3 million (5%) followed by South Africa 
at 2 million (7%). Ethiopia is reported to have an estimated 1,386,660 (3%) of people with 
diabetes while Angola has approximately 192.61 (3%), Benin approximately 62,090 (2%), 
Botswana approximately 96,420 (11%), Cameron approximately 517,860 (6%), Comoros 
approximately 24,300 (9%), Congo approximately 97,670 (6%), Cote d'Ivoire approximately 
421,030 (5%), Democratic Republic of Congo approximately 737,090 (3%), Kenya 
approximately 720,730 (5%), Madagascar approximately 477,470 (5%), Zambia 







Table 1: Prevalence of diabetes in Sub-Saharan Africa as estimated by the IDF Atlas 2012. 
These figures excluded people below the age of 20. Country populations as reported by the 
World Bank. 
Country/ Territory Diabetes cases (20 -79) in 
1000s with total country 













per person with 
diabetes (USD) 
Number of people 
with undiagnosed 
diabetes (20 -79) 
(in 1000s) 
Angola  192.61 (15,957,460) 2.91 4,154 276.70 154.09 
Benin  62.09 (7,397,985) 1.68 1,162 59.95 51.29 
Botswana  96.42 (1,852,243) 10.80 2,962 814.16 77.13 
Burkina Faso 182.44 (13,789,736) 2.95 4,826 68.64 150.71 
Burundi 97.87 (7,039,534) 2.72 2,781 34.84 80.85 
Cameroon  517.86 (17,165,267) 6.15 14,588 109.04 414.29 
Cape Verde 13.65 (466,784) 5.43 139 242 10.92 
Central African 
Republic 
57.09 (3952281) 3.05 1,850 34.31 47.16 
Chad  189.94 (9474792) 3.61 5,569 86.40 156.91 
Comoros  24.30 (625,876) 8.39 281 45.64 20.07 
Congo (Brazzaville) 97.67 (3445765) 5.52 2,254 142.67 78.13 
Congo (Democratic 
Republic) 
737.09 (55,754,885) 3.03 16.355 25.03 608.91 
Cote d'Ivoire 421.03 (17,731,840) 4.93 10,263 - 336.82 
Djibouti  26.89 ( - ) 6.30 502 131.09 21.51 
Equatorial Guinea  14.57 (589,794) 4.21 326 923.62 11.65 
Eritrea  94.62 (4,318,343) 3.41 1,182 17.12 78.17 
Ethiopia  1,386.64 (72,526,620) 3.32 23,869 24.91 1,145.50 
Gabon  69.96 (1,344,171) 10.19 1,378 388.20 55.97 
Gambia  12.79 (1,460,493) 1.97 201 45.63 10.56 
Ghana  354.2 (21,119,911) 3.16 6,9973 114.76 292.45 
Guinea  187.14 (8,889,321) 4.36 3,459 36.98 154.59 
Guinea-Bissau  19.39 (1340814) 3 490 30.35 16.01 





Country/ Territory Diabetes cases (20 -79) in 
1000s with total country 













per person with 
diabetes (USD) 
Number of people 
with undiagnosed 
diabetes (20 -79) 
(in 1000s) 
Lesotho  29.96 (2,047,006) 3.46 2,133 101.09 23.97 
Liberia  50.23 (3,092,721) 3.12 1,036 47.20 41.49 
Madagascar  477.47 (17,357,913) 5.09 6,857 37.64 394.44 
Malawi  363.94 (12,472,794) 5.63 12,776 31.27 300.65 
Mali  89.30 (12,772,264) 1.67 2,083 70.47 73.77 
Mauritania  53.27 (2,964,526) 3.64 948 47.91 44.01 
Mauritius  141.64 (1,233,386) 14.76 1,664 478.18 72.34 
Mozambique  305.05 (20,246,287) 3.14 11,325 36.82 252 
Namibia  75.73 (2,043,339) 7.68 1,727 469.48 60.58 
Niger  293.93 (12546945) 4.15 5,333 38.54 242.82 
Nigeria  3,165.31 (136,399,438) 4.83 88,681 129.17 2,532.25 
Réunion  95.03 (-) 16.01 - - 76.02 
Rwanda  131.21 (9009655) 3.12 3,220 82.32 108.39 
Sao Tome & Principe 3.75(150,311) 5.54 51 162 3 
Senegal  160.11 (10,581,316) 3.26 2,430 109.52 132.27 
Seychelles  5.56 (82,500) 12.13 38 589.33 2.85 
Sierra Leone 73.01 (4,952,134) 3.07 2,300 82.80 60.31 
Somalia  172.25 (8,170,899) 3.87 3,567 20.03 142.30 
South Africa 1,978.25 (46,664,771) 7.04 63,061 695.05 1,582.60 
Sudan  1,824.67 (30,101,696) 9.12 29.966 150.50 1,016.98 
Swaziland  14.20 (1,016,094) 3.07 856 246.31 11.36 
Tanzania  492.95(37,786,946) 2.81 15,156 40.26 407.22 
Togo  140.13 (5,288,273) 5.21 2,583 62,88 115.76 
Uganda  319.73(27,521,632) 2.85 11,296 83.61 264.13 
Western Sahara 18.47 ( - ) 5.08 - - 15.28 
Zambia 268 (11,192,422) 5.13 10,535 124.96 221.39 
Zimbabwe  568.68 (12,597,877) 9.75 29,987 55.58 468.79 





As indicated above, there is a paucity of data on the prevalence of diabetes in African children, 
but there is evidence that it is an important medical problem in most African countries. For 
instance, Elamin and colleagues in Sudan reported a survey of nearly 43,000 school going 
children (age 7 to 11 years) and found a prevalence rate of approximately 1 per 1,000 [28]. 
This rate is comparable to a reported prevalence rate of approximately 0.3 per 1,000 in Nigeria 
[29]. The reported incidence was approximately 10 per 100,000 children per year in Sudan [28] 
and approximately 2 per 100,000 per year in Tanzania [30]. Other studies indicate that the age 
of onset in South Africa and Ethiopia was later than elsewhere [31-32] and the peak age of 
onset of type 1 diabetes in Sub-Saharan Africa was a decade later than in the West [29-31]. 
Ethnic differences in the peak age of onset have also been reported in some African countries. 
For instance, in South Africa it has been reported that the peak age of onset was about 13 years 
in the white South Africans (similar to Europeans) but about 23 years in the black South 
Africans [31]. In addition it affects more girls than boys [31]. 
 
Although little is documented on the prevalence of type 2 diabetes in children, it is believed to 
be increasing in African children [17]. A few African studies that include adolescents reviewed 
in a systematic review gave insight into the prevalence of T2DM in African adolescents [21]. 
The prevalence in the general population of T2DM (i.e. both adolescents and adults) as 
recorded in these studies ranges from approximately 6.06 in Cameron, 4% in Kenya, 3% in 
Nigeria, 4% in South Africa, 7% in Tanzania and 1% in Uganda as indicated in cross sectional 
surveys of children and adults in sub-Saharan Africa from 1999 – 2011[21]. The exact figures 






These figures combined suggest that diabetes mellitus is a huge medical problem in Africa 
which needs attention and more research focusing on its prevalence, incidence, demographics 
and clinical characteristics especially in SSA where there is a dearth of proper and valid records 
of the disease epidemiological data.  
 
Consequences and risks of diabetes in children 
The consequences and risks associated with diabetes in children can be categorized into acute 
and chronic complications. 
 
Acute Complications 
In Sub-Saharan Africa, diabetes ketoacidosis (DKA), hyperosmolar non-ketotic coma and 
hypoglycemia are acute conditions that have been reported. DKA has been found in the range 
of 7 - 80% in newly diagnosed patients and 25 - 90% in children who have already been 
diagnosed with diabetes [25]. Mbanya and Ramiaya reported that diabetes ketoacidosis in 
patients ranges from 25% in Tanzania to 33% in Kenya per year and that it is the most common 
diabetes emergency which carries high mortality [3]. Though little is known about the mortality 
associated with hypoglycemia, it is one of the leading reasons for hospitalization of children 
with diabetes. For instance, a study in South Africa with 43 patients that were admitted at 
Baragwanath Hospital in Soweto, a total of 51 episodes of hypoglycemia in a 5 months period 
were recorded [33]. Hypoglycemia has been observed to range between 25 - 55% in Sub-
Saharan African diabetes patients [25]. The other complication associated with diabetes is 
hyperosmolar nonketotic coma which has been reported to be associated with T1DM and less 







As early as pre-pubertal age, most Sub-Saharan African children with diabetes will have 
developed chronic complications of diabetes [25]. According to Dowshen, people with diabetes 
have a greater risk of developing eye problems including cataracts, retinopathy and glaucoma 
[34]. A multi-ethnic cohort study indicated that Africans are 55% more at risk than Indians and 
Caucasians of retinopathy [35]. In Sub-Saharan African children retinopathy prevalence ranges 
from 10-30% [25]. It was estimated that by 2010, 4,510 people in Africa with diabetes had eye 
complications and a number of 423,500 were blind due to diabetes complications [18].  
 
Diabetes nephropathy is also common among those diagnosed with diabetes accounting for 
approximately 2,230,000 people needing dialysis because of kidney problems in Africa [18]. 
The prevalence rate of nephropathy ranges between 14-33% in children [25]. Another 
complication that people with long time diabetes may develop is diabetic neuropathy [34]. 
People with diabetes are also prone to develop cardiovascular diseases with problems such as 
heart attack, stroke and blockages of blood vessels. It is estimated that 907,500 people have 
cardiovascular diseases in SSA [18] although heart attacks, strokes, blockages of blood vessels 
are more likely to be experienced by adults with diabetes [34]. People with diabetes are also 
susceptible to gum disease (dental problems) and foot problem. About 169,400 people with 
diabetes have lost a foot because of amputation [18] and foot ulcer is a major cause of hospital 
admission and bed use for diabetes in some countries for example Cameroon [36]. Diabetes 
can also cause poor growth among children [25]. Overall, it is important to note that diabetes 
comes in different types with the effects, infection rates and disease development varying from 







There is growing evidence indicating that children with diabetes mellitus compared to control 
subjects are at risk of developing neuro-cognitive difficulties [37]. Children with diabetes are 
at risk of neuro-cognitive problems given the vulnerability of the young brain to hypoglycemia 
and hyperglycemia [38]. Using magnetoencephalography (MEG) to assess functional brain 
connectivity in T1DM patients, compared with sex and education matched with T1DM and 
control subjects, T1DM had decreased functional connectivity [39]. There was also a positive 
relationship between cognitive functioning and functioning connectivity. Specific cognitive 
domains that are affected in children with T1DM include: slowed information processing, 
psychomotor efficiency, attention, memory, learning, problem solving, motor speed, 
vocabulary, general intelligence, visuoconstruction, somatosensory examination, motor 
strength, mental flexibility and executive function. In T2DM, cognitive domains affected by 
diabetes include; verbal memory, visual retention, working memory, immediate recall, delayed 
recall, psychomotor speed, executive function, processing speed, complex motor function, 
verbal fluency and attention [40]. 
 
Meta-analytic studies show moderate to high effects of diabetes on most of these domains in 
children. For instance, children with T1DM have been found to perform significantly worse on 
tasks assessing visual spatial abilities, motor speed and writing, sustained attention and writing 
[38] and slightly low performance (d = -0.13) in overall cognitive domains, except learning 
and memory [37, 41]. Although other studies have shown that children with diabetes perform 






The risks of developing cognitive difficulties have been linked to early illness onset and illness 
duration, recurrent hypoglycemic episodes and hypoglycemia [38]. Elsewhere, they have been 
associated with the presence of microvasular complications and not with the occurrence of 
severe hypoglycemic episodes or metabolic control [41]. The risks associated with cognitive 
difficulties have been shown graphically in Figure 2. 
 









Source: Kodl & Seaguist, 2008 (reprinted with permission) 
Psychosocial Risks 
Some psychosocial issues in children with diabetes have been found to be associated with the 
diagnosis of diabetes. For instance, children with diabetes have often shown adjustment 
problems at the onset of diagnosis after the “honeymoon” period has finished [43-44]. Diabetes 
can also interfere with the daily routine and participation in activities children previously 
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enjoyed doing following diagnosis. The notion of having a life threatening illness, complex 
care and management of diabetes is daunting and can be also a source of stress and depression 
[45]. The worst part is that high levels of stress in children have been associated with poor 
glycemic control and that prolonged problems with psychosocial adjustments affect diabetes 
management in early childhood [43]. Immediately following diagnosis, children report mild 
depression and anxiety, which fluctuates over the years between boys and girls [44]. In a recent 
systematic review, it was not clear that depression was high among adolescents with T1DM 
compared with control, although there was evidence of the association between depression and 
worse glycated hemoglobin (HbA1C) level and other health outcomes [46]. People with 
impaired glucose metabolism (IGM) or undiagnosed type 2 diabetes are not at increased risk 
for depression compared with the general population with normal glucose metabolism [47]. 
However, when compared with T2DM, individuals with IGM have a significantly lower risk 
of having depressive symptoms. 
 
A systematic review with studies mainly from the USA and Western Europe showed that there 
are minimal differences in quality of life (QoL) between children and adolescents with T1DM 
and the health controls [48]. However, there are indications that boys report better generic QoL 
than girls and also that older children report better generic QoL than younger children. 
 
Co-Morbidity 
Co-morbidity is becoming common in an already disease inflicted population, more and more 
people now have more than one disease in SSA [49-50]. For instance, a study in Ghana found 
that 46% of patients with type 2 diabetes mellitus also had a plasmodium falciparum (malaria) 





seropositive with the HIV virus, 35 out of 475 had had stroke, 46% reported foot numbness 
and 25% had sight threatening eye diseases in type 2 patients in Ghana [52-53]. Psychosocial 
issues such as depression and stress are also common in children and adults with diabetes [54-
55]. The burden of having to manage this disease, the knowledge that the illness is chronic and 
the potential for the illness to disrupt normal childhood activities could certainly pose 




There have been relatively few structured mortality studies in Africa, making quantification of 
outcome difficult [3]. However, it is estimated that a child in Sub-Saharan Africa that is newly 
diagnosed with type 1 diabetes has a short life expectancy (on average less than 5 year if not 
properly treated), and it is projected that diabetes deaths will increase by over 80% in upper-
middle income countries between 2006 and 2015 [57]. The high death rate, especially among 
children is often due to a lack of diagnosis or misdiagnosis and the non-availability of insulin 
because of high prices [16]. Evidence shows that more than twice as many deaths occur in 
females with diabetes than males [24]. A study in Mali which followed up 20 children with 
T1DM for 8 years showed that half of the children had deceased after 8 years [16]. In Tanzania, 
for the period 1981-1987 the five year survival rates (95% confidence intervals) for patients 
with diabetes requiring and not requiring insulin therapy were 71% (62% to 80%) and 84% 
(80% to 89%) respectively for known deaths and 60% (51% to 69%) and 82% (77% to 86%) 
respectively for known plus probable deaths 49 (3.9%) [58-59]. 2012 data by IDF indicate that 
the number of diabetes related deaths in populated countries like Nigeria was approximately 





approximately 29,966 and Ethiopia approximately 23,869 [24]. Other countries like Kenya 
recorded approximately 17,733, Congo DR approximately 16, 355, Tanzania approximately 
15,156, Cameroon approximately 14,588, Mozambique approximately 11,325 and Zambia 
approximately 10,535 deaths [24]. Table 1 indicates diabetes related deaths in SSA.  
 
Socioeconomic burden 
Sub-Saharan African countries have the lowest per capita income compared to the rest of the 
continent and chronic conditions engender increasingly serious economic and social 
consequences in the region and threaten health care resources [50]. Diabetes not only has life-
long costs of treatment and care but also has negative effects on the productivity of an already 
financially threatened population. The economic burdens are related to health care costs 
incurred by society in managing the disease, indirect costs resulting from productivity losses 
due to patient disability and premature mortality, time spent by family members accompanying 
patients when seeking health care and intangible costs [60]. At the time of the analysis, the 
grand total indirect cost was about US$ 8.1 billion (32%) in WHO African countries that is 
US$ 1,154.15 per diabetes patient. In East African patients, the annual cost for care was $ 229, 
of which two third was for purchase of insulin as of 2005 [61]. In Khartoum, Sudan, of the total 
family expenditure on health, 65% was used for the child with diabetes [62]. It is estimated that 
the direct cost of treating diabetes in the year 2000 ranged from US$ 2302 to US$ 3207 per 
person [21], in a continent with the per capita for expenditure on health in the same year pegged 
at US$ 86 [64]. About 7.02 million cases of diabetes recorded by African countries in the year 
2000 resulted in a total economic loss of US$ 25.51 billion that is US$ 3633 per patient with 





picture of the expenditure on diabetes as estimated by IDF in 2012 [27] can be seen in Table 
1. 
 
Challenges in care and treatment 
More than three quarter of a century after the discovery of insulin in 1922, insulin is still not 
available on an uninterrupted basis in many parts of Africa as indicated in a survey by Beran, 
Yudkin and de Courten [63]. Of course there are variations from country to country or from, 
urban setting to rural setting. Insulin is generally available in urban health settings. For 
instance, in Zambia the differences are due to diagnostic infrastructure, distance to health 
facilities and insulin selling points and difficulties are often faced by those living in rural areas 
across the provinces [26]. 
 
The other problem that hampers adequate health care for children with diabetes is lack of 
adequately trained health personal in SSA health care systems. The World Health Organization 
indicated that there were 2 physicians per 10,000 person in Africa [64]. Even when health care 
personnel were available, they often lacked knowledge on how to diagnose and treat chronic 
illnesses such as diabetes [61]. In Zambia, there was no qualified diabetologist for children at 
the time of the inquiry, care and treatment was received from pediatricians who had interest or 
had been assigned to attend to diabetes cases. The situation is not very different in many SSA 
countries. This explains why most children with diabetes in Africa are undiagnosed. Table 1 
indicates cases of people with undiagnosed diabetes in Africa. 
 
The prevailing situation regarding high tech medical products and equipment is poor, for 
instance there were 9 hospital beds per 10,000 population in Africa as of 2000-2009 [64]. 





access health services and advance health knowledge through research and development [64]. 
Even the number of published studies on diabetes in Sub-Saharan Africa leave more to be 
desired, at 84 as of 2010 [65]. 
There are also problems with access to medical instruments and materials such as syringes in 
most Sub-Saharan African countries. A survey in Mozambique and Zambia found that patients 
in rural areas had the most difficulties in accessing syringes while in urban areas there were 
problems with quantification of syringes and trips, which were often in short supply [61]. 
Furthermore, only the wealthy patients possessed their own glucometers and the majority poor 
of children relied on their blood sugar being monitored once in a while for free in public 
hospitals [61]. In some cases, public health facilities did not have medical essentials for caring 
and treating patients. For instance, only 6% of health centers in Mozambique had facilities for 
blood glucose testing compared with 25% in Zambia [61]. Countries like Zambia have not even 
decentralized treatment and care in small and medium sized health facilities, making children 
travel long, costly and laborious distances to major central hospitals. 
 
In most Sub-Saharan African countries, diagnosis is a problem hence a large number of 
undiagnosed diabetes patients in Africa as already indicated above. Knowledge and familiarity 
of diabetes symptom presentation are the major reasons for problems with diagnosis. Health 
workers in countries like Zambia and Mozambique rarely encounter patients with diabetes and 
because of this lack of familiarity and tools for proper diagnosis; as a consequence, many 
patients are missed or misdiagnosed with cerebral malaria or HIV and AIDS [61]. In Sub-
Saharan African countries, most of the children who suffer from type 1 diabetes are actually 






The increase in the levels of obesity poses another challenge to children and adolescents with 
diabetes. Regulating and managing weight is a challenge in adolescents especially that body 
fat and body mass index (BMI) have been shown to be linked to insulin resistance in Western 
adolescents [66]. Being overweight and obese is increasingly challenging health practitioners 
more so that being thin in the African context is associated with poverty. As such, it is 
prestigious to be fat because it is seen as being attractive and a sign of wealthy [16]. In some 
countries like Mauritania, girls are forced to eat and become fat so as to be attractive and attract 
more bridal price. Linked to this, is the difficulties of a suitable diet in most SSA children with 
diabetes. In most African countries, establishing a suitable diet is problematic due to cost of 
food, family size and seasonal availability of food [16]. Misconceptions about diet and low 
levels of understanding regarding insulin use is a challenge and leads to poor diabetes 
management and frequent complications [61]. 
 
Role of Traditional Healers 
Another challenge is the role of traditional medicine and beliefs when it comes to treatment 
and care for diabetes in African children. There are many problems linked with the use of 
traditional medicine in chronic diseases like diabetes [16]. Some traditional healers claim that 
they can cure diabetes. This has dangerous and perverse effects on attracting a great number of 
patients who have been told by modern medicine that they will live with diabetes for the rest 
of their life. People have faith in them and they are very accessible to the extent that patients 
shun modern medicine. WHO estimated that in Africa more than 80% of the population consult 
traditional healers [67]. Associated with this, are certain beliefs of parents and girls who have 
diabetes: many hold the opinion that living with the diseases affects child bearing which is 





between 2006 and 2011 showed that there were 4717 macrosomic and 187 117 normal birth 
weight out of 219780 newborns who were analyzed. In this study, macrosomia was defined as 
a birth weight of 4000 grams or more and normal birth weight as 2500–3999 grams. The 
strongest predictors of macrosomia were high BMI (adjusted odds ratio [AOR] = 2.88; 95% 
confidence interval [CI] 1.95–4.24), prior macrosomic newborn (AOR, 7.60; 95% CI, 6.81–
8.49), and history of diabetes (AOR = 3.09; 95% CI 1.36–6.98). Macrosomic newborns were 
at increased risk for cesarean delivery (AOR = 1.63; 95% CI 1.35–1.96), fresh still-birth (AOR 
= 2.24; 95% CI 1.56–3.21), Apgar score of under 7 at 5 minutes (AOR = 2.03; 95% CI 1.33–
3.11), and neonatal intensive care admission (AOR = 2.07; 95% CI 1.32–3.23) [77]. Although 
studies have documented the relationship between maternal glucose levels and macrosomic 
babies or congenital malformation, if glucose levels are well managed macrosomia and other 
birth defects can be prevented [68-69]. As such, claims from traditional healers sometimes give 
hope to patients with such beliefs. 
 
Education on diabetes is also limited among children with diabetes in SSA. In SSA, 
consultation times are short, resulting in little or no time for patient education and mental health 
care [3]. Knowledge on prevention, care and how to stay health is critical for children with 
diabetes, however, lack of resources for education programs, skilled manpower and adequate 
consultation times are all bottlenecks to diabetes education activities in SSA. 
 
Implications 
To begin with, there is a need for epidemiological studies on children with diabetes in SSA. 
Lack of such studies thwarts knowledge on the extent, characteristics and nature of diabetes in 





diabetes in order to prevent the occurrence of acute and chronic complications of diabetes in 
future. This will need increasing funding to non-communicable diseases, training skilled 
manpower, adequate medical essentials and equipment and developing policies that support 
these issues. 
There is also need for dialogue and partnership with the private sector to make treatment and 
care for children with diabetes accessible and affordable. This is important especially in 
countries were the private sector plays a crucial role in the health system. For instance, Beran, 
Yudkin and de Couten found that the private sector (private wholesalers) in Zambia sold insulin 
85-125% more expensive than in the public sector [61]. This is a situation also true for syringes 
and glucometers in most SSA countries. Therefore, involving different stakeholders in health 
care can improve health service delivery for children in Africa. 
 
Santé Diabète suggests working in partnership with traditional healers regarding the 
management of chronic diseases by getting them to collaborate in a healthy and active way 
[16]. One way of doing this is to pass a set of ideas about diabetes, its complications and 
treatment. By doing so, traditional healers all over Africa could become useful partners for 
diabetes education and advocacy since they are already involved in diabetes management 
although using methods not recommended. 
 
The American Diabetes Association (ADA) recommends that ultimately every child newly 
diagnosed with diabetes mellitus should be evaluated by a diabetes team consisting of a 
pediatric endocrinologist, a nurse educator, a dietitian and a mental health professional 
qualified to provide up to date pediatric-specific education care and support [44]. The 





in most Sub-Saharan African countries [70]. Linked to this is the need for SSA countries to 
develop comprehensive care programs integrating both physical and psychosocial needs, 
families and schools in the care and management processes of diabetes as well as understanding 
the period of childhood especially physical development and the increased sense of autonomy 
and independence in young people. Further, because family diabetes-related behavior patterns 
have been documented to affect glycemic control, there is a need to assess both the risk factors 
and the strength of the child and family at the time of diagnosis, with the hope of intervening 
[44]. This proposition may not suffice in most SSA countries given the struggle to meet priority 
needs by patients and governments. SSA countries could look for relative cheap but effective 
ways to meet the psychosocial needs of children with diabetes. In addition, guided by Maslow's 
need model, children should have insulin, good housing and healthy diet in order to optimize 
their psychosocial needs [71]. This is not to say that the later needs are not important, but this 
proposition makes sense given the prevailing situation in most African contexts. 
 
Prevention programs 
We recommend investing in diabetes prevention programs is essential. Lifestyle interventions 
have been documented to prevent or delay onset of diabetes in individuals with impaired 
glucose tolerance (IGT). A community healthy lifestyles intervention in a high-risk indigenous 
Maori rural community of New Zealand showed a 10% decrease in insulin resistance 
prevalence and associated changes in a group who actively participated in a lifestyle 
intervention [72]. In the USA, a lifestyle intervention to 1,079 participants significantly 
resulted in a 58% reduction in the incidence of diabetes [73] and a systematic review showed 







Studies have demonstrated the efficacy of using text messaging via cell phone in diabetes 
patients. For instance, patient confidence in diabetes management significantly improved using 
their text messaging based diabetes program in an African American population [75]. 68% of 
African population was expected to have a mobile phone within 5 years [76] at the time of the 
review. For example in 2014, the Zambia Information and Communication Technology 
Authority (ZICTA) reported that there were 10.1 million mobile phone subscribers in Zambia 
out of the approximately 14 million population [78]. Moreover, most mobile phone service 
providers in Zambia have a portal on their sim card which contain health tips, entertainment, 
sport etc. Therefore diabetes specific education can be delivered through such portal or dial 
free numbers.  A successful example of the use of mobile phones in the health sector is a study 
in Southern province of Zambia on early infant diagnosis of HIV infection through mobile 
phone texting of blood test results which showed that the mean turnaround time for delivery of 
test results to relevant health facilities from test laboratories fell from 44.2 days at pre-
implementation to 26.7 days at post implementation [79].Therefore, opportunities like this one 
must be utilized by the health care system. 
 
In summary, there seem to be an increase in the incidence of diabetes in SSA and comorbid 
psychosocial problems including depression, anxiety and distress among others among 
individuals with diabetes are reported. Although there is abundant evidence in developed 
nations, little is known about the psychosocial issues affecting children with diabetes in SSA 
and Zambia. Therefore, more studies on psychosocial problems affecting children with diabetes 
in SSA are needed. As established earlier, data on diabetes in Zambia is scarce. Therefore, this 





not only in Zambia but also in Sub-Saharan Africa. The comparison assumes some degree of 
equivalence on socioeconomic status across Sub Saharan Africa. Although socioeconomic and 
cultural factors are not exactly the same in Africa, cross–cultural validation may be the only 
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Aim: Psychosocial problems are common in patients living with diabetes. However, data 
on psychosocial issues affecting patients with diabetes in Zambia are scarce. The present 
study explored sources of stress, stress coping strategies, stigma and perceived quality of 
life and care as experienced by adolescents living with Type 1 Diabetes in Zambia. 
Methods: Semi-structured interviews were carried out. Three groups of participants 
involving adolescents with Type 1 Diabetes (n=10), caregivers (n=8) and health 
practitioners (n=4) were interviewed. Transcripts were analyzed using a thematic 
approach.  
Results: Stress was commonly reported by adolescents mainly stemming from social, 
psychological and physical sources. To deal with stress, adolescents often employed 
different coping strategies such as adapting, accepting and avoiding among others. Both 
internal factors (those relating to the patients themselves) and external factors (those 
related to the context of the patients’) influenced the patients’ quality of health care. In 
addition, low quality of life was an issue among adolescents and their families. Poor diet, 
low socioeconomic status and lack of medicine were factors affecting quality of health 
care. 
Conclusion: Stress was an issue affecting adolescents; the coping strategies employed 
were sometimes maladaptive such as avoiding injecting themselves to escape stress. 
Several aspects of quality of life were suboptimal in both adolescents and their families, 
such as stigmatization, short life expectancy, low socioeconomic status and poor social 
participation. Findings show that there is an urgent need for a strong response from all 
stakeholders (governments, patients, organizations and companies) to improve diabetes 







Diabetes is one of the leading causes of mortality and disability around the world. The most 
common complications of diabetes that lead to mortality and disability include cardiovascular 
diseases, neuropathy, nephropathy, retinopathy and foot ulcers [1]. It is also common to find 
co-morbid problems among diabetes patients such as depression [2], hypertension [3], HIV and 
AIDS [4] and malaria especially in developing countries. To prevent acute and chronic 
complications of diabetes, treatment and care must be optimized by patients with diabetes and 
their health care team, for example by achieving and/or maintaining a good level of glycemic 
control. 
 
Constantly seeking treatment and engaging in everyday self-care activities such as frequent 
glucose monitoring, following a meal plan and correctly preparing or remembering to take 
insulin or oral medications at the right times can be a source of diabetes-specific emotional 
stress and can be difficult to follow a regime in times of stress for people with diabetes [5]. 
Stress refers to a physiological or a psychological response to external stimuli or to stressful 
events themselves which can be negative or positive or both [5]. Common signs of stress in 
patients include changes in sleep patterns, changes in appetite, anxious thoughts and irritability 
[6]. General emotional stress can affect the blood glucose levels and glycemic control and 
interfere with the ability to self-manage diabetes. Moreover, it has been found to be associated 
with poor quality of life [5, 7]. Stressful experiences influence diabetes control not only 
because of the devastating effect on poor blood glucose control but also because of the 
association between high blood glucose levels and the development of diabetes related 
complications [5, 8]. For example, in prospective studies involving individuals with type 1 





[9]. In addition to the physiological influence that stress has on glycemia, stress interferes with 
the ability to self-manage diabetes such as monitoring glucose frequently, following a meal 
plan and correctly preparing or remembering to take insulin or oral medication at the right time 
[5]. In adolescents with Type 1 diabetes specifically, research shows that stress stems from the 
need to manage a complex medical condition that requires daily completion of multiple self-
care behaviors, the impact of diabetes on social interactions with family members, peers and 
teachers as well as the interference of symptoms such as hypoglycemia with daily activities 
[10]. The observed effect of stress on individuals with diabetes shows great intra-individual 
and inter-individual variance depending on situational factors, type and amount of stress, 
personal characteristics and coping strategies [11]. The few African studies that have been 
conducted suggest that there is a link between stress and development of diabetes. In Kenya 
for example, patients linked diabetes to stress caused by disharmony and conflicts within the 
family and strong emotions due to shock [12]. In South Africa, children with diabetes were 
found to have experienced more frequent stressful events compared to control children [13]. 
 
Chronic stress is an important risk factor for depression and depressed persons with diabetes 
have considerably lower Quality of Life (QoL) [14]. Most of the studies in this area have been 
conducted in Western countries, African data are still scarce. For instance, in Zambia at 
baseline, mean values of QoL was significantly lower in adolescents with diabetes compared 
to healthy controls (19 vs. 22) [15]. In a Nigerian sample of 251 patients with diabetes, poor 
QoL was associated with diabetes-related physical complications, lower education status and 
having type 2 diabetes [16]. In Sub-Saharan countries, low QoL is exacerbated by 
inaccessibility of medical care and the relatively high costs of insulin, a lack of medical tools 





increased risk of misdiagnosis and failure to detect diabetes [17]. Given the above background, 
in the present study we explored sources of stress, ways of coping with stress, perceived quality 
of care and life as experienced by Zambian adolescents living with type 1 diabetes (T1D) from 
the viewpoints of the adolescents themselves, their caregivers and their health care providers. 
Specific objectives were to explore: 
1. The adolescents’ sources of stress and the coping strategies that they used to deal with 
stress;  
2. The perceived quality of health care and barriers to quality care for the adolescents; 





Zambia is located in the southern part of Africa with an estimated population of 13,000,000 
inhabitants. Zambia is categorized as a lower middle income nation [18]. Lusaka is the biggest 
city in Zambia with 1,742,979 inhabitants [19]. 
Study site 
The study was conducted at the Diabetes Clinic within the Pediatric Department of the 
University Teaching Hospital (UTH), the main referral hospital in Lusaka city. The Diabetes 
clinic provides services to approximately 109 diabetes patients (age range: newborns to 17 year 
olds). The services offered to them include medical reviews and examinations, such as blood 
glucose and ketone testing, treatment and disease management plans, diabetes education and 







Sampling procedure and sample size determination  
Participants (adolescents, guardians of adolescents and health providers of adolescents with 
diabetes) were recruited using a purposive sampling method from the University Teaching 
Hospital in Lusaka. Adolescents with diabetes had to be aged between 12 and 18 years and 
currently using insulin therapy to meet inclusion criteria. Adolescents were included in the 
study because they were key informants on their experience living with diabetes. Guardians 
had to be primary caregivers (guardian here means anyone responsible of taking care of the 
adolescent). It was important to include guardians because they had first-hand experience living 
with an adolescent with diabetes while health care practitioners had to work at the diabetes 
clinic to be involved in the study. Health care practitioners were included because they 
interacted with adolescents during clinical care; hence their views on experiences of 
adolescents with diabetes were valuable. 25 participants were approached but three (1 female 
guardian and an adolescent girl and 1 male guardian) declined to participate in the study. The 
final sample size was 22, comprising 10 adolescents with T1D, 8 guardians of adolescents with 
T1D and 4 health care practitioners (Table 1). We were able to reach interview data saturation 
from our adolescents’ interviews3. However, because only a few guardians accompanied the 
adolescents during medical appointments we did not reach data saturation in the guardians; 
time and cost could not allow us to follow them up in their respective homes. Further, given a 
small number of health care providers who routinely attend to adolescents with diabetes, we 
interviewed all we could identify at the time of the study.  
 
 
                                                          






Table 1. Demographic characteristics of informants 
Adolescents with Type 1 diabetes  N      % 
Sex  Males     2      20 
 Females     8      80 
Age  
 12-15 years (1 each)   4      40 
 16 years    3      30 
 17 years    3      30 
Mean Age 15.3 years 
Grade Grade 6    2      20 
 Grade 8    2      20 
 Grade 9    2      20 
 Grade 10    2      20 
 Grade 11-12    2      20 
Duration on insulin 
 1 years     1      10 
 2 years     2      20 
 3 years     3      30 
 5-6 years (1 each)   2      20 
 7 years     2      20 
Lives with 
 Biological parents   8      80 
 Sibling (sister)   1      10 
 Grandparent(s)   1      10 
Guardians     N       % 
Sex  
 Male(s)    2      25 
 Females    6      75 
Age  30-54 years    8      100 
Mean age 37.3 years 
Number of children keeping 
 2 children    2      25 
 4 children    2                  25 
 5 children    2                25 
 7 children    2                25 
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Data collection 
The current study employed semi-structured interviews, because this qualitative methodology 
is particularly useful when researchers aim to understand the lived experiences, opinions, 
stories and views of the specific respondents on a certain phenomenon [20]. Interviews were 
conducted using open-ended questions. All interviews were held in a quiet place that was most 
convenient to participants and interviews were conducted by the first author (Given Hapunda). 
The majority of interviews were conducted in English and five in either Bemba, Nyanja or 
Tonga (three local Bantu languages). The interviewer is a native Tonga speaker and individual 
multilingualism is common in Zambia. Interviews were audio recorded after permission of the 
participant and notes were also taken by the researcher. Interviews that were in the local 
languages were translated to English and all transcripts were checked by a research assistant 
who was fluent in the three local languages and English. Guiding questions focused on source 
of stress, coping strategies and perceived quality of care and life as experienced by adolescents 
living with T1D. Semi-structured interviews were not piloted but they were discussed with 
health practitioners under the diabetes association for content-related validity (expert validity) 
before data was collected. The interviews lasted between 25 and 40 minutes. 
 
Ethical approval 
The study was approved by the ethics committee of the School of Humanities and Social 
Sciences, University of Zambia (reference number IRB: 00006464, IORG: 005376); all 
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Data analysis 
Audio recorded interviews were transcribed verbatim and translated to English whenever 
applicable and further checked for accuracy. In order to develop the themes and the categories, 
as near as possible to the material, an inductive category process was used [21]. After careful 
and thorough reading and re-reading, the initial coding and categorization of the themes was 
done by the first author and verified by the second author to ensure trustworthiness. Sentences 
or paragraphs related through their content or context were assigned codes and related codes 
were finally categorized as themes in a tally table. This process continued until no new themes 
emerged from the data. Emergent themes were discussed and refined by authors G.H and A.A. 
Data were analyzed manually. 
 
Results 
The study explored: stressors, stress coping strategies, diabetes care, quality of diabetes health 
care and life as experienced by young patients with diabetes in Zambia. Here we present data 
on the main forms of stressors in patients with diabetes which fall under social stressors (e.g., 
discrimination), psychological stressors (e.g., worry about the future) and physical stressors 
(e.g., poverty) and data on ways patients dealt with stressors to include: adapting to the stressor, 
avoiding the stressor, seeking spiritual support and normalizing the condition. Further, factors 
that influenced patients’ perceptions of quality of health care are presented under the headings 
of internal factors (within control of patients) and external factors (outside the control of 
patients). The main issues that affected adolescents’ QoL and their families are presented as 
poor wellbeing, restricted social participation and perceived lack of independence. A thematic 
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Stressors 
About 18% [4/22] of the participants reported that adolescents experienced social stressors. An 
important social stressor in adolescents came from their need not to disclose their diabetes 
condition to others. Many adolescents worked hard to keep their condition a private issue. They 
were also stressed because of the discrimination they faced from others, mainly because peers 
thought diabetes is a communicable disease: 
Sometimes they face segregation, they let them play alone or let them do things alone 
because some of them think that it is communicable and they can get it if they hang out 
with them. Pediatrician  
 
Another factor that contributed to social stress was lack of family support as exemplified by 
some family members pressuring the adolescents to stop injecting themselves insulin: 
In my family, they want me to stop injecting myself with insulin. What they say stresses 
me a lot. They say that injecting myself is damaging my body. Female, grade 9 
 
Psychological stressors were reported by 36% [8/22] participants and involved the feeling that 
the adolescents were different from other peers. Most adolescents were frustrated and 
wondered why they had to do certain things that their peers were not doing, such as carrying 
insulin and injection kits. Adolescents, especially the girls, were also stressed by the fact that 
the use of insulin was contributing to their weight gain but they still had to continue using it: 
Insulin makes them fat and when you look at adolescent particularly if I narrow it to 
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Adolescents were also scared of diabetes related death which became a source of stress 
especially among the boys who thought having diabetes was a death sentence. There was also 
a worry especially among the female guardians and adolescents girls with diabetes that they 
were unwanted by men who think that they cannot bear a child: 
Children with such condition (diabetes) find it difficult to get married and cannot have 
children. Diabetes comes with many complications; so many men will not want to marry such 
a girl. Female guardian 36 years old 
Sometimes I just ask why me? I have friends and most of them have no diabetes. But what I 
hate most is that I cannot take (eat) sweet things (food – authors’ insertion). And I also now 
wonder whether people with diabetes give birth, so I feel stressed. Female grade 10 
 
About 59% [13/22] of participants mentioned that adolescents face physical stressors. Physical 
stressors revolved around self-care activities including dietary limitations that adolescents 
faced because certain food stuffs (e.g., cakes and soft drinks) were not healthy and thus their 
intake was discouraged. In addition to diet restrictions, strict and rigid diabetes self-care was a 
source of stress especially the thought of injecting themselves multiple and painful insulin shots 
per day: 
Some inject themselves two times a day some three times a day. So the thing of injecting 
themselves every time is a stress as well. It brings stress to them whereby you have to be 
thinking about that needle and if you don’t do that anything can happen. Diabetes Peer 
educator 
I become depressed because of injecting myself, you see I have been injecting myself for seven 
years on the same spot but what can I do it’s my life. Most of my stress comes from injecting 
myself. Female, grade 12 
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Adolescents were stressed by the limitations they faced. For example, previously enjoyed 
activities were no longer possible due to the challenges of the danger of severe low blood sugar 
levels or of carrying medical essentials and also the worries of parents that adolescents may be 
unable to take care of themselves outside their parents’ homes. Many adolescents had 
challenges managing their sugar levels and experienced side effects of low or high sugar levels: 
I am stressed if the blood sugar is high I start feeling very sick and sometimes vomiting 
and become tired. I even get slim such that I start looking like I am HIV infected 
(Laughs). Female grade 10 
 
For girls, having infections in their sexual organs (vaginal thrush) as a result of diabetes was 
stressful perhaps because they worried that they may have contracted sexually transmitted 
infections which are rampant among Zambian adolescents: 
Female adolescents often get stressed in the sense that they usually have vaginal thrush 
and that stresses them more because they think how did I get it especially if they do not 
engage in sexual relationships. Pediatrician  
 
In addition, about 27% [6/22] of participants mentioned that adolescents experienced social 
stigmatization from peers and society especially among girls with diabetes who are seemingly 
not wanted for marriage. Social stigmatization was also common during play with peers. 
Adolescents were often excluded from play because others thought the condition was 
communicable: 
Sometimes my friends refuse playing with me, like my cousin used to say that we can’t 
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Coping strategies 
To cope with stress, about 14% [3/22] of participants mentioned that adolescents adapted to 
the situation, especially those that were diagnosed when they were still children, mainly 
because they were accustomed to having diabetes and managing it. Adolescents reframed the 
situation by thinking about their condition in a more positive way so as to get the best out of 
their health conditions. Other adolescents tried to change the situation through attending 
psychosocial support and psycho-education activities: 
It also helps for instance through counselling like psychosocial support and not just 
educating them and giving support to both adolescents and their parents. Diabetes Peer 
Educator 
 
Avoiding the stressor was also mentioned by about 14% [3/22] participants to be a coping 
strategy that adolescents used such as by avoiding injecting themselves insulin or engaging in 
activities that would distract them from stressful thoughts but also make them forget to take 
insulin:  
I have to find what to do. Like when I am at school I have to start playing with my 
friends that way, I stop thinking about those things (stressors – authors’ insertion). 
Female, grade 11 
 
In addition, some adolescents accepted their diabetes by looking at the upside “what does not 
kill you makes you stronger”. Diabetes was looked at as an opportunity for personal growth. 
Seeking spiritual help through prayers was also a common 36% (8/22) strategy adolescents and 
their guardians used to cope with diabetes related stress:  
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Prayers! I pray a lot. Mostly alone but sometimes with my family members. I usually 
go for prayers on Tuesdays, Thursdays, Fridays, Saturdays and Sundays. Male, grade 
8 
For me it is to pray and go to church. You see if you go to church you get a lot of 
encouragement and support and that helps a lot to deal with her situation. Female 
guardian aged 30 
 
Normalizing the situation so that the adolescents did not feel they were alone with their 
condition were other common coping strategies 10/22 (45%) among adolescents: 
We try to integrate them with other peers with diabetes so that they don’t feel they are 
alone in this situation. Once, they see their friends and know that they are also going 
through the same things as them it helps reduce the stress they go through. Pediatrician 
 
Diabetes care and diabetes self-care 
Health care providers and guardians were the only ones who reported (83% [10/12]) that non-
adherence to diabetes self-care activities and keeping diabetes a secret (which hindered help 
and care from others when adolescents were in need) were the main internally driven factors 
that affected the quality of care among adolescents. Non-adherent behaviors included not 
attending clinical appointments at the clinic, not changing site for injecting insulin, taking 
wrong dosages of insulin and avoiding taking insulin: 
Especially the girls when they reach adolescence they do not want to inject themselves 
with insulin in certain parts of the body like shoulder (upper arm - authors’ insertion) 
and thighs because these parts are important to a girl cosmetically but they are also 
good parts for insulin absorption. In addition insulin makes them fat, so they avoid it. 
Nurse in Charge of Diabetes Clinic 
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About 86% [19/22] of the participants also mentioned external factors as major problems for 
diabetes care and self-care. Externally driven factors that were reported to influence the quality 
of diabetes care included diet problems among adolescents because of poor economic 
background and lack of medical commodities which could make some patients stay for days 
without insulin: 
Sometimes I come at the hospital and I find that there is no medicine, insulin, so they 
can be keeping more insulin and other medication. Male, grade 8 
Monitoring of sugar is practically impossible in our environment because when you 
look at a glucometer it is roughly about US$ 47.60 – US$ 65 and that just a one off 
thing because they need also strips which are expensive roughly about US$40 for 50 
strips”. Pediatrician 
 
Quality of care was affected by lack of family support in managing diabetes especially among 
young adolescents and traditional belief that certain herbs could cure diabetes: 
Others have their own beliefs that if you continue taking the medicine like insulin 
worsens the condition so they stop and start giving them (adolescents) herbal medicine. 
Nurse in Charge of Diabetes Clinic 
 
Language limitations also affect quality of care because most Zambian languages have no 
equivalent words for some English diabetes and care-related words. As with many technical 
words, insulin does not feature in standard colloquial English any more than it does in any of 
the Zambian languages making it difficult to explain things: 
There are certain things that you cannot properly explain in a local language for 
instance when you say insulin, this person wants to understand what insulin is. Many 
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times we don’t know the equivalent words in local languages, so language is a barrier. 
Diabetes Peer educator 
 
In addition, lack of trained and specialized manpower to deal with diabetes cases especially 
diagnosing diabetes and delays in referrals. Data also revealed that respondents had the 
impression that diabetes was not yet among the priority diseases for authorities compared to 
malaria, HIV and AIDS. Co-morbid conditions also made it difficult to manage diabetes 
especially for children with malaria or HIV and AIDS. Specifically, adolescents and caregivers 
reported lack of nearby health facilities, expensive and sometimes inaccessible insulin, 
challenges handling medicine and following a recommended diet as some of the factors that 
were affecting quality of care. Others included poverty. Many patients bemoaned lack of 
money to buy food when they had an appointment at the hospital and they had to wait for a 
while before they could receive attention: 
 
The biggest is distance and transport- you see we all have to come here (UTH) because 
in clinics they don’t do reviews. So we all have to come here for reviews and some come 
very far and transport is very expensive. But also transport money and money for food. 
Especially if I am here and I am hungry I need money to buy the food, I was told to be 
eating but I cannot get money here. Grade 8 male 
 
The medicine that we receive requires that we keep it in the fridge but when I am at the 
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How diabetes affects adolescents’ QoL and their families 
Diabetes was regarded as being associated with a shorter life expectancy due to various external 
factors including poor health care system, socioeconomic circumstances, lifestyle choices and 
unavailability of certain medical essentials: 
So really when you talk about an African child with diabetes the life span is quite short 
because of the health care system and the availability of the critical things that they 
need to survive on that is the insulin. And also the commodities, the needles, the 
syringes are unavailable sometimes. Pediatrician 
 
Other factors included poor socioeconomic circumstances (86% [19/22]), which hamper the 
use of advanced technologies to manage diabetes. Co-morbidity (14% [3/22]), emotional (32% 
[7/22]), cognitive (18% [4/22]) and physical health problems (14% [3/22]) were also issues 
that affected the QoL of adolescents and their families: 
My mother gets very emotional like she even cries and sometimes she tells me, “If I 
could take it away from you I would have done it”. But also sometimes when I am at 
school, I lose concentration and many times I can’t see properly on the blackboard. 
Female grade 12  
 
The fact that having diabetes limited adolescents’ participation in social activities because their 
movements were restricted was mentioned by about 18% (4/22) as affecting their QoL. Many 
reported that they were expected not to stay away from their guardians’ homes for a long period 
of time in order for them to be monitored by adults: 
Sometimes if I want to do something or go somewhere they tell me, you have diabetes 
you don’t have to go somewhere, because one time I collapsed while at school because 
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of hypoglycemic episodes and in the past I used to play with my friends for a long time, 
but now within a short period of time I have to go and eat. Male in grade 8 
 
Adolescents’ sense of independence was mentioned by about 27% [6/22] as it seemed to have 
been adversely affected because of their condition. Many adolescents felt their guardians were 
constantly monitoring them. In addition, adolescents were worried about adjusting in their 
future roles without interference from others especially when experiencing hypoglycemia. This 
theme was mentioned about 55% [12/22] by our participants: 
My parents now have to monitor me and constantly ask me if I have injected or eaten. 
I feel bad. Female, grade 10 
 
Discussion 
This study explored sources of stress, ways of coping with stress, perceived quality of care and 
life of Zambian adolescents living with T1D. To the best of our knowledge, this is the first 
qualitative study in Zambia to explore this subject providing views from all these three key 
stakeholders (adolescents, caregivers and health professionals). 
 
Having diabetes was regarded and experienced as an important source of stress in the present 
sample. Lack of support from family and others was reported to exacerbate stress in children 
and adolescents as they still depend on adults. The adolescents reported multiple sources of 
stress. There is not only an urgent need to help lower the stress levels experienced by 
adolescents, but also a strong need to educate family members. It was for example shocking to 
note that a family member gave potentially life endangering advice to a young person with 
T1D to stop injecting herself with insulin. Families can play a powerful role in the treatment 
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of chronic illness not only by offering instrumental support but also by providing unconditional 
support and the opportunity for expression of emotions [22]. Evidence has shown that family 
functioning and stronger support are related to more optimal metabolic control in T1D [23]. 
Interventions involving joint sessions between adolescents and significant family members 
should be encouraged so that health care providers can give useful information about diabetes 
and also about the danger of certain traditional healing practices. They can also teach adequate 
skills that empower families in the process of not only adapting to the situation but also helping 
the adolescent manage the blood glucose levels and thus live a more fulfilling life with diabetes. 
However, family and other instrumental support systems are by far not enough; other sources 
of stress should be resolved through improving treatment and care, by increasing access to 
insulin, glucometers, strips and other basic medical essentials for patients with diabetes. 
 
The adolescents in the present study used three main coping strategies: 1. “adapting”, for 
example by accepting that one has diabetes. This coping style seemed more common in those 
who were diagnosed when they were still young; 2. “Normalizing”, such as assuring the 
adolescent patients they are not the only ones with diabetes; 3. “Avoiding” such as avoiding 
insulin injections or avoiding to talk about having diabetes. However, some of these strategies 
(notably avoidance) are not helpful and effective at least for long-term benefits; avoiding and 
engaging in distracting activities are short term strategies since most of the patients still come 
back to confront the stressor. In a Taiwanese sample of adolescents with T1D, avoidance was 
used when faced with unpleasant situations like increased inquisitiveness from peers about 
their conditions, leading to stopping self-management related behaviors in order to minimize 
attention from others [24]. Research shows that young patients with poor glycemic control are 
more likely to be stressed when they use maladaptive coping strategies [25]. The use of 
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maladaptive coping strategies such as avoiding insulin injections is likely to exacerbate 
condition. Therefore, adolescents must be taught skills that are more adaptive such as 
improving self-care skills and healthy lifestyles coupled with positively interpreting their 
situations, doing something about the source of stress and accepting their health circumstances. 
Almost a decade since the publication of a case study by Beran and colleagues [26] diabetes 
health care in Zambia is still suboptimal. Patients still have difficulties acquiring insulin 
because of high costs and sometimes erratic availability. A study by the International Insulin 
Foundation in 2006 found that patients could only access insulin 26-49% of the time. Today 
the situation has not improved much according to the perceptions of adolescents, guardians and 
health care providers. The syringes used to cost between $0.01-$1.50 [27] but now only the 
patients in urban bigger hospitals are given free syringes whenever available, because 
sometimes the hospitals do run out of these commodities, whereas patients in rural areas still 
need to buy syringes. However, these commodities are not always available in hospitals and 
some patients stay for days without such medical essentials. Testing costs for outpatients used 
to be as high as $51.60 a month [26], now at least in urban big hospital testing is free because 
many patients cannot afford to buy their own glucometers. Patients still have problems 
accessing health care facilities because local clinics do not offer specialized diabetes care due 
to lack of adequate trained health care providers, leading to increased risk of misdiagnosis and 
late detection of diabetes. However, the Ministry of Health in Zambia now recognizes non-
communicable diseases (NCD) as increasingly common conditions in the country and have 
since developed a strategic plan regarding NCD including diabetes. The NCD program has 
since embarked on a number of interventions for the prevention and early detection of NCDs. 
These include; the development of treatment protocol, development of clinical nutrition and 
dietary guidelines, training of health workers in the management of NCDs and raising 
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awareness levels of NCDs among other [28]. Future studies should evaluate the impact of the 
strategic plan on the diabetes health-care system, especially commodity availability for patients 
and needed health care providers and skills. 
 
We found stigmatization and discrimination to be common experiences among our patients, 
particularly by peers and society at large. Peers often thought diabetes was contagious and thus 
avoided interacting with the patients while society had beliefs that diabetes patients were not 
reproductively fit and had low status value in romantic relationships especially among the girls. 
Similar beliefs were reported in Japan where both women and men with insulin dependent 
diabetes were 22% less likely to be married compared to 65% for their aged matched controls 
[29]. Stigma was practiced through restricting patients from engaging in most everyday 
activities, such as sports. The sources and causes of stigma in patients with diabetes differ 
across cultures. For instance, in Australia, stigma was perpetuated by the media, friends, health 
care professionals and teachers who often had a notion that diabetes was a self-inflicted 
condition and stigmatization often took the form of negative social judgments and exclusions 
from activities [30]. In Iran, persons with T1D were reported to be stigmatized as miserable 
humans, rejected marriage candidates and were deprived of a normal life because they were 
equated to disabled people who could not enjoy life [31]. Thus, it also seems important to 
educate family members and friends about diabetes in Zambia. 
 
A systematic review on the quality of life of children with T1D showed worry and treatment 
barriers, diabetes symptoms and worries, communication and treatment barriers, family burden 
related to diabetes, disease impact and disease related worries as the main issues that affect the 
quality of life in mainly Western children with T1D [32]. Our results were somewhat similar; 
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however we found at least one more salient aspect in our sample: adolescents reported a limited 
sense of independence and social participation to be issues adversely affecting their lives; 
health care providers confirmed this perception. Being monitored by adults was one of the 
issues that affected adolescents’ sense of independence. Restricted and sometimes short play 
time were some of the issues that affect social participation and their lives. Improved treatment 
that can reduce dependence and perceived sense of intrusiveness from significant others such 
as the use of insulin pumps and care can improve the QoL of adolescents from developing 
countries. However insulin pumps are not available in Zambia because most patients cannot 
afford them. Our results are in sharp contrast with those obtained in developed countries, where 
on average, children with T1D show no difference in physical, psychosocial and overall quality 
of life as compared to their healthy peers [32].  
 
Parental monitoring or support from significant others is essential for diabetes care in children 
and adolescents. Less parental monitoring is a risk for poor glycemic control [33]. However, 
monitoring and support should never be perceived as intrusive by the adolescent to avoid the 
impression that it affects their sense of independence. When adolescents perceive their parents 
to be intruding in their personal lives, they are likely to get rebellious which often leads to 
parent-adolescent conflict. It would therefore be important that parents of adolescents with 
diabetes learn to show support without risking a conflict. Families and parents must agree about 
diabetes management responsibilities, show supportive behaviors towards adolescents and 
collaborative problem solving plans, all of which have been shown to be associated with better 
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This study had some limitations. To begin with, although the qualitative design enabled us to 
examine detailed experiences of the subjects in the study and to discover themes as well as 
their subjective views of the experience of living with diabetes, we cannot provide quantitative 
figures to underscore our findings, nor can we claim representativeness of our findings. 
Secondly we were unable to collect information from healthy peers to confirm the social 
stigmatization reported by our adolescents.  
 
In conclusion, lack of health care resources, stress and stigmatization, poor health care and 
inadequate advice by family and friends, due to a lack of knowledge are common problem in 
Zambian adolescents with diabetes. Adaptive strategies to buffer stress such as positive 
reframing and accepting of the condition, may be helpful to adolescents with diabetes. Major 
barriers are not only poverty and poor access to diabetes care, but also lack of knowledge 
among family members and friends. These barriers need to be removed in order to improve the 
quality of diabetes care and the quality of life of young persons with diabetes in Zambia. The 
themes related to stress, stigma and diabetes care and self-care seemed interwoven, therefore 
solving some problems may have trickle down effects on other problems. Health authorities 
and policy makers in developing countries face the challenge of improving health care delivery 
to patients with T1D who also face high poverty levels. While therapies such as Continuous 
Subcutaneous Insulin Infusion (CSII) have shown robust improvements in glycemic control, 
reduced severe hypoglycemia and general QoL, only very few patients in Zambia can afford 
such therapies. Overcoming the economic barriers to providing good diabetes care in Zambian 
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ABSTRACT 
Background: Data on diabetes-specific emotional distress among people living with diabetes 
in Sub-Saharan Africa are lacking. The present study aims to examine the psychometric 
properties of the Zambian version of the Problem Area in Diabetes (PAID) scale and to 
determine the levels of diabetes-specific emotional distress in Zambian people with diabetes. 
Methods: A total of 157 Zambians living with type 1 and 2 diabetes completed the 20-item 
PAID, Self-Care Inventory (SCI), Fear for Hypoglycemia Scale (HFS) and the Major 
Depression Inventory (MDI) in study 1. Exploratory factor analysis (EFA), Cronbach's alpha 
and lambda2, item-total correlations, Pearson's product moment correlations and regression 
analysis were performed. In study 2, eight patients participated in cognitive interviews, in order 
to evaluate the extent to which participants were able to comprehend the scale items. 
Results: EFA showed that a one-factor solution was the best interpretable solution. Internal 
consistency of the PAID in the Zambian version of the PAID was 0.90 and stable across the 
types of diabetes. Diabetes-specific emotional problems were common, with problem 
endorsements ranging from 22 – 61% across PAID items. The PAID showed low to moderate 
associations with the SCI, HFS and the MDI. Cognitive interviews showed that participants 
were able to comprehend question intent while a few participants faced some challenges with 
the meaning of words such as “anxious” and “physician” and with comprehension of some 
items. 
Conclusion: The Zambian version of the PAID is a reliable and valid measure to assess 
diabetes-specific distress. Zambian people with diabetes expressed high levels of diabetes-
specific distress; yet some items may need to be simplified or clarified to enhance 
comprehensibility. Policy makers, clinicians, researchers and people with diabetes need to 
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combine forces to find ways to reduce the high levels of diabetes-specific emotional distress in 
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Introduction 
Diabetes has become a major public health concern globally and Sub-Saharan African (SSA) 
has not been spared. An estimated 15 million people in SSA are living with diabetes [1]. In 
Zambia alone, approximately 437,570 people are known to have diabetes although this is 
potentially a gross underestimation of the magnitude of the problem since many diabetes cases 
remain undiagnosed and the health care institutions do not keep systematic records of those 
who go for care. The number of people with undiagnosed diabetes in Zambia is estimated at 
221,000 [1].  
 
Evidence from mainly European and North American studies has shown that being diagnosed 
with diabetes either type 1 mellitus (TIDM) or type 2 mellitus (T2DM) can be daunting and 
demanding and its treatment and care can impact work, interpersonal relationships, social 
functioning, as well as physical and emotional well-being of patients [2-5]. Psychosocial 
distress not only burdens patients but can also hamper adequate self-care behaviors, 
consequently compromising glycemic control [4, 6-7].  
 
Depression has also been reported to be a common problem in people with diabetes, which is 
associated with suboptimal glycated hemoglobin (HbA1C) level, higher mortality rates and 
impaired quality of life [8-14]. Diabetes-specific emotional distress appeared to mediate the 
relationship between depression and glycemic control [15]. Hence, it is not surprising that 
depression symptoms and diabetes-specific emotional distress are highly correlated; both affect 
glycemic control and quality of life, among others [15]. Addressing diabetes-specific emotional 
distress can presumably simultaneously lower depression and help improve health outcomes 
of patients with diabetes mellitus. 
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Having diabetes mellitus in Zambia differs from having diabetes in Europe or the US. Access 
to care is often problematic, cost of insulin and/or syringes are high, especially in rural areas 
[16]. Further, in Zambia certain cultural beliefs prevail that can impede the functioning of 
diabetes patients such as: “a girl with diabetes cannot have children” or “diabetes complications 
such as foot ulcers result from witchcraft” found in an earlier study in Zambia [17]. Given this 
array of issues specific to Zambia and Africa, a study of diabetes-specific emotional distress in 
Zambia is needed. 
 
To be able to adequately monitor the levels of diabetes-specific emotional stress, there is need 
for adequately developed and standardized measures for monitoring and identifying those 
experiencing distress. The Problem Areas in Diabetes Scale (PAID) is a widely used measure 
to monitor diabetes related distress. The PAID has been translated and used to assess diabetes-
specific emotional problems in many countries, such as Brazil, China, Iceland, Iran, the 
Netherlands, Norway, Sweden, Turkey and the US [3, 6-7, 18-24]. Given its wide use, good 
psychometric properties and clinical utility, this measure has the potential to fill the gap in 
assessment measures in the diabetes population in Africa. However, its factor structure has 
been found to differ across studies. For instance, some studies reported the scale to be 
composed of one [3, 20], two [6], three [7] and four factors or scales [18-19]. The measure has 
not been evaluated and validated in the African context to date. Therefore, the aim of the 
present study was to examine psychometric properties of the PAID in Zambian people with 
diabetes and to determine the level of diabetes-specific emotional distress in that group using 
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Methods 
The study comprised of two data:  quantitative data to test the validity and reliability of the 
PAID and cognitive interview to assess the adequacy, comprehensibility and cultural 
appropriateness of the PAID among the urban sample. 
Study 1 
Subjects 
The study sample comprised of outpatients with either type 1 diabetes mellitus (T1DM) or type 
2 diabetes mellitus (T2DM) from major hospitals in Lusaka, Ndola, Kitwe and Livingstone. 
Patients were classified T1DM or T2DM based on what was indicated on the patients' hospital 
record cards. Patients were invited to participate in the study if they were at least 12 years old 
and were diagnosed at least 6 months before the study. In total 157 patients signed the consent 
form and were recruited over a one-year period. Of the 157 participants, 80 were females 
(51%). We did not find significant differences in gender compositions from our sample. Mean 
age was 39±17 years with age ranging from 12-68 years. Of the total sample, 115 (73%) were 
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Table 1: Demographic characteristics of 157 participants with type 1 and type 2 diabetes 
__________________________________________________________________________________ 
Sex, n (%) 
 Females         80 (51%) 
Age, mean (SD)         39±17 
Age range          12-68 years 
Type of diabetes n (%)          
 Type 1          93 (59%) 
 Type 2          58 (37%) 
 Unknown            6 (4%) 
Developmental stage n (%) 
 Adolescents         42 (27%) 
 Adults          115 (73%) 
BMI mean (SD)          25 (5) 
 Males          25 (5) 
 Females         26 (5) 
 Adolescents         22 (4) 
 Adults          27 (5) 
Educational levels n (%) 
Adolescents (42) 
 5-7th Grade (Primary school)       14 (31%) 
 8-12th Grade (Secondary school)      16 (38%) 
 Missing          14 (31%)
  
Adults (115) 
 Primary education        10 (9%) 
 Secondary education        29 (25%) 
 Tertiary education        22 (19%) 
 Unknown         54 (47%) 
Marital status (Adults/115) n (%)  
 Single           6 (5%) 
 Married          80 (70%) 
 Missing          29 (25%) 
 
    
Measures 
Demographic variables. Questions asked about age, sex, education level, properties and 
services owned by families of participants and diabetes type. In addition, the body mass index 
of the participants was recorded. 
 
Diabetes-specific emotional distress. The PAID is a 20-item self-report measure used to assess 
diabetes-specific emotional distress [2], including a range of feelings such as diabetes related 
anger, fear, depression, worry and guilt. Items can be responded to on a scale from 0 (not a 
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problem) to 4 (serious problem). An overall score for PAID can be calculated by adding all of 
the item scores and multiplying by 1.25, which gives a total score ranging from 0-100. Higher 
scores indicate more distress. Reported Cronbach's alpha for the PAID is 0.84 to 0.96 [3, 6-7, 
18-24].  
 
Fear of Hypoglycemia. The Hypoglycemia Fear Survey (HFS) consists of 26 items. HFS 
comprises two scales assessing “worries about hypoglycemia” and “hypoglycemia-related 
behaviors”. The items are rated on a 5-point scale ranging from 1 (never) to 5 (very often). It 
has a Cronbach’s alpha of 0.90 suggesting high internal consistency [25].  
 
Diabetes Self-Care. The 13 item Self-Care Inventory (SCI) is a self-report measure used to 
assess patients' perceptions of their adherence to diabetes self-care recommendations over the 
previous 1-2 months. Individuals rate themselves on a 5-point Likert scale that reflects on how 
well they followed recommendations for self-care during the past month (i.e., 1 = “never do it” 
to 5 = “always do this as recommended, without fail”). Higher scores indicate more optimal 
diabetes self-care. Cronbach’s alpha for the SCI was 0.84 for T1DM and 0.85 for T2DM [26].  
 
Depression. The Major Depression Inventory (MDI) is a 12-item self-report questionnaire used 
to assess depression. Items of the MDI ask the patient to rate how long in the past two weeks 
each of the symptoms of the depressive syndrome was present on a six point scale ranging from 
0 “not at all” to 5 “all time”. It can be used as an instrument measuring severity of depression 
with a range from 0 - 50. The internal consistency of the MDI appeared to be good as indicated 
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Translation of Measures 
Zambia is a multi-lingual country with 5 main languages and English as the official language. 
Measures were administered in English and in 2 local languages; Nyanja and Bemba. Back 
translations were done by two native speakers in each language and were fluent in the other 
language and English. The translators met to discuss the translation together with the first 
author to discuss the translation in each language and the differences between forward and back 
translation versions. The goal was to maximize both linguistic and psychological equivalence. 
The final translation was piloted on 6 adolescents with type 1 diabetes and feedback on their 
understanding of the items was obtained. 
 
Statistical analyses 
Demographic characteristics in the total sample were examined using descriptive statistics. 
Missing data from the PAID were determined as Missing Complete at Random (MCAR) and 
replaced using Expectation Maximization/ Maximum Likelihood (EM) in SPSS. To assess the 
factor structure of the PAID, exploratory factor analysis was conducted; we used direct oblique 
rotation (direct oblimin), Keiser-Mayer-Olkin measure of sampling and Bartlett's test of 
sphericity using the scree plot criterion. Keiser-Mayer-Olkin values of greater than 0.6 indicate 
that data are suitable for conducting a factor analysis [29-30]. Oblique rotation was used 
because factors of the PAID were expected to be moderately correlated. Factor loadings of 0.30 
or higher have been recommended for a sample size of 300 or more [31]. The reliability was 
evaluated using data on the type of diabetes (T1DM and T2DM) and included Cronbach's alpha 
and lambda2 (i.e. for PAID total alpha and alpha for each subscale). Values above 0.70 are 
regarded as satisfactory [32]. Concurrent validity was assessed using Pearson’s correlation 
between PAID total score and other psychosocial variables of interest. In addition, item total 
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correlation was computed to evaluate the degree to which differences among patients’ 
responses to the items were consistent differences in their total PAID scores. Correlations 
among measures of the same attribute should be between 0.40 and 0.80 [7]. A lower correlation 
indicates either an unacceptably low reliability of one of the measures, or that the measures are 
measuring different phenomena [33]. Discriminant validity was examined by conducting a 
multiple regression analysis to determine the extent to which PAID scores were predicted by 
body mass index, depression, fear for hypoglycemia and diabetes self-care after adjusting for 
age, diabetes type, gender and socioeconomic status.  
 
Results 
The lowest PAID item with missing value accounted for 1.4% and highest item accounted for 
3.8%. In particular, 5 items had the largest missing value percentages; “feeling constantly 
burned out by constant effort to manage diabetes” (3.8%), “feeling constantly concerned with 
food” (3.8%), “feeling diabetes is taking up too much of your mental and physical energy” 
(2.5%), “not accepting diabetes” (2.5%) and “feeling overwhelmed by your diabetes regimens” 
(2.5%). These items accounted for 15.1% missing values. 
 
Item total correlation showed that he greatest increase in alpha resulted from deleting the 
following items; “coping with complications” (0.06), “feeling constantly concerned about 
food” (0.17), “deprivation regarding food and meals” (0.23), “feeling overwhelmed by diabetes 
regimens” (0.24) and “not having a clear and concrete goal for diabetes” (0.33). Removal of 
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The Bartlett test of sphericity was highly significant (χ²(190) = 1005.533, p < .001). The KMO 
value was 0.86. These statistics suggest that EFA can be adequately applied. In the second step 
principal component analysis using oblique rotation (direct Oblimin) was conducted and 
inspection of the Eigenvalues yielded a maximum of five factors: 6.69, 2.14, 1.35, 1.14 and 
1.02 (values before rotation). Given the ambiguity as to the number of factors reported in the 
literature, we explored solutions with different numbers of factors, working back from five 
factors. The 5-factor solution could not be used, as many items loaded on more than one factor 
and some of the factors could not be interpreted.  
 
Consistent with Snoek and colleagues [18], a forced four-factor model was inspected. 
However, the results were not consistent with the four-factor described by Snoek and 
colleagues, who found the following four factors: 1) emotional problems related to diabetes 2) 
treatment problems 3) food problems 4) lack of social support [18]. As can be seen in Table 4, 
our four-factor solution was not interpretable with the exception of factor 1 which had some 
resemblance to Snoek and colleagues’ emotional subscale; yet, items from the food related, 
social support and treatment related distress subscales loaded on the same factor.
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Table 2: PAID mean scores on items and subdimensions for the male and female samples with type 1 and type 2 diabetes 
__________________________________________________________________________________________________________________________________________________________________ 
        Type 1 diabetes                Type 2 diabetes 
       __________________________                      _______________________ 
Subdimension      Males        Females       Males            Females 
__________________________________________________________________________________________________________________________________________________________________ 
N         47                              46                       P-value            28         30     p-Value 
       M  SD    95% CI             M  SD    95% CI                       M  SD    95% CI              M  SD    95% CI 
Diabetes-related emotional problems     30.9±15.3 (26.4-34.5)     30.0±13.8 (26.9-35.6)              31.6±14.1 (26.1-37.1)      34.3±13.9 (29.0-31.5) 
Feeling that diabetes is taking up too much mental and physical energy 3.1±2.1 (2.5-3.8)      2.8±2.1 (2.3-3.4)       .62                3.3±2.3 (2.5-4.1)     3.9±1.8 (3.1-4.5)         .38 
Not knowing if the mood or feeling you are experiencing are related to  2.6±2.1 (2.0-3.3)      2.9±2.1 (2.3-3.5)       .60                  3.5±2.0 (2.6-4.1)     3.3±2.0 (2.5-4.0)             .64     
your blood glucose     
Feeling guilt/anxious when you get off track with your diabetes management 3.3±1.9 (2.8-3.9)      2.5±2.1 (1.9-3.1)       .09                    3.6±1.9 (2.9-4.3)     3.3±2.0 (2.5-4.0)             .36 
Feeling constantly burned out by the constant effort to manage diabetes    2.9±2.1 (2.3-3.5)      2.4±2.3 (1.8-3.0)          .35                     3.0±2.1 (2.1-3.8)     3.3±1.9 (2.5-3.9)             .83 
Coping with complications of diabetes       1.9±2.1 (1.3-2.5)      2.1±2.1 (1.5-2.8)       .32                   1.4±2.0 (0.6-2.1)     3.1±2.1 (2.3-3.9)             .02* 
Feeling depressed when you think about living with diabetes   2.8±2.3 (2.1-3.8)      3.1±2.0 (2.5-3.8)          .23                    3.0±2.1 (2.1-3.9)     3.0±2.0 (2.3-3.8)             .93 
Worry about low blood sugar reactions    3.1±2.0 (2.5-3.8)      3.0±2.0 (2.5-3.6)       .96                    3.3±2.1 (2.4-4.1)       3.1±2.0 (2.4-3.9)             .95  
Feeling scared when you think about living with diabetes   2.6±2.3 (2.0-3.3)      2.9±2.1 (2.3-3.5)          .61                    2.6±2.1 (1.8-3.5)     2.9±2.3 (2.0-3.6)             .64 
Feeling overwhelmed by your diabetes regimen   1.3±1.8 (0.8-1.8)      1.9±1.8 (1.4-2.4)        .09                  0.8± 1.6 (0.1-1.4)     1.9±2.0 (1.3-2.6)          .01** 
Worrying about the future and possibility of serious complications  3.0±2.1 (2.4-3.8)      3.4±2.0 (2.8-3.9)           .50                         3.6±2.0 (2.9-4.4)     2.6±2.3 (1.8-3.4)             .06† 
Not accepting diabetes     2.5±2.3 (1.8-3.1)      2.1±2.1 (1.5-2.8)         .52                    2.6±2.5 (1.6-3.5)            2.3±2.4 (1.3-3.1)             .28 
  
Treatment-related problems     6.6±4.4 (5.3-7.9)      7.1±4.9 (5.6-5.5)                       8.0±4.5 (6.3-9.8)     7.6±4.1 (6.1-9.3) 
Not having clear and concrete treatment goals for your diabetes care 2.4±2.0 (1.8-2.9)      2.3±2.1 (1.8-2.9)       1.0                 2.0±2.3 (1.3-2.9)     3.1±2.1 (2.4-3.9)            .06† 
Feeling discouraged with your diabetes regimens      2.5±2.1 (1.6-2.9)      2.3±2.1 (1.6-2.9)       .87                    2.8±2.1 (1.9-3.5)      2.5±2.3 (1.8-3.4)            .64 
Feeling unsatisfied with your diabetes physician    2.0±1.1 (1.4-2.6)      2.6±25 (1.9-3.3)           .40                    3.3±2.5 (2.4-4.1)     2.0±2.1 (1.1-2.8)            .02* 
Food-related problems     6.4±4.5 (5.0-7.6)      6.8±4.3 (5.5-8.0)                      6.1±4.3 (4.4-7.8)     7.3±5.3 (5.3-9.3) 
Feelings of deprivation regarding food and meals   2.0±2.1 (1.4-2.5)      2.3±2.3 (1.6-2.9)       .48                     2.0±2.3 (1.1-2.9)     2.8±2.3 (1.9-36)             .27 
Feeling constantly concerned about food    2.3±2.3 (1.6-2.9)      2.4±2.1 (1.8-3.0)       .71                    1.9±2.3 (1.0-2.6)     2.4±2.4 (2.6-3.3)            .19 
Uncomfortable interactions around diabetes with family/friends (e.g., other 2.1±2.0 (1.5-2.8)      2.1±2.1 (1.5-2.6)       .45                    2.5±2.5 (1.4-3.1)     2.1±2.1 (1.4-2.9)            .80 
people telling you what to eat)  
 
Social support-related problems     5.1±4.0 (4.0-6.4)      4.6±3.9 (3.5-5.9)                      5.6±4.0 (4.0-7.1)     4.4±3.0 (3.4-5.5) 
Feeling that friends/family are not supportive of diabetes management efforts 2.9±2.5 (2.5-3.6)      2.4±2.3 (1.6-3.0)         .31                     3.4±2.1 (2.5-4.3)     2.3±2.1 (2.6-3.2)            .99 
Feeling alone with diabetes     2.3±2.1 (1.6-2.9)      2.3±2.3 (1.6-3.0)      .86                   2.3±2.3 (1.4-3.1)        2.1±2.1 (1.4-3.0)            .81 
 
PAID 20-item scale         40.3±34            49.0±24.0 (41.8-56.0)    49.5±23.0 (42.6-56.40)   .84    51.4±21.9 (42.8-59.9)      53.5±20.9 (45.8-61.4)  .74 
Total PAID 16 items         3.8±27.2 
__________________________________________________________________________________________________________________________________________________________________ 
Transformed from 0-4 scale (0-80) to a scale 0-5(0-100) by multiplying the results by 1.25;* <.05, ** <0.01, † borderline. M = mean, SD= standard deviation, 95%CI = confidence intervals at 95% based on gender and 
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Table 3:  Proportion of participants that endorsed an item as a “serious problem”¶ 
__________________________________________________________________________________________________________________________________________________________________ 
                                            Type 1 diabetes                                        Type 2 diabetes                       Type 1&2 diabetes     p-value 
                                                     __________________________            _______________________ 
PAID 20 items                               Males                           Females                      Males                    Females                  (type 1 vs.2) 
__________________________________________________________________________________________________________________________________________________________________ 
N        47  46  28  30  157 
        %(n)  %(n)  %(n)  %(n)  %(n) 
Diabetes-related emotional problems 
 Worry about low blood sugar reactions    57(27/47)* 59(27/46)* 61(17/28)  63(19/30)*                 61(95/157)*        .20 
 Feeling that diabetes is taking up too much mental and physical energy 62(29/47)* 50(23/46)  68(19/28)* 67(20/30)*                 60(94/157)*         .14 
 Feeling guilt/anxious when you get off track with your diabetes management 66(31/47)* 41(19/46)  75(21/28)* 60(18/30)*                 58(91/157)*         .25 
 Worrying about the future and possibility of serious complications  55(26/47)* 61(28/46)* 71(20/28)* 47(14/30)                  57(90/157)*        .60 
 Feeling depressed when you think about living with diabetes  55(26/47)* 54(25/46)* 57(16/28)  53(16/30)                   54(84/157)           .97                   
 Feeling scared when you think about living with diabetes  53(25/47)  54(25/46)* 50(14/28)                      53(16/30)                  52(82/157)          .91  
 Not knowing if the mood or feeling you are experiencing are related to 47(22/47)  54(25/46)* 61(17/28)* 53(16/30)                   53(83/157)          .11     
 your blood glucose  
                    Feeling constantly burned out by the constant effort to manage diabetes    51(24/47)  37(17/46)  54(15/28)  63(19/30)*                  49(77/157)         .29 
 Not accepting diabetes     45(21/47)  37(17/46)  50(14/28)  43(13/30)                   41(64/157)          .86 
Coping with complications of diabetes       38(17/47)  39(18/46)  21(6/28)  60(18/30)*                  40(62/157)          .47 
Feeling angry when you think about living with diabetes  40(19/47)  30(14/46)  39(11/28)  50(15/30)                    39(61/157)         .25 
 Feeling overwhelmed by your diabetes regimen   19(9/47)  28(13/46)  11(3/28)  27(8/30)                    22(34/157)         .69 
   
Treatment-related problems        
 Not having clear and concrete treatment goals for your diabetes care 38(18/47)  37(17/46)  36(10/28)  63(19/30)*                   41(65/157)          .35 
      Feeling unsatisfied with your diabetes physician    34(16/47)  46(21/46)  61(17/28)* 33(10/30)                    41(65/157)          .40 
 Feeling discouraged with your diabetes regimens      36(17/47)  39(18/46)  46(13/28)  43(13/30)                    40(62/157)          .32 
  
Food-related problems        
 Feeling constantly concerned about food    45(21/47)  44(20/46)  32(9/28)  43(13/30)                   42(66/157)           .37 
Feelings of deprivation regarding food and meals   34(16/47)  44(20/46)  32(9/28)  50(15/30)                    40(63/157)           .60 
 Uncomfortable interactions around diabetes with family/friends (e.g., other 38(18/47)  35(16/46)  39(11/28)  40(12/30)                    37(58/157)          .92 
 people telling you what to eat) 
 
Social support-related problems        
 Feeling that friends/family are not supportive of diabetes management eff      55(26/47)* 41(19/46)  64(18/28)* 40(12/30)                  48(75/157)            .86 
    Feeling alone with diabetes     40(19/47)  44(20/46)  43(12/28)  37(11/30)                  40(63/157)         . 73 
__________________________________________________________________________________________________________________________________________________________________ 
¶Total PAID ranges from 0 - 80 on a scale (0-1)”not a problem”, (2)”a little problem” & (3-4) “serious problem”. * Very high areas concerning diabetes specific distress in Zambian patients. % of aggregated data 
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Table 4: 1-,2-,3-,4- and 5- factor solution for the PAID as reported by 157 Zambian participants (aged 12-68 years) with type 1 and 2 diabetes 
__________________________________________________________________________________________________________________________________________________________________ 
                    Factor solution 
Shortened item content  1 Factor        2 Factor              3 Factor   4 Factor                             5 Factor 
 
       F1  F1 F2 F1 F2 F3       F1 F2 F3    F4   F1          F2           F3      F4     F5  
__________________________________________________________________________________________________________________________________________________________________ 
Feeling depressed?   .71 .70  .76        .75    .74  
Worry about low blood sugar reactions? .58                 .62  .63         .76    .77 
Worry about complications?  .70 .70  .69         .68    .69  
Feeling angry?          .63 .60  .74  -.40       .72  -.40  .71           -.37              
Feeling scared?   .73 .73  .77         .62    .63    
Feeling discouraged with treatment...? .73 .72  .75         .64    .61  
Mood related to diabetes?  .63 .63  .54         .61  .31  .59   
Feeling “burned out”?  .70 .67  .60         .64    .53       -.40  
Feelings of guilt or anxiety?  .65 .64  .63         .55    .55  
Diabetes is taking up to much energy? .59 .54  .51         .53    .57 
Uncomfortable social situation?  .63 .65  .60            .76         .76           
Feeling that others are not supportive?   .67 .67  .55  .39         .31 .63         .65             -.31  
Feeling alone with your diabetes? .62 .64  .69      .72          .70  
Not “accepting” your diabetes?  .68 .72  .63  .31       .30   .51          .53  
Unsatisfied with diabetes physician? .56 .60  .40  .64   .59 .44               .53        .46  
Concerned about food and eating? .11  .72  .73      .75    .87    
Feelings of deprivation regarding food? .17  .76  .73      .79    .76   
Coping with complications?  -.00  .69  .75      .66  -.42  .59        -.42 
Not having clear and concrete goal? .36  .43  .43      .38           -.90  
Feeling overwhelmed by your diabetes? .23  .59  .41 -.59      .49 -.57                  -.79      -.32 
Eigenvalue before rotation  6.69 6.69 2.14 6.69 2.14 1.35      6.69           2.14 1.35 1.14 6.69          2.14         1.35       1.14       1.02  
% variance before rotation         33.45 33.45 10.70 33.45 10.70 6.73     33.45          10.70 6.73 5.71 33.45        10.70       6.73       5.71       5.12  
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Principal factor analysis using oblique rotation (Direct Oblimin). 
 
Table 5: Correlations between the total PAID, Diabetes self-care, Fear for hypoglycemia, Age, SES, Body Mass Index and Major Depression Inventory 
__________________________________________________________________________________________________________________________________________________________________ 
     Diabetes self-care Fear for hypoglycemia   Age  SES¶  BMI  MDIǁ 
__________________________________________________________________________________________________________________________________________________________________ 
PAID total     0.30**   0.35**   0.12  0.00  -0.14  0.39** 
__________________________________________________________________________________________________________________________________________________________________ 
** p < 0.01, *p < 0.05. 
¶ Socio- Economic Status 
ǁ Major Depression Inventory total score
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We also inspected a three factor model and a two factor model using EFA; both solutions were 
not interpretable. The first factor of the two factor solution consisted of items assessing 
“diabetes stress” and a second factor containing items covering not only “food-related 
problems” but also items covering “coping with complications and being overwhelmed with 
the diabetes regimens”. The second factor had item combinations that rendered it difficult to 
interpret, partly because of various secondary loadings. Therefore the two-factor solution was 
discarded. 
 
Lastly, we examined a one-factor solution. Our data provided the strongest support for a one 
factor model although it had four items with low loadings below 0.30 (concerned about food 
and eating = .11, deprivation regarding food = .17, coping with complication = -.00 and feeling 
overwhelmed by your diabetes = .23). Although item total correction suggested removing 5 
items, 16 items were maintained and used because the factor loadings of these items were 
greater than 0.30. The retained items had factor loadings ranging from 0.36 to 0.73. Internal 
consistency remained high even after removing these items Cronbach’s alpha 0.90 (lambda2 = 
0.90). 
 
The internal consistency of the total PAID, as indicated by Cronbach's alpha, was 0.88 
(lambda2 = 0.89), for the 16 items PAID alpha was 0.90 (lambda2 = 0.90). For subjects with 
T1DM Cronbach's alpha was 0.89 (lambda2 = 0.90) while for subjects with T2DM Cronbach's 
alpha was 0.86 (lambda2 = 0.88). Inspections of the item total correlations revealed that 15 out 
of 20 items were worthy of retention. Cronbach's alpha for HFS was 0.80 and lambda2 0.81, 
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Table 3 shows that regardless of the type of diabetes, “Worry about low blood sugar reactions” 
was most endorsed as a serious problem (i.e. score of 3 or 4 (i.e. “a problem” /a serious 
problem”) among T2DM patients and in all patients (62% and 61% respectively). Overall 60% 
of the patients (T1DM and T2DM) endorsed “the feeling that diabetes was taking up too much 
of their mental and physical energy” to be a serious problem. 
 
Women with T2DM scored higher (54±21 (95% CI: 46-61) than men or women with T1DM 
49.0±24.0 (41.8-56.0), 49.5±23.0 (42.6-56.40) respectively. Men with T2DM scored higher 
51±22 (95% CI: 43 - 60) than men 49±24 (95% CI: 42 - 56) and women 50±23 (95% CI: 43 - 
60) with T1DM and these differences were significant (see table 2). 
 
Concurrent validity of the PAID was evaluated by assessing the correlations between the PAID 
and age, BMI, SES, fear for hypoglycemia, depression and diabetes self-care. Table 5 shows 
the correlation between the PAID and other variables of interest. There was a moderately 
significant correlation between the PAID with the diabetes self-care r(157) = -0.30, fear for 
hypos r(157) = 0.35 and depression r(157) = 0.39 scores. However, there was no significant 
correlation between the PAID and age r(157) = 0.12, socioeconomic status r(156) = -0.01 and 
Body Mass Index r(157) = -0.14. 
 
Table 6 shows a stepwise multiple regression model that examined the relationship of six 
variables with the total PAID score. In the first step, demographic variables were entered as 
control variables; no significant associations were found with diabetes distress. In the second 
step, clinical variables (body mass index, depression, diabetes self-care and fear for 
hypoglycemia) were entered. These variables were positively associated with total PAID 
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scores, except for body mass index which was negatively associated with diabetes-distress. The 
strongest predictor of diabetes-specific distress was fear for hypoglycemia (beta = 0.29), 
followed by depression beta = 0.27, perceived diabetes self-care was the third most significant 
predictor of diabetes-specific distress (beta = 0.25). The predictor variables explained 32% (p 
< 0.01) of total variance of the PAID.  
 
Table 6: Stepwise multiple regression analyses predicting PAID by demographic and clinical 
characteristics in 157 patients with T1DM and T2DM 
Models       Beta   t   P 
Model 1: Demographic characteristics 
Age       .122  1.286  .23 
Being T2DM      .029  .313  .95 
Being female      .011  .138  .95 
Socioeconomic status     .005  .054  .95 
R2 = .020 
Adj R2 = -.007 
Model 2: clinical characteristics 
Body mass index     -.107  -1.348  .08 
Depression (MDI)     .268  3.122  .001*** 
Fear for hypoglycemia     .289  3.456  .001*** 
Diabetes self-care     .252  3.249  .001*** 
R2 = .335*** 
Adj R2 =.315*** 
__________________________________________________________________________________ 
*p < 0.05, ** p < 0.01, ***p < .001. 
 
Study 2 
As a further study of the adequacy of the PAID in the Zambian context, we conducted a 
qualitative study, addressing the adequacy of the instrument’s instructions, items and response 
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Eight patients with diabetes (3 adolescents and 5 adults) participated in the study. These 
cognitive interviews focused on the 20 items of the PAID. Patients were asked to provide verbal 
feedback on each item regarding 1) response categories, 2) clarity, 3) the respondent’s 
knowledge about the specific topics that were inquired and recall of experiences and sensitivity 
of the items and overall impression of the content (see Table 7). All interviews were conducted 
in English, were audio-recorded and verbatim transcribed. Interviews lasted between 30-45 
minutes. Of the 8 patients that were interviewed only one had completed the PAID scale earlier 
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Table 7: Cognitive interview question 
Warm up question/instruction clarity  
Tell me what this introduction is telling you? 
Comprehension (question intent and meaning of term) 
Can you tell me in your own words what this question was asking? 
What does the [word/term] mean to you as it has been used in this question? 
Tell me what you were thinking when I asked about [topic]? 
Assumption 
How well does this question apply to you? 
Can you tell me more about that? 
Knowledge /memory 
How much would you say you know about [topic]? 
How much though would you say you have given to this? 
How easy or difficult is it to remember [event]? 
You said [answer]. How sure are you about that? 
How did you come up with that answer? 
Sensitivity/social desirability  
Is it ok to talk about this diabetes problem area or it’s uncomfortable? 
The question uses the [word/term]. Does that sound ok or would you choose something different? 
Specific and general probes 
Why do you think that [topic] is the most serious diabetes problem? 
How did you arrive at that answer? 
Was it easy or hard to answer? 
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Data analysis 
Verbatim transcriptions were first read through several times in order to get familiar with the 
data. After established familiarity with the data, each question response was analyzed and 
comments assigned to each response based on the cognitive theory model by Tourangeau [35]. 
The model consist of four processes: 1) comprehension of the question (question intent and 
meaning of terms), 2) retrieval from memory of relevant information (recallability` of 
information and recall strategy – recalling each one individually vs. estimation strategy), 3) 
decision process (motivation – devotion of mental effort to answer question and sensitivity of 
question or indication of social desirability) and 4) response process which involves matching 
responses to scale categories. 
 
Results 
In general most of our patients could understand the majority of the items (16/20 = 80% of the 
items). The following items were problematic to understand for some patients: “feeling 
constantly burnout by constant effort to manage diabetes and not having a clear and concrete 
goal for managing diabetes care”. Some adolescents and adults had challenges with specific 
words in items although they were able to deduce the meaning of the entire question. The words 
and concepts that the patients found challenging were “overwhelmed”, “regimens”, 
“unsatisfied”, “burnout”, “physicians” and “concrete goal”. The patients were also able to 
suggest some replacements to the words they initially had challenges with to include “treatment 
plan” for “regimens”, “unhappy” or “happy” for “unsatisfied”, “doctor” for “physicians”. In 
some cases it was difficult to recall occurrences of certain events evoked by the questions such 
as when patients were angry, guilty or anxious and uncomfortable. These challenges were 
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Table 8: Problematic issues identified after cognitive interviews analyses 
Comprehension problems: Question intent        Tally    Adolescent vs. adult patient 
Feeling constantly burnout by the constant effort to manage diabetes       III     both  
Example response: it was asking if I feel lazy to manage my diabetes  
Coping with complications of diabetes          II     both 
Example response: it was asking about my blood sugar and about my diabetes 
Not having clear and concrete goals for your diabetes care       II     both 
Example response: it was asking if I have set goal for my future on what I want to do and how I plan to do it 
Feeling that diabetes is taking up too much of your mental and physical energy     I    adolescent  
Example response: it was asking how I feel physically and how I feel diabetes is affecting my life 
Comprehension problems: meaning of terms   Tally   Proposed change by patients  Adolescent vs adult patients 
Anxious       I  -       Adolescent 
Regimens      II  Treatment plan     Both 
Burnout       IIII  -      Both  
Unsatisfied       I  Happy or unhappy    Adolescent 
Physician      III  Doctor       Adolescents 
Overwhelmed       I  -      Adult 
Concrete goals      III  -      Both 
Coping        I        Adolescent 
Deprivation       I  -      Adolescent 
Recall problem of specific events evoked by questions 
Feeling *guilt or anxious when you get off track with your diabetes management  
Feeling *angry when you think of living with diabetes 
*Uncomfortable interactions around diabetes with family or friends 
* Moments patients could not recall the last time they experience something like that 
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Discussion 
The aim of current study was to examine the latent structure, reliability and validity of the 
PAID among individuals with type 1 or 2 diabetes in Zambia. Results of our study strongly 
support a one-factor solution of the Zambian translation of the PAID, although four items 
“concerned with complications”, “feelings of deprivation regarding food”, “coping with 
complications” and “feeling overwhelmed by diabetes” had factor loadings less than 0.30. 
These low loadings may result from the fact that all our subjects were outpatients, without any 
serious complications. It remains unclear why the item “concerned about food” had a low 
loading considering that initial interviews by the first author with the patients showed that it 
was a major concern [17].  
 
Our data rejected the two factor model found in Iceland by Sigurdardottir and Benediktsson, 
[6], the three-factor model found in Sweden by Amsberg and colleagues [7] and the four factor 
model found in the USA/The Netherlands [18-19]. A one factor model was also found the 
USA/The Netherlands [18]. Originally, the PAID was conceptualized as a unidimensional scale 
[2]; therefore, our one-factor structure using all 20 items remains plausible. Moreover, in 
studies among Chinese [20], Dutch and US [18] individuals with diabetes, the one-factor 
solution was also supported. The Zambian version of the PAID showed high internal 
consistency with Cronbach’s alpha and lambda2 which has recently been recommended in the 
literature because it shows the least amount of bias [36]. Consequently, a total of 16 items at 
least from EFA results seem useful for clinical assessment to detect diabetes-related distress 
and suggest psychological help to Zambian patients with such distress, with possibly some 
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Our study also found that most patients endorsed, “worrying about low blood sugar reactions”, 
“feeling that diabetes is taking up too much mental and physical energy”, “feeling guilt/anxious 
when you get off track with your diabetes management”, “worrying about future and possible 
serious complications” and “feeling depressed when you think about living with diabetes” as 
the most bothersome diabetes-specific problems which is consistent with findings by 
Sigurdardottir and Benediktsson [6]; worrying about the future and possible complications and 
feeling guilty when you get off track with your diabetes management were also found to be the 
most commonly endorsed by Snoek and associates [18]. It was not surprising that our patients 
endorsed these items, considering that the mean score for fear for hypoglycemia was relatively 
high (58±12) and the diabetes self-care score was below average (48±9). Moreover, having a 
hypoglycemic episode in Zambia might be more stressful, as medical care is less available 
compared to Europe or the US. Further, all the participants with T1DM were on insulin 
injection therapy which has been shown to be physically and mentally challenging. Patients are 
required to buy their own strips for blood glucose testing which are often unaffordable for most 
patients. Generally, diabetes patients get off track with diabetes management and care which 
can cause a sense of guilt and anxiety. 
 
The mean value for the 16 items of the PAID was 33.8±27.2 (would be 40.3±33 in case for 20 
items) suggesting that the Zambian participants experienced high levels of diabetes-specific 
emotional distress. In the Icelandic participants (T1DM only) the mean value for the PAID was 
28±18, Swedish participants (T1DM only) 27±18, Dutch, 24±19 and USA participants 31±23. 
The results suggest that living with diabetes in Zambia is perceived as much more stressful 
compared to Western Europe and the US and that it imposes many demands on the patients, 
which may exacerbate diabetes-specific emotional distress. These differences in levels of 
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diabetes-specific emotional distress may reflect differences in access to physical and mental 
health care and costs associated with diabetes management. Another explanation could be 
cultural differences in the experience of psychological problems. Graue and colleagues also 
speculated that differences in diabetes-specific emotional distress across countries may be due 
to cultural differences in the explanation of psychological problems [24]. Most importantly, 
definitions and attributes of depression are dominated by Western cultural assumptions which 
may not reflect the conceptualization and treatment of depression in Zambia. To the best of our 
knowledge diabetes patients in Zambia are not given any psychosocial help; moreover about 
48% of our participants indicated that family/friends were not supportive of their diabetes 
management efforts (Table 3).  
 
In the present study, the PAID scores were positively associated with fear for hypoglycemia, 
depression and negatively associated with diabetes self-care. Equally PAID scores were 
predicted by the patients’ depression levels, diabetes self-care and fear of hypoglycemia. This 
was expected as literature has shown associations between self-care and depression and with 
other variable such as body mass index, SES, glycemic control although the later were not 
associated with self-care in our sample [37-41]. 
 
Overall, the cognitive interviews demonstrate that our respondents were able to comprehend 
the scale items and to link them to the scale category. Four items (“feeling constantly burnout 
by constant effort to manage diabetes”, “not having a clear and concrete goal for managing 
diabetes care”, “coping with complications of diabetes” and feeling diabetes was taking up too 
much of your mental and physical energy”, were not well comprehended by 5 respondents the 
difficulties were beyond word difficult or vague concepts but the comprehension of the 
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question intent. Although some of the respondents had difficulties with the meaning of some 
word/terms (e.g., anxious, physician, concrete goals), overall they were able to comprehend 
the intent of the questions with an exception for few questions. Of the main items that 
influenced the missing values figure, “feeling constantly burnout by constant effort to manage 
diabetes” and “feeling diabetes is taking up too much of your mental and physical energy” were 
also items that patients found difficult to comprehend. Patients had also problems with the 
meaning of the word overwhelmed in the item “feeling overwhelmed by your diabetes 
management”. It is possible that patients were uncomfortable to answer the items “feeling 
constantly concerned with food” and not accepting diabetes hence leaving them unanswered 
by some patients. Implementing the feedback from respondents on some changes to key words 
(e.g. doctor for physician, regimen for treatment plan etc.) can improve the strength of the 
items. In addition, including items covering patients “worrying not getting married or 
difficulties having children, have trouble getting insulin/testing strips, having to walk long 
distances to get medical care, feeling discriminated against because of diabetes” would enrich 
the Zambian version of the PAID. 
 
This study is the first to validate an African version of the PAID. The sample in this study was 
drawn from three provinces in Zambia including adolescents and adults, type 1 and 2 diabetes 
mellitus making the sample heterogeneous and generalizable within the Zambian urban 
context. Secondly, we were able to demonstrate that participants did not employ response style 
bias instead respondents were able to map responses based on the categories given in the survey 
and were able to comprehend the question intent. However, the study is not without limitations. 
First, the sample size was relatively small and drawn from urban settings only. Second, due to 
the small sample size, we could not conduct a Confirmatory Factor Analysis, which would 
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have enabled a more rigorous comparison of different factor solutions. Therefore, future studies 
should work with a bigger sample size and subject the Zambian version of the PAID to 
Confirmatory Factor Analysis. Thirdly, we cannot rule out the influence of social desirability 
in the manner participants responded to the scale. In social research participants have the 
tendency to respond to survey questions in a manner that will be viewed favorable by others 
[42]. 
 
In conclusion, the current study revealed good internal consistency, reliability and validity of 
the PAID among patients with type 1 and 2 diabetes mellitus in Zambia. Moreover, the majority 
of our patients demonstrated that they were able to comprehend most questions well and match 
their responses to the scale categories, although some items may need to be rewritten. The 
measure has satisfactory psychometric properties to assess individual levels of diabetes 
specific-distress that qualifies it for diagnostic and clinical use, although some items may need 
to be clarified and simplified to enhance its comprehensibility. We found a single factor 
solution to be the best approximation of the data. The existence of a single factor implies that 
the participants did not make a distinction between clusters of domains or complaints. Rather, 
diabetes seems to work as a global stressor that comes with multiple complaints. To our 
knowledge, findings in the current study are the first to highlight the use of the PAID in 
Zambian patients with diabetes. The study also demonstrated that diabetes-specific emotional 
distress is very high in Zambian patients compared to patients with diabetes in Western Europe 
or the USA. These results show that there is a very strong urge to further improve the quality 
of medical treatment of Zambian people with diabetes, particularly it would be helpful to 
educate the families. There is need to improve the composition of the health care profession so 
that the team attending to patients is multi-disciplinary and includes a general health care 
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practitioner, cardiologist, nutritionist, psychologist, etc. all are currently available in major 
hospitals but just need to be coordinated to make this possible. There is also need to increase 




















































  130 
 
References 
1. International Diabetes Federation. IDF Diabetes Atlas [Internet]. [cited 2013 Mar 13]. 
Available from: https://www.idf.org/diabetesatlas.  
2. Polonsky WH, Anderson B J, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz 
CE. Assessment of diabetes related distress. Diabetes Care 1995; 18(6): 754-760. 
doi:10.2337/diacare.18.6.754. 
3. Welch GW, Jacobson AL, Polonsky WH. The problem areas in diabetes scale: An 
evaluation of its clinical utility. Diabetes Care 1997; 20(5): 760–66. 
doi:10.2337/diacare.20.5.760. 
4. Kakleas K, Kandyla B, Karayianni C, Karavanaki K. Psychosocial problems in 
adolescents with type 1 mellitus. Diabetes & Metabolism 2009; 35(5): 339-350. 
doi:10.1016/diabet.2009.05.002. 
5. Rane K, Wajngot A, Wändell, PE, Gåfvels C. Psychosocial problems in patients with 
newly diagnosed diabetes: Number and characteristics. Diabetes Research and Clinical 
Practices 2011; 93(3): 371-378. doi:10.1016/j.diares.2011.05.009. 
6. Sigurdardottir AK, Benediktsson R. Reliability and validity of the Icelandic version of 
the problem areas in diabetes (PAID) scale. International Journal of Nursing Studies 
2008; 45(4): 526-533. doi:10.1016/j.ijnurstu.2006.10.008. 
7. Amsberg S, Wredling R, Lins P, Adamson U, Johnsson U. The psychometric properties 
of the Swedish version of the Problem Areas in Diabetes Scale (Swe-PAID-20): Scale 
development. Internal Journal of Nursing studies 2008; 45(9): 1319-1328. 
doi:10.1016/j.ijnurstu.2007.09.010. 
8. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, 
Grey M, Anderson B, Holzmesiter LA, Clark N. Care of children and adolescents with 
 
 
  131 
 
type 1 diabetes. A statement from the American Diabetes Association. Diabetes Care 
2005; 28(1): 186-212. doi:10.2337/diacare.28.1.186. 
9. Rush, WA, Whitebird RR, Rush MR, Solberg LI, O'Connor PJ. Depression in patients 
with diabetes: Does it impact clinical goals? Journal of the American Board of Family 
Medicine 2008; 21(5): 392–397. doi:10.3122/jabfm.2008.05.070101. 
10. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, Pouwer F. European 
Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk 
factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 
2010; 53(12): 2480-2486. doi:10.1007/s00125-010-1874-x. 
11. Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, Peyrot M, 
Pouwer F. European Depression in Diabetes Research Consortium. Prevalence of 
depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a 
systematic review and meta-analysis of the European Depression in Diabetes (EDID) 
Research Consortium. Diabetes Care 2011; 34(3): 752-62. doi:10.2337/dc10-1414. 
12. Johnson B, Eiser C, Young V, Brierley S, Heller S. Prevalence of depression among 
young people with type 1 diabetes: A systematic review. Diabetes Medicine 2012; 30(2): 
199-208. doi:10.1111/j.1464-5491.2012.03721.x. 
13. Pouwer F, Nefs G, Nouwen A. Adverse effects of depression on glycemic control and 
health outcomes in people with diabetes: a review. Endocrinology Metabolism Clinics of 
North America 2013; 42(3):529-544. doi:10.1016/j.ecl.2013.05.002. 
14. Van Dooren FEP, Nefs G, Schram MT, Verhey FRJ, Denollet J, Pouwer F. Depression 
and risk of mortality in people with diabetes mellitus: A systematic review and meta-
analysis. Plos One 2013; 8(3): e57058. doi:101378/journal.pone.0057058. 
 
 
  132 
 
15. Van Bastelaar KMP, Pouwer F, Geelhoed-Duijvestin PHLM, Tack CJ, Bazelmans E, 
Beekman AT, Heine RJ, Snoek FJ. Diabetes-specific emotional distress mediates the 
association between depressive symptoms and glycaemic control in type 1 and type 2 
diabetes. Diabetic Medicine 2010; 27(7): 798–803. doi:10.1111/j.1464-
5491.2010.02025.x. 
16. Beran D, Yudkin, JS, de Courten M. Access to care for patients with insulin-requiring 
diabetes in developing countries. Case studies of Mozambique and Zambia. Diabetes 
Care 2005; 28(9): 2136-2140. doi:10.2337/diacare.28.9.2136. 
17. Hapunda G, Abubakar A, van Vijver F, Pouwer F. Living with type 1 diabetes is 
challenging for Zambian adolescents: qualitative data on ways of coping, stress, stigma 
and quality of life. BMC Endocrine Disorder 2015; 15(1). doi:10.1186/s12902-015-
0013-6..  
18. Snoek FJ, Welch GW, Pouwer F, Polonsky WH. Diabetes related emotional distress in 
Dutch and U.S diabetic Patients. Cross-cultural validity of the Problem Areas in Diabetes 
Scale. Diabetes Care 2000; 23(9): 1305-1307. doi:10.2337/diacare.23.9.1305. 
19. Gross CC, Scain SF, Scheffel R, Gross JL, Hutz CS. Brazilian version of the Problem 
Areas in Diabetes Scale (B-PAID): validation and identification of individuals at high 
risk for emotional distress. Diabetes Research & Clinical Practice 2007; 76(3): 455-9. 
doi:10.1016/j.diabres.2006.09.033. 
20. Huang M, Edwards H, Courtney M, McDowell J. Validation of the Chinese version of 




  133 
 
21. Arzaghi SM, Mahjouri MY, Heshmat R, Khashayar P, Larijani B. Psychometric 
properties of the Iranian version of the Problem Areas in Diabetes Scale (IR-PAID-20). 
Journal of Diabetes & Metabolic Disorders 2012; 11(4). doi:10.1186/2251-6581-11-4. 
22. Huis In 'T Veld EMJ, Makine C, Nouwen A, Karşidağ C, Kadioğlu P, Karşidağ K, 
Pouwer F. Validation of the Turkish version of the Problem Areas in Diabetes Scale. 
Cardiovascular Psychiatry and Neurology 2011. doi:10.1155/2011/315068. 
23. Weissberg-Benchell J, Antisdel-Lomaglio J. Diabetes-specific emotional distress 
among adolescents: feasibility, reliability and validity of the problem areas in diabetes-
teen version. Pediatric Diabetes 2011; 12(4pt1): 341-344. doi 10.1111/j.1399-
5448.2010.00720.x. 
24. Graue M, Haugstvedt A, Wentzel-Larsen T, Iversen MM, Karlsen B, Rokne B. 
Diabetes-related emotional distress in adults: Reliability and validity of the Norwegian 
version of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale 
(DDS). International Journal of Nursing studies 2012; 49(2): 174–182. 
doi:10.1016/j.ijnurstu.2011.08.007. 
25. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of 
hypoglycemia: Quantification, validation and utilization. Diabetes Care 1987; 10(5): 
617-621. doi:10.2337/diacare.10.5.617. 
26. Weinger K, Welch GW, Butler HA, La Greca AM. Measuring diabetes self-care. A 
psychometric analysis of the self-care inventory-revised with adults. Diabetes Care 
2005; 28: 1346-1352. doi:10.2337/diacare.28.6.1346. 
27. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and 
specificity of the Major Depression Inventory, using the Present State Examination as an 
 
 
  134 
 
index of diagnostic validity. Journal of Affective Disorder 2001; 66: 159–164. 
doi:10.1016/s0327(00)00309-8. 
28. Cuijper P, Dekker J, Noteboom A, Smit N, Peen J. The sensitivity and specificity of the 
Major Depression Inventory in outpatients. BMC Psychiatry 2007; 7. doi:10 1186/1471-
244X-7-39. 
29. Brace N, Kemp R, Snelgar R. SPSS for psychologists. New York: Palgrave Macmillan; 
2009. 
30. Tacq J. Multivariate analysis techniques in social science research. London: Sage 
Publishing Co; 1997. 
31. Field A. Discovering statistics using SPSS. 3rd ed. London: Sage Publications Ltd; 2000. 
32. Streiner DL, Norman GR. Health measurement scale-A practical guide to their 
development and use. New York: Oxford University Press; 2003.  
33. Fayers P, Machin D. Quality of life. In The assessment, analysis and interpretation of 
patient-report outcome. New York: Wiley; 2007. 
34. Miller K, Chepp V, Willson S, Padilla JL. Cognitive interviewing methodology. ed. 
New York, NJ: Wiley; 2014. 
35. Tourangeau R. Cognitive science and survey methods: a cognitive perspective. In: 
Jabaine T, Straf M, Tanur J, Tourangeau R, (ed). Cognitive aspects of survey methods: 
building a bridge between disciplines. Washington DC: National Academy Press; 1984. 
p. 73-100. 
36. Tang W, Cui Y. A simulation study for comparing three lower bounds to reliability. 




  135 
 
37. Lustman PJ, Anderson RJ, Freeland KE, de Groot M, Carney RM, Clouse RE. 
Depression and poor glycemic control. A meta analytic review of literature. Diabetes 
Care 2000; 23, 934-942. doi:10.2337/diacare.23.7.934. 
38. Everson SA, Maty SC, Lynch JW, Kaplan GA. Epidemiologic evidence for the 
relationship between socioeconomic status and depression, obesity and diabetes. Journal 
of Psychosomatic Research 2002; 53, 891-895. doi:10.1016/s0022-3999(02)00303-3. 
39. Lorant V, Croux C, Weich S, Deliége D, MacKencback J, Ansseau M. Depression and 
socioeconomic risk factors: 7-year longitudinal population study. British Journal of 
Psychiatry 2007; 190: 293-298. doi; 10.1192/bjp.bp.105.020040. 
40. de Wit LM, van Straten A, van Herten M, Penninx BWJH, Cuijper P. Depression and 
body mass index, a u-shaped association. BMC Public Health 2009; 9. doi:10.1186/1471-
2458-9-14. 
41. Zuberi SI, Syed EU, Bhatti JA. Association of depression with treatment outcomes in 
type 2 diabetes mellitus: A cross sectional study from Karachi, Pakistan. BMC Psychiatry 
2011; 11(1): 27. doi:10.1186/1471-244x-11-27. 
42. Naemi BD, Beal DJ, Payne SC. Personality predictors of extreme response style. 



































                                                          
5  This chapter is based on a published article. Hapunda G, Abubakar A, Pouwer F, van de Vijver F. (2015) 






  137 
 
ABSTRACT 
Aims: To replicate, in Zambia, a recent global study by the WHO, which reported that the odds 
of depression were not increased in African people with diabetes, and to explore the 
sociodemographic and clinical factors associated with depression. 
Methods: A total of 773 control subjects and 157 Zambian patients with diabetes completed 
the Major Depression Inventory and a list of demographic indicators. 
Results: Compared with control subjects (mean ± SD Major Depression Inventory score 15.10 
± 9.19), depressive symptoms were significantly more common in patients with diabetes (mean 
± sd Major Depression Inventory score 19.12 ± 8.95; P < 0.001). ANCOVA showed that having 
diabetes [F(1,698) = 16.50, P < 0.001], being female [F(1,698) = 7.35, P < 0.01] and having 
low socio-economic status (F(1,698) = 13.35, P < 0.001) were positive predictors of 
depression. 
Conclusions: Contrary to the WHO study, we found that depression was a common comorbid 
health problem among Zambian people with diabetes. Clinicians should consider patients’ 












  138 
 
Introduction 
Abundant evidence suggests that the prevalence and incidence of depression is elevated in 
people with Type 1 or Type 2 diabetes [1–4]. Depression in diabetes is not only associated with 
impaired quality of life [5], but prospective studies have also shown that depression is 
associated with poor glycemic control, an increased risk of developing microvascular and 
macrovascular complications and higher mortality rates [6,7]. 
 
Only a few studies on diabetes and depression have been conducted on the African continent. 
In a Nigerian study, in 83 people with diabetes, 25% had an elevated depression score on the 
Hospital Anxiety Depression Scale [8]. Further two Nigerian studies used a diagnostic 
psychiatric interview [9,10]. The first was conducted among 200 outpatients with Type 1 or 
Type 2 diabetes: 30% had a depressive disorder, compared with 9.5% in a control group 
without diabetes [9]. Agbir et al. [10] found that the prevalence of major depressive disorder 
was 19.4% in an outpatient diabetes clinic. In another global study, diabetes was associated 
with a twofold increase in the prevalence of depressive symptoms except in Africa [11]. 
 
Little is known about the prevalence of depression in people with diabetes in Zambia. The 
aim of the present study, therefore, was to address two questions: (1) Do Zambian people 
with diabetes mellitus have more depressive symptoms than control subjects without 
diabetes? and (2) Which sociodemographic and clinical variables are associated with 
depression in patients with diabetes? 
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Patients with diabetes were recruited from four central hospitals. Healthy adolescent control 
subjects were recruited from secondary schools and healthy adult control subjects were 
recruited from various public places within Lusaka. Healthy adolescents gave consent and the 
head teachers of their schools also gave permission. A total of 930 subjects were included, of 
whom 773 were healthy subjects and 157 had diabetes (42 adolescents with Type 1 diabetes, 
51 adults with Type 1 diabetes and 64 with Type 2 diabetes). Adolescents comprised 72% of 




Data on age, sex, education level and diabetes type, and a list of the properties and services 
owned by the families of the study subjects (e.g. car, maid, television), were obtained. The 
Major Depression Inventory (MDI), a validated, 12-item self-report questionnaire, was used to 
assess depression [12,13]. 
 
Statistical analysis 
To establish whether the questionnaire was comparable for the two groups (patients and control 
subjects), we computed a two-group confirmatory factor analysis, in which we tested 
invariance of factor loadings and measurement intercepts as tests of metric and scalar 
invariance, respectively [14]. ANCOVA was used to examine the influence of our predictor 
variables (healthy status and sex of our subjects) on the mean MDI score, while partialling out 
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Results 
The mean ± SD age of the entire study cohort was 23.5 ± 11.73 years, for adults with diabetes 
it was 47.14 ± 11.21 years, for healthy adults it was 30.09 ± 8.39 years, for adolescents with 
diabetes it was 15.17 ± 2.11 years and for healthy adolescents it was 16.84 ±1.24 years. Age 
was significantly different in each group (P < 0.001). Further, for the Major Depression 
Inventory, Cronbach’s  was 0.81, while λ2 was 0.80. We tested a single factor model for the 
Major Depression Inventory. The configural invariance (unconstrained) model yielded a good 
fit, chi-squared test (131, N = 930) = 325.66 (P < 0.001), Tucker–Lewis index = 0.911, 
comparative fit index = 0.911 and root mean square error of approximation = 0.040. 
 
In addition, we examined the proportions and means of depression in our sample. As Table 1 
shows, adults with Type 2 diabetes (26%; mean ± sd MDI score 21.06 ± 7.94) or Type 1 
diabetes (27%; mean ± SD MDI score 18.45 ± 9.59) had higher depression scores compared 
with adult control subjects [9.9%; mean ± sd MDI score 11.45 ± 8.33; P < 0.001). Similarly, 
adolescents with Type 1 diabetes scored higher (27.8%; mean ± SD MDI score 17.53 ± 10.34) 
than did adolescent control subjects (17.2%; mean ± sd MDI score 16.14 ± 9.20; P < 0.05). In 
general, patients with diabetes had a higher mean MDI score [25.4%; mean ± sd score 19.12 ± 
8.95) compared with control subjects (16.3%; 15.10 ± 9.18; P < 0.001). Both men and women 
with diabetes reported more symptoms of depression than did control subjects (Table 1). 
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Table 1: Demographic and clinical characteristics of the study cohort 
___________________________________________________________________________________________________________________________________________________________ 
Sample composition n (%) 
 Healthy sample              773 (80%) 
 Clinical sample              157(20%) 
Type 1 diabetes patients              93(59.2%) 
Type 2 diabetes patients              64(40.8%) 
Sex n(%) 
Males                481 (51.7%) 
Females                407 (43.8%) 
Missing                42 (4.5%) 
Mean age (SD)               23.05(11.73) 
Age range               12-68 years 
Marital status 
 Single               61(23.6%) 
Married               164(63.3%) 
Widowed               2(0.8%) 
Missing                32(12.3%) 
___________________________________________________________________________________________________________________________________________________________ 
        Controls        with diabetes 
             _____________________                 _____________________________________________________ 
            adolescents       adults     adolescents  adults    all Patients 
___________________________________________________________________________________________________________________________________________________________ 
Education level (n/%)  
 Unknown             25(4%)    3(2.1%)     ---   54(47%) 
 Primary             ---     2(1.4%)    14 (33.3%)  10(9%) 
 Secondary         629(96%)             36(25%)    28 (66.7%)  29(25%) 
 Tertiary        ---                103(47%)    ---   22(19%)      
Depression categories (n/%)        Type 1  Type 1  Type 2  Type 1&2 
___________________________________________________________________________________________________________________________________________________________ 
No to mild depression  369(82.7%) 100(90.1%)    26(72.2%) 54(73%)  38(74.5%) 97(74.6%) 
Moderate depression  38(8.5%)                 11(9.9%)     6(16.7%)   12(16.2%) 7(13.7%) 19 (14.6%) 
Severe depression                  39(8.7% ) ---      4(11.1%)                  8(10.8%) 6(11.8%)  14(10.8%) 
      
Gender aggregated   Females     Males      Females   Males 
___________________________________________________________________________________________________________________________________________________________ 
No to mild depression  220(80.9%)   276(86.8%)    45(68.2%)               52(81.2%) 
Moderate depression    52(19.1%)              42(13.2%)    13(19.7%)                  6(9.4%) 
Severe depression                     ---                 ---       8(12.1%)                  6(9.4%) 
___________________________________________________________________________________________________________________________________________________________ 




Table 2: Mean±sd depression scores and ANCOVA results stratified by health status, 
sex and two covariates 
 
    Controls   with Diabetes  p value 
    ________   ____________  ______ 
 
All    15.10±9.18   19.12±8.95  *** 
Adolescents: type 1diabetes 16.14±9.20   17.53±10.34  *** 
Adults: type 1 diabetes  11.45±8.33   18.45±9.59  *** 
Adults: type 2 diabetes  11.45±8.33   21.06±7.94  *** 
Females                  16.85±9.11   19.53±8.95  * 
Males    12.63±9.02   18.70±9.00  *** 
Independent variables  F    P   η2 
Having diabetes  16.542    ***   0.023 
Being female    7.350    **   0.010 
Age†    2.360    ns   0.003 
Socioeconomic Status†  13.341    ***   0.019 
Having diabetes *being female 2.075    ns   0.003 
R2 = 0 .080 Adj R2 = 0. 074 
*= < 0.05; ** = < 0.01; *** = < 0.001; ns =non-significant, † = covariate. 
 
The ANCOVA test showed that, after adjustment for covariates, having diabetes was 
significantly associated with depression: F(1,704) = 16.54 (P < 0.001), partial η2 = 0.02. The 
adjusted mean MDI score for those without diabetes was 14.98 compared with 19.20 for those 
with diabetes. After adjustment for the covariates, the model showed that gender was still 
statistically significant: F(1, 704) = 7.35 (P < 0.01), partial η2 = 0.01. The adjusted mean MDI 
score for females was 17.76 compared with 14.36 for males. The corrected model for the 
between-subjects effect was statistically significant: F(5,704) = 12.18 (P < 0.001), partial η2 = 
0.08 and adjR2 = 0.074 account for 7.4% of the total variance in MDI scores. Table 2 shows 
the results of the ANCOVA test. Within the group with diabetes, MDI scores for women (32%, 
mean 19.53 ±8.95) and those for men (19%, mean 18.70 ± 9.00) were not significantly 





Both adults and adolescents with diabetes reported elevated levels of depression compared with 
healthy control subjects, and adults with diabetes had higher depression scores compared with 
adolescents. Approximately one quarter of our sample reported elevated depression levels 
compared with 39.5% in a study involving a Nigerian adult outpatient cohort with both Type 
1 and Type 2 diabetes in Benin City [9]. In that study, 30% of participants had a depressive 
disorder [9]. In another Nigerian study, the 1-year prevalence of depression was 19.4% [10]. 
In the present Zambian sample, as in other African countries [9,10], levels of depression were 
high. In the WHO study [11], the overall odds of depression were not found to be higher for 
patients with diabetes in Africa. Cultural differences regarding the concept of depression might 
play a role here. Differences in measuring tools used, poverty levels and comorbid conditions 
may also explain differences across studies. The results of the present study show that 
depression is also an important comorbid health problem in African patients with diabetes, and 
thus are not in line with findings from Mommersteeg et al. [11]. 
 
In addition, we found that women and those with a low socio-economic status reported more 
symptoms of depression. This is in line with a systematic review that provided strong evidence 
that the occurrence of depression among people with diabetes in low- and middle-income 
countries is associated with socio-economic status [15]. A lack of mental health services, a lack 
of insurance coverage and unguaranteed social support for people from communities with low 
socio-economic status may explain the association between depression and socio-economic 
status [15]. In addition, as reported by previous studies, our data indicate that females were 
more depressed than males. The more favorable everyday life conditions of males may explain 
this difference. In addition, women play many roles which expose them to increased 




and contribute to the development of depression in people with diabetes. According the 
International Diabetes Federation, stigma is a bigger problem for girls and women, ‘who carry 
a double burden of discrimination because of their health status and the inequalities perpetrated 
in male-dominated societies’ [17]. 
 
The present study has some limitations. Firstly, there was the potential for selection bias 
because we used a non-random sampling technique and the data only represented selected areas 
of Zambia because of financial and other logistical constraints. Secondly, our study lacks 
clinical data specific to diabetes and its complications. The self-report measure we used can 
only measure relative levels of depression; in future, diagnostic interviews would be ideal 
because they measure absolute levels of depression. Strengths of the study include the use of 
control subjects in exploring the prevalence rates of depression in our sample. To the best of 
our knowledge this study is the first to show how common depression is among adolescents 
and adults with diabetes in Zambia compared with control subjects. 
 
The present results have public health and policy implications; clinicians and policy-makers 
should pay increasing attention to depression, as the WHO projects that depression will become 
one of the leading causes of disabilities [18], and because depression appears to be severely 
underdiagnosed in Zambia, for example, in patients with epilepsy [19]. Furthermore, 
depression appeared to be a highly recurrent or persistent problem in people with diabetes [20]. 
Among both adolescent and adult patients in the present study, depression levels were 
significantly higher. Given the developmental stage of adolescents, depression levels in these 
patients are of particular concern. Clinicians should discuss the nature, causes and treatment of 





In conclusion, the main aim of the present study was to investigate the prevalence of depression 
among patients with diabetes in Zambia. Contrary to the results of the WHO study, our findings 
show that depression in patients with diabetes was more common than in a healthy control 
group. In addition, female gender and low socio-economic status were found to be associated 
with higher levels of depression. Clinicians should consider these variables when tailoring 
interventions for individual patients. Policies that directly encourage screening for depression, 
especially among adolescents, and the development of age-appropriate mental health 
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Aim: Depression is an established risk factor for cardiovascular disease and mortality, and 
impaired self-care behaviors may play a mediating role. However, depression is a rather 
heterogeneous construct. We therefore examined the associations between depressive 
symptoms and different aspects of diabetes self-care in Zambian individuals with diabetes 
mellitus. 
Methods: A total of 157 individuals with diabetes mellitus participated. The sample was drawn 
from four city hospitals in Zambia. Diabetes self-care was assessed using the Diabetes Self-
Care Inventory (SCI) and depression was assessed using the Major Depression Inventory 
(MDI).  
Results: 59% of the sample had type 1 diabetes. Increased appetite was the most endorsed 
symptom (53%) and trouble sleeping at night was the least endorsed symptom (27%) by our 
patients. The symptoms “low in spirit or sad” (β = -0.226, p = < 0.05) and “feeling life was not 
worth living” (β = 0.235, p = < 0.05) were found to be significantly associated with self-care. 
The symptom “lack of energy” (β = -0.192, p = > 0.05) was marginally associated with self-
care. However, these symptoms were no longer significant after controlling for all clinical and 
demographic variables. In patients with type 1 diabetes, no symptoms were significant. In type 
2 diabetes only the symptom “had bad conscience or feeling guilty” was  associated with better 
diabetes self-care (β = 0.349, p = < 0.05). Being young and female were significantly associated 
with poor self-care scores while having a high socioeconomic status was significantly 
associated with better self-care scores.   
Conclusion: Although it was initially hypothesized that depression was associated with 
diabetes self-care, much of the variance in depression seemed to be explained by demographic 
characteristics specifically gender, age and SES. Clinicians attending to diabetes patients need 





It is estimated that 350 million people worldwide with diabetes have elevated levels of 
depression [1]. Depression worldwide affects 10-30% of the people with diabetes [2]. A recent 
survey indicated that globally, individuals with diabetes had increased odds of experiencing an 
episode of depressive symptoms compared to those without diabetes [3]. Diabetes patients with 
depression are at increased risk for poor glycemic control and development of cardiovascular 
complications and have higher mortality rates [2, 4-5]. One of the behavioral mechanisms that 
may link depression with poor outcomes in diabetes is sub-optimal self-care. In developed 
countries, patients with comorbid depression and diabetes have been found to have less 
frequent fruit and vegetable intake, more frequent fat intake, more sedentary behaviors and 
fewer exercise sessions per week [6-8]. Moreover, smoking was twice as prevalent among 
depressed than non-depressed diabetes patients [4]. However, studies on the association 
between depression and self-care in diabetes patients are scarce in the Sub-Saharan African 
(SSA) context. Nevertheless, studies that have looked at the association between depression 
and other chronic illness, especially HIV and AIDS, have consistently found that depression is 
associated with sub-optimal self-care in patients [9-11]. 
  
Diabetes care mostly consists of self-care behaviors [12]. After consultations with their health 
care providers, patients are responsible for their diabetes care 24 hours per day. Optimal 
outcomes in diabetes require diligent daily self-care [4]. Diabetes self-care consists of proper 
use of medication (insulin or oral medication, correct timing/correct doses), counting of 
carbohydrates, a healthy diet (e.g., low in saturated fat, low in salt, high in vegetables/fruits, 
and moderate alcohol intake), being physically active, monitoring of blood glucose levels, 
proper foot care, and refraining from smoking, among others [13]. Since comorbid depression 




[2, 5] and that people with both disorders rarely participate in recommended health behaviors 
mentioned above [6-8], the relationship between self-care behaviors and depression remains a 
very important, yet hardly explored area of research in SSA.  
 
Major depressive disorder is a medical illness that affects feelings, thoughts and behaviors. 
Depression results in persistent feelings of sadness and loss of interest in previously enjoyed 
activities [14]. Depression is a heterogeneous construct with an interrelated set of diverse 
symptoms mostly derived from Western studies; depression is often comorbid with diabetes, 
which warrants research on the link between depression and diabetes self-care. In this study 
we attempt to examine the applicability of this link in a non-Western context. To date, the 
diagnosis of depression is based on the frequency and severity of a set of symptoms. For the 
diagnosis of major depression, 5 symptoms out of 9 (which include depressed mood or 
diminished interest in daily activities) are required. These symptoms include depressed mood 
or irritability, decreased interest or pleasure, change in appetite (increased or reduced appetite), 
change in sleep (hypersomnia or insomnia), change in activity (psychomotor agitation or 
psychomotor retardation), fatigue or loss of energy, guilt/worthlessness, diminished 
concentration, and suicidal ideation [15]. As a result, a considerable number of different 
combinations of symptoms is possible. 
 
A recent study conducted among Dutch patients showed that particularly depressed mood, 
sleeping difficulties, appetite problems and suicidal ideation were significantly related with 
higher glycated hemoglobin (HbA1C) in patients with type 1 or 2 diabetes mellitus 
(TIDM/T2DM) [15]. Research has shown that anhedonia (loss of interest or loss of pleasure) 
is related to sub-optimal glycemic control (a product of self-care) in patients with T2D [16]. 




important for clinical practice. Particularly, depression management improves patient’s quality 
of life and patients’ ability to achieve and maintain diabetes self-care goals.  Therefore, the aim 
of the present study is to explore the associations between specific symptoms of depression 




This study employed a cross-sectional design. We assessed the link between the independent 
variable of interest (e.g., depressive symptoms, type of diabetes, age, sex, SES and body mass 
index) and the dependent variable, diabetes self-care [17]. 
 
Study sample 
The study sample comprised of outpatients with either T1DM or T2DM from major urban 
hospitals in Lusaka, Ndola, Kitwe and Livingstone. The T1DM or T2DM diagnosis was based 
on what was indicated on the patients' hospital record cards and their verbal confirmation. 
Patients were invited to participate in the study if they were at least 12 years old and were 
diagnosed at least 6 months before the study. In total 157 patients signed the informed consent 
form and were recruited over a one-year period. Assent was obtained from younger patients 
below 18 years old. Their guardian consented for them to participate in the study. Table 1 








Table 1: Demographic characteristics of 157 participants (12-68 years) with type 1 and type 2 
diabetes 
__________________________________________________________________________________ 
Sex, n (%) 
 Females         80 (51%) 
Age, mean (SD)         39±17 
Age range          12-68 years 
Developmental stage n (%) 
 Adolescents         42 (27%) 
 Adults          115 (73%) 
Educational levels n (%) 
Adolescents (42) 
 5-7th Grade (Primary school)       14 (31%) 
 8-12th Grade (Secondary school)      16 (38%) 
 Missing         14 (31%)
  
Adults (115) 
 Primary education        10 (9%) 
 Secondary education        29 (25%) 
 Tertiary education        22 (19%) 
 Missing         54 (47%) 
Marital status (Adults/115) n (%)  
 Single           6 (5%) 
 Married          80 (70%) 
 Missing         29 (25%) 
__________________________________________________________________________________
        
 
Measures 
Demographic variables. Information on age, sex, education level, properties and services 
owned by families of participants and diabetes type was obtained. 
 
Diabetes Self-care. The 13-item Diabetes Self-Care Inventory (SCI) is a self-report measure 
used to assess patients' perceptions of their adherence to diabetes self-care recommendations 
over the past month. Individuals rate themselves on a 5-point Likert scale that indicates how 
well they followed recommendations for self-care during the past month (i.e., 1 = “never do it” 
to 5 = “always do this as recommended, without fail”) on several items including glucose 
testing, administering correct insulin dose, eating the proper foods; sticking to meal plan and 




derived using the average of the items 1, 2, 5, 7, 8 and 13; these items cover areas that are 
linked to better metabolic control [18]. The item “wearing a medic alert ID” was dropped 
because it did not apply to Zambian patients. Higher scores on the scale indicate good diabetes 
self-care. The SCI shows good reliability, with values of the Cronbach’s alpha of 0.84 for 
T1DM and 0.85 for T2DM [19]. In the current study Cronbach's alpha was 0.71 and Lambda2 
was 0.74. 
 
Depression. We used the symptoms from the Major Depression Inventory (MDI), a 12-item 
self-report questionnaire used to assess depression. Items of the MDI ask the patient to rate 
how long in the past two weeks each of the depressive symptoms was present on a six point 
scale ranging from 0 “not at all” to 5 “all time” on items such as have you felt low in spirit or 
sad, have you felt less self-confident, have you suffered from reduced appetite etc.? The 
instrument can be used to measure severity of depression with a score range from 0 - 50.  
According to the manual (based on Western norms), an MDI total score between 0-24 indicates 
“no depression to mild depression”, 25-29 “moderate depression” and 30-50 “severe 
depression”. Items 8 and 10 are divided into two sub-items, a and b. Only the highest scores of 
item 8 and 10 (either a or b) are included in the statistical analysis. This self-report measure 
contains the ten ICD-10 symptoms of depression and is identical with the DSM-IV symptoms 
apart from one that relates to low self-esteem [20]. The symptoms for major depressive disorder 
covered in this measure include (i) depressed mood, (ii) decreased interest, (iii) increased and 
reduced in appetite, (iv) changes in sleep pattern, (v) changes in daily activities interests, (vi) 
loss of energy, (vii) feeling of worthlessness and (viii) diminished concentration. The symptom 
“suicidal ideation” is not part of this measure. In the current study, each symptom was scored 
as present if the chosen response was “slightly more than half the time”, “most of the time”, or 




0.89 [35] and 0.94 [20]. In the current study, the value of Cronbach's Alpha was 0.79 and the 
value of Lambda2 was 0.80. 
 
Statistical analyses 
Linear regression analyses were conducted for each individual depressive symptom as assessed 
by the MDI. This was done in order to test their associations with diabetes self-care behaviors. 
Since T1DM and T2DM have different etiology and management styles, we also ran separate 
regression analyses for each type of diabetes. Using a hierarchical approach, we adjusted our 
linear regression models for the following potentially confounding variables: sex, age, 
socioeconomic status (SES), type of diabetes and BMI. All analyses were conducted with SPSS 




Table 1 shows the demographic characteristics of the sample. Of the 157 participants, 80 were 
females (51%). Mean age was 39±17 years, with ages ranging from 12 - 68 years. Of the total 
sample, 115 (73%) were adults. About 25% of the adults sample had secondary education. 
About 69% of the adolescents were school-going and the rest had not indicated their education 
level. Most of the adult subjects (80%) were married. Table 2 shows that a total of 93 subjects 
were classified as having T1DM (59%) in the medical charts and 58 had T2DM (37%). The 
type of diabetes for 6 patients could not be determined because the clinical record cards for 
these patients were not available at the time data was collected. In the total sample the mean 
body mass index (BMI) was 25±5 kg/m2. The mean BMI was 22±4 kg/m2 for adolescents and 





Table 2: clinical characteristics of the participants (n =157) 
 
Type of diabetes          n   % 
          ___________________ 
Type 1          93/157   59 
 Type 2         58 /157  37 
 Missing         6 /157  4 
 
BMI mean (SD)          25 (5) kg/m2 
 Males          25 (5) kg/m2 
 Females          26 (5) kg/m2 
 Adolescents         22 (4) kg/m2 
 Adults          27 (5) kg/m2 
 
SCI score          19.52±6.06 
 Min vs. Max         9 - 32 
Table 2 continue 
  
MDI score          19.12±8.95 
 
Self-care activities  
       Self-care level 
      Below average  Average  Above 
average 
1. Glucose testing    92 (60.5%)  17(11.2%) 43(28.3%) 
2. Glucose recording    93(62%)   11(74%)  45(30.2%) 
3. Ketone testing    99(79.8%)  6(4.8%)  19(15.3%) 
4. Administering correct insulin dose  10(8.8%)  16(14.2%) 87(77%) 
5. Administering insulin at right time  11(9.7%)  14(12.4%) 88(43.6%) 
6. Adjusting insulin intake based on sugar… 43(39.1%)  19(17.3%) 48(43.6%) 
7. Eating proper food; stick to meal plan 16(10.3%)  21 (13.5%) 119(76.3%) 
8. Eat meals on time    28(18.2%)  26(16.9%) 100(64.9%) 
9. Eating regular snacks   86(57%)   22(14.6%) 43(28.5%) 
10. Carrying quick-acting sugar to treat… 83(56.1%)  21(14.2%) 44(29.7%) 
11. Coming for appointments/review  10(6.5%)  13(8.4%) 132(85.2%) 
12. Exercise regularly    48(31.4%)  26(17%)  79(51.6%) 
13. Exercise strenuously*   103(70.5%)  10(6.8%) 33(22.6%) 
_______________________________________________________________________________________________ 
 
Below average (“never do it” and “sometimes follow recommendations”), average (“ follow recommendations 50% of 
the time”), above average (“usually do as recommended; occasional lapses” and “ do as recommended without fail”), 




Proportions of depression and self-care 
Based on the cutoff of the measure, 74.6% of our patients had no to mild depression, 14.6% 
had moderate depression and 10.8% had severe depression. Table 2 shows that the most 
endorsed symptom of depression was increased appetite (53%), followed by low in spirit or 
sad (46%), feeling restless (39%), lack of energy (38%), difficulties concentrating (37%), 
feeling subdued (36%), feeling life was not worth living (34%), feeling less confident (32%), 




sleeping at 27%. The mean depression score was 19.94±8.95. A t-test analysis revealed that 
there was no statistical difference between adults and adolescents with diabetes on self-care 
scores (t = 0.21, df =155, p >.05). The majority of patients scored above the midpoint of the 
self-care scale (19.52±6.06). The majority of patients reported glucose testing (60.5%), glucose 
testing (62%), ketone testing (79.8%); eating regular snacks (57%) and carrying quick-acting 
sugar to treat reactions (56%) as major problems related to required self-care activities. 
 
The association between depressive symptoms and diabetes self-care 
Our results showed no association between total diabetes self-care and the composite score of 
the Major Depression Inventory (β = 0.080, p > 0.05). We then conducted 12 linear regression 
analyses to study the associations between diabetes self-care and the 12 individual depression 
symptoms of the MDI while controlling for demographic characteristics. Linear regression 
analyses showed a small, negative correlation between diabetes self-care and the symptoms 
“low in spirit or sad” (β = -0.226, p = < 0.05) and positive correlations with “feeling life was 
not worth living” (β = 0.235, p = < 0.05) and “less self-confident” (β = 0.201), p = < 0.05 (Table 
3). These associations remained significant even after applying Bonferroni correction except 
for the symptom “feeling life was not worth living”. There was no association between the 12 
symptoms of depression and diabetes self-care in patients with T1DM. In patients with T2DM, 
only the symptom “having a bad conscience or feeling guilty” was positively and significantly 
associated with diabetes self-care. 
  
We found that being younger (β = -0.239, p = <.05), being female (β = -.196, p = < .01), and 
type 2 diabetes (β = -0.211, p = <.01) were the demographic characteristics that were associated 
with poor self-care. Having high SES (β = 0.224, p = < .01) was associated with better self-




Table 3: Standardized regression coefficients from 12 separate liner regression analyses for the association of each MDI items and diabetes self-care (n = 
157). 
    Model 1  model 2            model 3           model 4           model 5 
    Β p  β p  β p  β p  β p 
MDI 1: low in spirit          -.226 *            -.164 ns            -.162 ns           -.146 ns       -.151 ns 
MDI 2: lost interest          -.028 ns             .012 ns             .036 ns             .036 ns        .039 ns 
MD1 3: lack of energy           -.133 ns            -.172 ns            -.144 ns            -.192         †         -.192 † 
MDI 4: less self-confident         .201 ns             .177 ns             .178 ns             .137 ns         .137 ns 
MDI 5: feeling guilt            -.053 ns            -.069 ns                   -.086 ns              -.077 ns          -.078 ns 
MDI 6: life no worth living       .235 *             .213 *             .188 *             .174 ns          .170 ns 
MDI 7: diff. concentrating       -.044 ns            -.010 ns                       .019 ns             .055 ns          .056 ns 
MDI 8a: very restless           -.043 ns              .031 ns                       .016 ns                       .011 ns          .012 ns 
MDI 8b: felt subdued           -.002 ns              .048 ns                       .069 ns              .106 ns          .107 ns 
MDI 9: trouble sleeping          -.068 ns            -.045 ns              .002 ns              .025 ns          .028 ns 
MDI 10a: reduced appetite       .119 ns              .090    ns                   .098 ns              .109 ns          .117 ns 
MDI 10b: increased appetite     .142 ns              .126   ns              .110 ns              .112 ns           .120 ns 
R2 (Adj R2)   .14 (.04)  .27 (.16)  .30 (.18)  .36 (.25)  .36 (.24)  
Model 1: unadjusted         * = >.05, ns = non significant, † = marginally significance  
Model 2: adjusted for sex, age 
Model 3: adjusted for sex, age, SES 
Model 4: adjusted for sex, age, SES, type of diabetes  





Table 4: Standardized regression coefficients from 12 separate liner regression analyses for the association of each MDI items and diabetes self-care in type 1 
diabetes patients. 
    Model 1  model 2  model 3  model 4  model 5 
MDI1: low in spirit  13 ns  .09 ns  .10 ns  .11 ns  .11  ns 
MDI2: lost interest  .06 ns  .02 ns  .02 ns  .02 ns  .01 ns 
MDI3: lack of energy  .08 ns  .07 ns  .05 ns  .04 ns  .02 ns 
MDI4: less self-confident .06 ns  .04 ns  .03 ns  .04 ns  .04 ns 
MDI5: feeling guilty  -.10 ns  -.09 ns  -.09 ns  -.08 ns  -.08 ns 
MDI6: life not worth-living .05 ns  .04 ns  .03 ns  .04 ns  .05 ns 
MDI7: diff. concentrating -.04 ns  -.05 ns  -.04 ns  -.07 ns  .-07 ns 
MDI8a: very restless  .10 ns  .13 ns  .13 ns  .15 ns  .15 ns 
MDI8b: felt subdued  .-.09 ns  -.11 ns  -.09 ns  -.09 ns  -.09 ns 
MDI9: trouble sleeping  .11 ns  .13 ns  .14 ns  .11 ns  .10 ns 
MDI10a: reduced appetite -.20 ns  -.19 ns  -.19 ns  -.20 ns  -.21 ns 
MDI10b: increased appetite .06 ns  .09 ns  .10 ns  .12 ns  .11 ns 
R2 (adj R2)   .11 (-.02)  .14 (-.01)  .14 (-.02)  .15 (-.02)  .15 (-.03) 
Model 1: unadjusted 
Model 2: adjusted for sex 
Model 3 adjusted for sex and age 
Model 4: adjusted for sex, age and SES 






Table 5: Standardized regression coefficients from 12 separate liner regression analyses for the association of each MDI items and diabetes self-care in type 2 
diabetes patients. 
    Model 1  model 2  model 3  model 4  model 5 
MDI1: low in spirit  .17 ns  .18 ns  .16 ns  .16 ns  .13  ns 
MDI2: lost interest  -.13 ns  -.20 ns  -.09 ns  -.17 ns  -.14 ns 
MDI3: lack of energy  .08 ns  .05 ns  .10 ns  .09 ns  .07 ns 
MDI4: less self-confident .06 ns  .04 ns  .04 ns  .09 ns  .07 ns 
MDI5: feeling guilty  .32 *  .32 *  .34 *  .36*   .35 * 
MDI6: life not worth-living -.23 ns  -.26 ns  -.24 ns  -.20 ns  -.22 ns 
MDI7: difficult concentrating  -.02 ns  -.01 ns  -.01 ns  -.00 ns  -.01 ns 
MDI8a: very restless  -.02 ns  -.00 ns  -.02 ns  -.04 ns  -.02 ns 
MDI8b: felt subdued  -.15 ns  -.14 ns  -.16 ns  -.20 ns  -.18 ns 
MDI9: trouble sleeping  -.02 ns  -.02 ns  -.01 ns  -.05 ns  -.03 ns 
MDI 10a: reduced appetite -.16 ns  -.16 ns  -.20 ns  -.18 ns  -.13 ns 
MDI 10b: increased appetite .22 ns  .20 ns  .22 ns  .15 ns  .20 ns 
R2 (adj R2)   .28 (.09)  .29 (.08)  .20 (.07)  .38 (.15)  .38 (.14) 
Model 1: unadjusted 
Model 2: adjusted for sex 
Model 3 adjusted for sex and age 
Model 4: adjusted for sex, age and SES 






The aim of the present study was to explore the associations between individual depressive 
symptoms and diabetes self-care behaviors. Our initial results revealed that only two cognitive-
affect symptoms and one somatic symptom of depression showed small associations with 
diabetes self-care even after Bonferroni correction except for the symptom “feeling life was not 
worth living”. The size of these associations decreased after statistical adjustment for potential 
confounders. However, in one unadjusted model (i.e., not correcting for age, sex and SES) we 
found that the symptom “feeling low in spirit or sad” was associated with poor diabetes self-
care, whereas “feeling life was not worth living” was associated with better diabetes self-care 
behaviors. The symptom “feeling life was not worth living” remained significant even after 
controlling for age, sex and SES but not significant after Bonferroni correction. The symptom 
“lack of energy or strength” was marginally associated with poor diabetes self-care only after 
controlling for confounding variables. Our results suggest that “feeling sad” and to a lesser 
extent “lack of energy” were linked with poor diabetes self-care behaviors. The association was 
observed for the former symptom only when considered with age, sex and SES of the patients. 
One explanation for these associations could be that these two depression symptoms interfere 
with memory, but perhaps also contribute to a lower motivation and decreased ability of a 
person to adhere to self-care activities. Feeling low in spirit or sad is a commonly (74%) used 
phrase to mean depression in Zambia [21]. Other symptoms such as “thinking too much” and 
“having a heavy heart” are cultural metaphors for fear and grief equivalent to those found in 
Zimbabwe [22-23].  
 
 The composite score and other individual depressive symptoms were not significantly 
associated with diabetes self-care. Interestingly, the ICD-10 requires any two of the following 




(anhedonia)” and “decreased energy” in order to be considered a depressive episode. The two 
core symptoms of depression, as defined in the DSM-IV, are “depressed mood” and “loss of 
interest or pleasure” [24]. Our results showed that two of these ICD-10 core symptoms were 
associated with diabetes self-care, namely “low spirit” and “lack of energy”. To some extent 
our findings support those of Van Tilburg et al who reported that variations in depressive mood 
were associated with differences in glycemic control (a critical outcome of self-care) among 
patients with type 1 diabetes [25].  This study, like ours, addressed the association between 
depressive mood and self-care although van Tilburg et al only focused on glycemic control, a 
critical outcome of self-care. Moreover, depressive mood disorders have been found to be 
higher in individuals with diabetes relative to those without diabetes, according to the World 
Mental Health Survey among community samples of adults across 17 countries including: 
Europe, the Americas, the Middle East, Africa, Asia and the South Pacific [26].  
 
The symptom “increased appetite” was the most endorsed item of the depression scale. 
Interestingly, polyphagia (to eat more) is common in patients with type 1 diabetes and is often 
caused by hypoglycemia and severe depression or stress [27]. However, this was not the case 
with our findings. In short-term human intervention studies, ingestion of high glycemic index 
(GI) foods increased hunger and lowered satiety. Literature shows that the consumption of high 
GI meals induces a sequence of hormonal and metabolic changes that promote excessive food 
intake [28]. As such, increased hunger and food intake is an attempt to restore energy 
homeostasis which could explain why the majority of patients endorsed increased appetite.  
 
The findings of this study may explain the importance of using individual depressive symptoms 
rather than depression composite scores when measuring diabetes constructs such as self-care. 




individual depressive symptoms and diabetes self-care. Thus, the association between 
depressive symptoms and self-care should not be restricted to the composite score. In our study 
the composite score was not significantly associated with self-care. In the Sub-Saharan African 
context, the conceptualization of depression and what it means is still unclear perhaps due to 
linguistic and psychological equivalence limitations (there is no word for “depression” in most 
Zambian languages, it is often expressed in a sentence; equivalent words are anxiety and fear). 
For instance, a study involving qualitative interviews among 139 women from a low income 
compound in Zambia identified symptoms of depression to include headache, unhappiness, 
disturbed sleeping patterns (problems of the mind), problems in making ends meet (worries 
and poverty), feeling of fragility and instability (mood swings), various supernatural causes, 
either bad fortune or because they thought they might be victims of an evil spell (Satan, God’s 
work) and high blood pressure (a symptom commonly said to have been caused by poverty, 
worries and problems of the mind) [21]. Like most other Sub-Saharan African countries, 
multiple somatic rather than cognitive and emotional complaints (symptoms), such as 
headaches and fatigue (related to the heart and head), are the main presentation of depression 
[22]. Therefore, it is important to understand culture-specific terminologies used by patients to 
mean depression especially that most Sub-Saharan African countries including Zambia have 
no direct equivalent term for depression but anxiety [22]. Until the conceptualization of 
depression is clear, focusing on individual symptoms and their relationship with self-care may 
prove to be important rather than the association with depression composite scores. 
 
Like other studies, our participants’ age, gender, SES and type of diabetes were significantly 
associated with self-care, moreover these background variables seem to moderate the 
relationship between depressive symptoms and self-care behaviors [29]. Being young was 




with self-care because young people often experience conflict of priorities that negatively 
affect their self-care behaviors. Young people often forget to adhere to their regimen because 
they engage in many competing activities, feel embarrassed in the presence of their peers and 
are less inclined to engage in self-care behaviors compared to adults. These results must be 
interpreted with caution because other studies suggest that older people have elevated 
depression which may interfere with their diabetes self-care behaviors compared to young ones 
[30]. Being female was negatively associated with self-care. Females are more likely to be 
depressed than men [3]. Moreover, we did find that female patients had higher depression 
scores than men in the current study, which is in line with results from the literature. We 
speculate that because women are more depressed then male patients and have more 
responsibilities (managing homes) than men, their self-care was sub-optimal. We also found 
that high socio-economic status was positively associated with self-care. Although socio-
economic status is a proxy for a wide variety of factors, these results could suggest that 
individuals with high SES have readily available money to buy healthy food, required 
medication and engage in social activities that do not side track them from self-care activities 
compared to patients with low SES. Having T2DM was also associated with problems with 
self-care.  
 
The strength of the present study is that we used individual items of the MDI, which are based 
on the DSM-IV and the ICD-10 symptoms of major depression [20]. Limitations of the study 
are that we do not know the refusal rate, therefore there might have been a selection-bias but 
is it difficult to estimate how big this selection bias was. The sample size was also small due 
to recruitment difficulties; as a consequence, probability sampling could not be used. Due to 
the limited sample size, we could not analyze our data separately for adolescents and adults, 




Interpretation of these results should be done with caution mainly because of the small sample 
size and the statistical analyses at item level, even when applying a Bonferroni correction. In 
addition, we were unable to screen for other illnesses, such as HIV, which could have a 
confounding effect on our results. Finally, we cannot rule out a possible overestimation of self-
care activities and underestimation of depressive episodes by our respondents due to social 
desirability often found in self-report measures. Moreover, the self-care inventory and the 
major depression inventory have no norms, yet still the former was not validated for the 
Zambian sample. However, in its form the SCI had items that were tapping into common self-
care activities except for one which was dropped “wearing a medic alert ID” because no 
subjects who participated in the study had any. This measure can be made more robust by 
adding items like “receiving reminders from family/friends to take medication” and “accessing 
medical essentials e.g. syringes”. 
 
Conclusions 
Although it was initially hypothesized that depression was associated with diabetes self-care, 
much of the variance seems to be explained by demographic characteristics specifically gender, 
age and SES. Therefore, clinicians need to screen and treat individual depressive symptoms in 
patients with diabetes, especially in women, young people and patients from low SES. Given 
the lack of manpower in cognitive behavioral therapy (CBT) in Zambian hospitals, in the 
meantime we recommend the use of anti-depressants in treating depression which have not 
only been found to be effective in treating depression [31-33], but are free and readily available 
in Zambian major hospitals. Specifically, if drugs are to be prescribed, we recommend the use 
of fluoxetine anti-depressants which have been found to be associated with improved glycemic 
control [35]. Not only is depression management meaningful from the perspective of a patient’s 




and maintain diabetes self-care goals [31]. In addition to depression treatment, patients with 
diabetes ought to be helped to optimize self-care by enhancing self-efficacy, healthy eating, 
physical activities, monitoring of blood sugar, and compliance to medication, good problem 
solving skills, healthy coping skills and risk reduction behaviors [13]. Therefore, interventions 
should simultaneously address depression symptoms and self-care skills to achieve optimal 
diabetes outcomes. Future studies should aim to identify Zambian symptoms of depression 
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This thesis examined psychosocial functioning in individuals with diabetes mellitus and also 
how psychosocial issues are associated with emotional wellbeing of patients in Sub-Saharan 
Africa (SSA), notably Zambia. The main goal was to understand diabetes in SSA and Zambia 
and also to identify psychosocial issues surrounding diabetes and how they relate with each 
other. To achieve this goal, the thesis addressed two themes: (1.) understanding the emotional 
factors associated with diabetes in Sub-Saharan Africa and/or Zambia (this is described in part 
one of the thesis) and (2.) psychosocial functioning in people with diabetes in Zambia in part 
two of the thesis. The following questions were addressed: 
1. What is the prevalence of diabetes in children in SSA, what are the consequences and 
risk factors for diabetes and what does diabetes care look like in SSA? 
2. What are the sources of stress, the ways of coping with stress, the perceived quality of 
care and the quality of life as experienced by Zambian adolescents living with type 1 
diabetes? 
3. Does the Zambian version of the Problem Areas in Diabetes (PAID) have sound 
psychometric properties and what are the levels of diabetes-specific emotional distress in 
people with diabetes in Zambia? 
4. How common is co-morbid depression in individuals with diabetes in Zambia? 
5. What is the association between symptoms of depression with diabetes self-care in 
individuals with diabetes? 
 
Although scientific evidence should guide and inform health care providers, policy makers and 
more importantly people with diabetes, published data on diabetes mellitus in Africa remain 
scarce [1]. Therefore, part 1 of the thesis aimed to increase our understanding of the prevalence 




questions addressed under this part were: What is the prevalence of diabetes in children? What 
are the consequences and risk factors for diabetes and what is the quality of diabetes care in 
SSA? This question was addressed in chapter 2 of the thesis using a narrative review of the 
literature on diabetes. This literature review revealed that many incidence studies have 
excluded children, due to lack of comprehensive statistics on children. A few studies suggested 
that the prevalence of diabetes in general is on the increase in the region. The causes of diabetes 
were similar with other regions but the peak age for the onset of diabetes and consequences of 
diabetes seemed to differ from other regions. Given that there were little data on diabetes in 
children and adolescents, particularly data relating to psychosocial issues affecting young 
people with diabetes in SSA, chapter 3 addressed the question: What are the sources of stress, 
ways of coping with stress, perceived quality of care and quality of life as experienced by 
Zambian adolescents living with type 1 diabetes mellitus (T1DM) from the viewpoints of the 
adolescents themselves, their caregivers and their health care providers? A qualitative design 
was used to address these questions. Results using thematic content analysis suggested that 
stress was common among adolescents with diabetes and their immediate family members. 
Various coping strategies were employed although some strategies were maladaptive such as 
avoiding injecting themselves with insulin. Quality of life and diabetes health care were 
suboptimal. The results of this study suggested that psychosocial issues affecting patients 
worldwide also affect patients in Zambia. Socioeconomic issues, such as poor health care and 
non-availability of medical essentials and other psychosocial issues, such as restricted lifestyle 
choices, should be incorporated in treatment models. 
 
Part 2 of the present thesis aimed at examining psychosocial functioning in people with 
diabetes in Zambia. This part of the thesis was necessary because little is known about 




reasons for the lack of information on psychosocial functioning and dynamics in individual 
with diabetes is a dearth of good, validated measurement tools. Therefore, the third question of 
the thesis addressed in chapter 4 was: Does the Zambian version of the Problem Areas in 
Diabetes (PAID) have sound psychometric properties and what are the levels of diabetes-
specific emotional distress in people with diabetes in Zambia? Using Exploratory Factor 
Analysis, results revealed that a one factor model was suitable for the Zambian version of the 
PAID, consistent with other validation studies done elsewhere [2-4] but not with others [46-
49]. Cognitive interviews on the content of the PAID items showed that participants were able 
to comprehend the questions but some participants faced some challenges with the meaning of 
some words such as “anxious” and “physician”. Diabetes-specific emotional problems were 
common in individuals with diabetes. These results suggest that the PAID is a good measure 
that clinicians and researchers in the area of diabetes can use. Given that diabetes-specific 
emotional problems are common in individuals with diabetes, there is need for a combined 
effort by different stakeholders to implement intervention programs aimed at reducing 
diabetes-specific distress in individuals with diabetes in Zambia. 
 
According to the World Health Organization, depression is one of the major leading causes of 
disability in the world [5]. In people with diabetes, depression increases risk of poor glycemic 
control, the development of diabetes complications, low adherence to treatment, poor quality 
of life, higher health-care utilization and cost, loss of productivity, increased disability and 
increased mortality rates [6-7]. Given the documented consequences of diabetes and co-morbid 
depression, chapter 5 addressed the question: how common is co-morbid depression in 
individuals with diabetes in Zambia? The study results revealed that, although a global WHO 
study showed that the odds of depression were not increased in African people with diabetes 




to healthy controls. Our findings are in line with other studies that demonstrate that depression 
is common in individual with diabetes [8-9] and there is need to diagnose and treat depression 
in people with diabetes. 
 
There is evidence that depression relates with negative self-care behaviors, such as infrequent 
fruit and vegetable intake, frequent saturated fat intake, more sedentary lifestyle and fewer 
exercise sessions per week than non-depressive diabetes people [10]. This research and the 
previous study support the thesis that depression is common in people with diabetes. Chapter 
6 addressed the question: what is the association between symptoms of depression and diabetes 
self-care behaviors in individuals with diabetes? The results revealed that depression was 
indeed associated with less optimal diabetes self-care behaviors, yet most of the variance in 
self-care was explained by socio-demographic characteristics and having type 2 diabetes. 
These results suggest that depressive symptoms may exacerbate poor diabetes self-care in 
people with diabetes especially when patients are young, female, poor and have type 2 diabetes.  
 
Different Perspectives and Their Integration 
There seems to be a sharp increase in the prevalence of diabetes. In the 1990s, diabetes was 
seen as a rare medical condition in Africa [11]. The recent International Diabetes Federation 
atlas estimated that about 22 million people in SSA are living with diabetes [12]. Although the 
prevalence of diabetes is increasing in SSA, the prevalence rate of 5.1% is still lower compared 
to 9.7% in the Middle East and North Africa, 7.9% in Europe, 8.3% South-East Asia, Western 
Pacific 8.5%, North America and Caribbean 11.4% and South America 8.1% [12]. These 
differences may be due to poor diabetes case record keeping and misdiagnosis (undiagnosed 
diabetes cases are estimated at 13 million plus in SSA) [12]. In addition, some persons who 




their conditions are registered. As a result, the prevalence rate may seem lower than in other 
regions. 
 
The fact that research on diabetes in SSA is relatively scarce compared to developed countries, 
probably has negative effects for the people with diabetes in SSA, because many policy makers 
and clinicians still think diabetes is a rare disease and misunderstand its clinical characteristics. 
As of 2010, there were only 84 published studies on diabetes in SSA [13]. Most of these studies 
were epidemiological in design and may not have had a complete picture of the extent of 
diabetes prevalence because most cases of diabetes remain undiagnosed. Studies on children 
with diabetes especially with T1DM are almost not available and there are claims that there is 
evidence of T2DM in overweight African children. There is a sharp difference between SSA 
and Western countries in terms of availability of data on the prevalence, incidence of diabetes 
and psychosocial challenges that are faced by people with diabetes. There are three main 
reasons for these differences: 1. Sub-Saharan African countries face a large burden of 
communicable diseases such as malaria and HIV/AIDS, consequently both the international 
community and local stakeholders including researchers have focused their attention on the 
communicable conditions at the expense of non-communicable ones such as diabetes. 2. SSA 
is characterized by a lack of resources that are essential in the process of identification and 
treatment of diabetes. 3. Policy guidelines on diabetes are either weak or nonexistent in most 
SSA countries. In addition, Africa is now just experiencing a demographic transition. Due to 
changes in lifestyle, people are becoming more sedentary, having a higher access to refined 
food, so the threat or burden of diseases like diabetes is really now emerging as a serious 
problem while in the past this was less of an issue.These factors among others are probably the 





There seem to be interethnic differences in the onset of diabetes and diabetes-related 
complications. Generally, the peak age of diabetes onset in African patients seems to be 
delayed compared to other ethnic groups. For instance, a study in South Africa demonstrated 
that the peak age of the onset for type 1 diabetes in Africans was at 22-23 years with early peak 
between the age 14-17 years later than white counterparts whose peak age was between 12 and 
13 years [14]. Environmental factors and social determinants could explain the variations for 
diabetes onset across different ethnic groups (see Appendix 1). Comorbidity such as depression 
[6-7] is common in diabetes patients. However, compared with developed nations, African 
people with diabetes also tend to be infected with illness such as malaria and HIV and AIDS 
[15-17]. Diabetes is often misdiagnosed as HIV and malaria [18]. Lack of diagnostic tools and 
trained health care providers are the factors behind misdiagnosis of diabetes in SSA. Another 
observation is that life expectancy in SSA children with diabetes is shorter compared to other 
regions of the world. On average, a child with diabetes only lives as short as 5 years and 
sometimes 1 year depending on the region [19-20], meaning quality of life is lower and life 
expectancy is shorter in children with diabetes compared to healthy children in SSA. Again, 
lack of resources, medical essentials and lack of proper skills among health care providers 
could explain this disparity with the west. 
 
Stress in adolescents in Zambia often stems from lack of physical and social support systems. 
Access to health facilities and medical commodities are the number one source of stress in the 
young people with diabetes and their families. It seems as if some of the adolescents do not to 
have necessary social support from their communities and families. Consequently, many 
adolescents living with diabetes in Zambia face numerous hurdles. The situation is made even 
more difficult because some adolescents with diabetes appear to use maladaptive coping 




wellbeing of the adolescent with diabetes. Yet, mental health services to help adolescents 
develop adaptive coping strategies were either weak or nonexistent. It was interesting to note 
that stigma in people with diabetes is perpetuated by different mediums and the cause of stigma 
seemed to differ across cultures. In Australia, stigma was found to be perpetuated by media, 
friends, health care professionals and teachers who often had a notion that diabetes was a self-
inflicted condition and stigmatization often took the form of negative social judgments and 
exclusions from activities [21]. In Iran, persons with T1D were reported to be stigmatized as 
miserable humans, rejected marriage candidates and were deprived of a normal life because 
they were equated to disabled people who could not enjoy life [22]. In Zambia it was negative 
social judgment and exclusion from activities like in Iran because it was believed diabetes was 
a contagious disease and that it negatively affected the reproductive system of female patients 
[44]. While in Australia it is seen as a self-inflicted disease carrying a negative connotation, in 
Zambia, type 2 diabetes is perceived as a disease for the rich “opulence” and a disease that 
separates the rich from the poor. 
 
Worrying about diabetes, treatment barriers, diabetes symptoms, poor communication and 
family burden seem to be the major factors that contribute to a poor Quality of Life (QoL) 
children with diabetes elsewhere [23]. Our study showed similar findings; additionally, limited 
sense of independence and low social participation were the main issues that seemed to affect 
QoL in the adolescents. These topics (sense of independence and social participation) are 
developmental issues that are extra important for adolescents. 
 
Interestingly, contrary to the earlier global WHO study which showed that the odds of 
depression were not increased in African people with diabetes [6], we found that depression 




Social and cultural factors could explain the prevalence of depression. People with depression, 
as explained in Chapter 3, are often stigmatized and face a lot of financial burdens associated 
with diabetes management. Cultural variations in the conceptualization of depression and 
differences in measurement tools (questionnaire vs. diagnostic interviews) may further explain 
why the WHO study did not find increased odds of depression in people with diabetes in Africa. 
Furthermore, the WHO study did not use data from Zambia. In addition, it was interesting and 
clinically relevant to learn that two depressive symptoms were associated with less optimal 
diabetes self-care although much of the variance was explained by socio-demographic 
characteristics of the participants. There are two implications for these results: (1.) depression 
symptoms may have a stronger association with self-care behaviors in females and type 2 
diabetes people. (2.) It is important to critically assess the reliability and validity of depression 
measures in different groups of people with diabetes and across cultures and nations for the 
screening of diabetes to be effective in Africa. More importantly, indigenous measures 
especially diagnostic interviews must be developed for proper assessment of depression.  
 
Potential Pathways that Link Emotional Stress and Diabetes Mellitus 
Emotional stress was a dominant variable throughout this thesis. Therefore, a description of 
the potential pathways that link emotional stress and diabetes mellitus is warranted. The 
literature suggests behavioral and bio-physiological mechanisms as the two main pathways that 
explain the link between emotional stresses especially depression and the development of 
diabetes mellitus [24]. Below is a review of such studies. 
 
Behavioral pathway that links stress, the development of diabetes and diabetes outcomes 
The associations between emotional stress, the development of type 2 diabetes and diabetes 




challenging diabetes self-care activities and the development of hypoglycemic events or the 
long-term complications of diabetes can be sources of stress. Different emotional reactions 
especially depression and anxiety have been associated with unhealthy lifestyle and poor self-
care behaviors in the general population [25, 26] but also in people with diabetes [27]. 
Unhealthy lifestyle behaviors, such as eating excess calories, low exercise, smoking and 
alcohol abuse, are all leading risk factors for the development of type 2 diabetes [24]. Not only 
does emotional stress, particularly depression, lead to the risk of developing diabetes, but also 
impair a range of self-care activities such as adherence to the prescribed treatment (testing 
blood glucose levels, adjusting insulin, physical inactivity and/or poor dieting) [28]. All these 




Chronic stress is an important risk factor for depression. Both chronic stress and depression are 
related to a number of bio-physiological changes that may lead to increased risk of developing 
type 2 diabetes or complications of diabetes. Studies have demonstrated that chronic stress and 
depression are often characterized by long term activation of the hypothalamic-pituitary-
adrenal axis and the sympathetic nervous system, all related to the development of abdominal 
obesity [24]. Therefore, it appears that depression moderates this relationship and may explain 
why depression or chronic stress increase the risk of developing type 2 diabetes [29]. Another 
potential pathway in which biological mechanisms may predispose depression towards the 
development of diabetes involves HPA-axis hyperactivity and sympathetic nervous system 
(SNS) activation. Specifically, depression has been associated with HPA-axis hyperactivity 
and enhanced SNS activity resulting in excessive cortisol exposure, catecholamines and 




HPA axis, SNS and inflammatory responses are connected such that activation of the HPA axis 
results in simultaneous activation of SNS. Then SNS activation stimulates releases of 
interleukin (IL)-6, activating the inflammatory cascade and increasing cytokine release [30]. 
As a result, these integrated biological systems can enhance insulin resistance which leads to 
the development of type 2 diabetes or worsening of glycemic and metabolic outcomes in 
individuals with already established diabetes. The above mentioned pathway is illustrated 
graphically in Appendix 2. 
 
There is also evidence that inflammatory mechanisms are involved in depression [31]. The rise 
in the concentration of cytokins and glucocorticids particularly cortisol, in response to chronic 
stress and depression contribute to behavioral changes associated with depression [24, 31]. A 
meta-analysis has shown that depression is related to increased levels of pro-inflammatory 
markers [32]. Inflammatory processes may be common antecedents of stress vulnerability, 
depression and type 2 diabetes, which can develop in parallel or in succession [24]. In another 
study, inflammatory processes were shown to play a role in the development of type 2 diabetes 
[45]. 
 
Although the above outlined potential pathways indicate the association between 
psychophysiological factors and diabetes, little is known about the mechanisms by which 
psychological issues such as depression and chronic stress increase the risk of the development 
of type 2 diabetes. In addition little is known on the intricate relationship between the 







Psychosocial perspective on diabetes in Zambia 
To be able to address psychosocial issues affecting Zambian patients with diabetes, treatment 
must be first made available and patients should be screened for depression and other 
psychological issues and then document different information relating to diabetes. One of the 
biggest challenges of managing diabetes in Zambia and in SSA in general, is lack of a good 
surveillance system that feeds into the national health system to provide trends and to measure 
exposure (e.g. risks factors and social determinants), outcomes (e.g., morbidity and mortality), 
and health system capacity and response to  diabetes management and care [51]. Providing data 
on trends and exposure will probably not only improve treatment and prevention of such cases 
but also help allocation of resources to high prevalent trends and exposures. It is also important 
for clinicians to begin to educate patients on not only physical complications of diabetes, but 
also psychosocial complications associated with diabetes. Health care providers, the diabetes 
association, health policy makers and perhaps also the pharmaceutical industry should join 
forces to empower the people with diabetes and their family with more knowledge about 
diabetes management, and make sure that they have the self-care tools they need. The studies 
in this thesis have shown high a incidence of psychosocial problems associated with diabetes 
such as stress, depression, stigma and discrimination, family support, access to essential 
commodities and resources to meet certain demands of diabetes such as food. It is expected 
that these psychosocial problems will increase and even complicate diabetes screening, 
treatment and care in Zambia especially with the rapid urbanization which will have impact on 
prevention, management and treatment of diabetes especially among the poor and slum 
dwellers.  Urban growth rate in Zambia was 4.2% in the 2000-2010 census from 1.5% in 1990-
2000 period [55]. With this increase, diabetes inequities will rise due to comorbidities 
associated with an aging population and other environmental agents such as viruses that may 




accompany urbanization [51]. Moreover Sub Saharan African consumers are increasingly 
aspiring for fast food choices and Zambia is among the top fast food establishment destination 
[52]. Consequently, urbanization and its consequences on diabetes may increase the risk of 
stress and depression which will exacerbate diabetes care. The development of stress and 
depression associated with urbanization may also led to the development of diabetes. The circle 
is a vicious one which may also led to other psychosocial problems such as increase in 
treatment cost, discrimination, and poor quality of life among others. 
 
Psychological needs are often attended to if immediate physiological needs are met. I propose 
the application of Maslow’s hierarchy of need theory to some of the psychosocial problems 
affecting patients with diabetes in Zambia. The application of Maslow’s theory is useful in this 
case because a robust health system firstly has to focus on prevention and medical treatment of 
diabetes and its complications and then on the negative psychosocial factors affecting people 
with diabetes [53]. Most psychosocial issues are as result of challenges meeting basic needs. 
Lack of insulin for example may be worrisome for patients which may contribute to stress and 
other psychosocial problems. The theory argues that basic needs are to be met for the 
satisfaction of higher needs to be sought [54]. 
  
Physiological needs 
Physiological needs are the physical requirements for human survival. If these requirements 
are not met, the human body cannot function properly and will ultimately fail [54]. 
Physiological needs are thought to be the most important; they should be met first. In relation 
to type 1 diabetes, insulin, proper diet and food, absence of other potentially life threatening 
illness such as HIV and AIDS and resources to meet basic requirements are important 




life threatening disease such as cardiovascular disease, access to health facilities, patients need 
education that aids survival [53]. For both type 1 and 2 diabetes policies that support provision 
of care and access to insulin and oral medication, and blood glucose measures in case of insulin 
treatment are useful, this can be accomplished with government subsidies, for example and 
help from international organizations such as International Diabetes Federation, International 
Insulin Federation and the World Health Organization [53]. In Zambia, this remains a 
formidable task for patients, policy makers and clinicians. As discussed in chapter 1 and 3, 
most patients still cannot afford physical requirements needed to survive with diabetes. It’s 
either patients cannot afford to buy essential medical commodities such as insulin for type 1 
diabetes patients or cannot afford a proper diet recommended for diabetes patients especially 
among type 2 diabetes patients. Moreover in Chapter 4, 40% of participants reported feeling 
deprived of food and meals. Access to medical facilities that can diagnose and manage diabetes 
is still a big challenge given that only big hospitals have specialized manpower to handle such 
disorders. This adds pressure to an already strained family on transport costs to such facilities. 
Coupled with the above challenges this leads to increased risks of misdiagnoses and late 
detection of diabetes. It is not surprising why the life expectancy of diabetes patients in Zambia 




If physical needs are relatively satisfied, the individual seeks safety needs at the individual, 
family or community level which often dominate behavior. For patients with diabetes safety 
and security needs should cover personal security, financial security, health and well-being 
security to able to satisfy safety needs. For individuals with type 1 and 2 diabetes (those who 




seeking helpful diabetes related information that can increase their safety. According to Beran 
information and education on diabetes can be a source of safety and can protect patients from 
potentially life threatening consequences of diabetes [53].  In addition, particularly for type 2 
diabetes, proper diet and exercising are protective factors. At the family and community level, 
interest must be developed by family members, peers and schools teachers for example to 
identify signs of hyperglycemia and hypoglycemia in order to help patients when they 
encounter such episodes. In Zambia, there is need to improve safety needs of patients’ 
especially through education to patients and family members. It was dreadful for example to 
learn that family members gave life threatening advice to young people with diabetes to stop 
injecting themselves with insulin and evidence that some adolescents engaged in maladaptive 
strategies of coping such as avoiding injecting themselves with insulin.  
 
Belonging needs 
After physiological and safety needs are fulfilled, the third level of human needs is 
interpersonal and involves feelings of belongingness. In terms of diabetes care and 
management, a conducive working relationship between a health care provider and a patients 
is a very important need. Patients need to few valued and cared for not only by health care 
providers but also by family members, peers, spouses, classmates and so on. Patients everyday 
experiences should make them feel they belong to a caring and loving family or community, 
free of discrimination and stigma. If patients feel they have adapted and are part of the wider 
community they will also be open about their condition adding even more support from peers 
and community members [53]. Moreover, many patients are susceptible to social anxiety, 
stress, and depression. Therefore, a strong sense of belonging can be a buffer to such 
psychosocial experiences. In Zambia, sensitization and education programs on diabetes for 




belonging of diabetes patients but also a fast track to help improve their self-esteem needs. In 
Chapter 3, stigmatization and discrimination were found to be common among people with 
diabetes. Peers discriminated their friends with diabetes because they felt diabetes was a 
contagious disease and society had belief that diabetes patients were not reproductively fit and 
had low status value in romantic relationship especially among girls; all these factors have 
potential to decrease a sense of belonging of a person. Moreover, in Chapter 4, 48% of patients 
reported that they felt friends or family members were not supportive of their diabetes 
management efforts. 37% reported experiencing uncomfortable interactions around diabetes 
with family or friends and 40% felt alone with diabetes. 41% felt they were not satisfied with 
their diabetes physician suggesting they had bad experiences in their relationship with their 
health care providers. 
 
Self-esteem needs 
Once a person’s belonging needs are met, a person strives to meet self-esteem needs. Human 
beings have a need for self-respect, need to be accepted and to be valued by others. From the 
diabetes perspective, people with diabetes need to feel accepted and valued by others, despite 
their condition. Patients with diabetes also need high self-efficacy, motivation and self-
confidence especially to manage their diabetes. Meeting this need is often challenging 
especially to children and adolescents. Psychological imbalance such as discrimination, 
depression and denial (not accepting diagnosis of diabetes) can be a bottleneck for a person to 
obtain high levels of self-respect and esteem. Deprivation of these self-esteem needs may lead 
to an inferiority complex, weakness, and helplessness which in turn may affect diabetes care. 
In general, in Zambian patients, there is need to improve self-esteem. For instance 58% of 
participants in Chapter 4 reported feeling guilty when they got off track with their diabetes 




independence due to strict monitoring from parents or guardians. It is also likely that many 
patients’ self-esteem was dampened following stigma and discrimination they faced due to 
their diabetes. As alluded to earlier, psychological imbalances such as depression, stress and 
diabetes specific distress, all found to be common among patients with diabetes in this thesis 
can hinder a person from obtaining a higher level of self-esteem or self-respect. 
 
Self-Actualization need 
This level of need is the highest in the hierarchy and refers to what a person's full potential is 
and the realization of that potential. According to Beran the person that describes “diabetes as 
something positive” do this in that they not only accept their intrinsic situation, but also help 
others and in some cases push the limits in terms of achievements (e.g. athletics) to a level that 
most cannot achieve [53]. This level is best summarized by Abraham Maslow’s’ own word 
“what a man can be, he must be” [54]. Zambian patients must be molded into feeling that they 
can be the person that they want to be, and achieve whatever they want to achieve. Doubts in 
adaption in future roles e.g. work and romantic relationships reported in chapter 3 must be spelt 
out through education and providing role models who have diabetes and have made high 
achievement in life. Winnie Mandela, Tom Hanks, Randy Jackson, Larry King and Halle Berry 
all have type 2 diabetes. Jack Cultler, a Chicago Bears quarterback, and the Singer Nick Jonas 
have type 1 diabetes. The actress, Salma Heyek, had gestational diabetes.  Models like these 
can help push young people with diabetes to achieve their self-actualization needs. 
 
Methodological Considerations 
The studies presented in this thesis have several strengths and limitations. This section reviews 






The studies included in this thesis were a narrative literature review (chapter 2), a qualitative 
study (chapter 3) and cross-sectional studies (chapter 4-6). Triangulating different designs 
enhanced the validity and credibility of the findings by comparing information obtained from 
different data collection methods; document reviews, interviews and cross-sectional data 
(questionnaires). Document review and interviews enabled collection of vast and rich 
information which would have not been possible using questionnaires. Cross-sectional designs 
are especially useful when testing different age groups, gender groups and type of diabetes as 
was the case with the studies described in this thesis. This enabled the thesis to obtain a wealth 
of information on group differences across age, sex, diabetes type and SES groups. However, 
the results of the cross-sectional data presented in the thesis should be interpreted with caution 
because of the small sample size used across the studies and the item-level (detailed) analyses, 
which would require cross-validation. The nature of the designs in this thesis does not allow to 
draw causal inferences from our studies. Randomized control designs can give more insight 
into the cause and effect of the variables covered in the studies. In addition, observational data 
such as those covered in the thesis involving mostly cross-sectional studies are likely to be 
confounded by other variables. Although potential confounders were controlled in the analyses, 
other confounders, such as duration of diabetes, self-efficacy of a patient, HbA1c levels and 
other biological markers, were not taken into account. Further, data on participation refusal rate 
were not available. As a result, it is not possible to estimate to what extent selection bias may 
have occurred. Persons who refuse to participate in a study may have important information 
that could not have been obtained from others. Participation refusal and non-response may 
increase uncertainty about the results and threaten the generalizability of the results especially 
that the sample size was very small in all the studies due to difficulties in accessing patients 





The tools of data collection used in this thesis were interviews and self-report measures. The 
use of mixed methods in this thesis strengthened the validity of findings and recommendations, 
as a mixed methods approach is useful to broaden and deepen our understanding of 
psychosocial processes involved in diabetes mellitus. However, both techniques may suffer 
from bias resulting from social desirability which can increase measurement error. Social 
desirability occurs when participants aim to answer questions in a manner that will be viewed 
favorably by others. It can result in over-reporting “good behavior” and under-reporting “bad” 
or undesirable behavior. Further, physiological measures of diabetes such as HbA1c levels were 
not used in the current studies because such data were not accessible at the time of data 
collection due to ethical and resource restrictions. Combining self-report and physiological 
measures can give more accuracy in the measured attributes. In addition, although these 
measures were validated, there were no established norms to be used as a benchmark for 
comparison with other studies in the same area.  
 
Assessment of our key variables 
The main psychological constructs that were used in this thesis were stress, diabetes-specific 
distress, self-care and depression. These terms were used in a general manner. For instance, the 
meaning of depression included depressive episode, depressive disorder and depressive 
symptoms. In addition, we only used self-report measures instead of diagnostic interviews seen 
as a gold standard for assessing depression. Evidence suggests that these two ways of assessing 
depression can produce different results. For example, 70% of diabetes patients with elevated 
self-reported depressive symptom scores do not meet diagnostic criteria for major depression 
disorder on the basis of a structured clinical interview [33]. The implication for this limitation 




measures could have threatened the validity of the study results. To improve on the validity of 
the study results, participants were: 1.) Instructed to be as honest as they could when answering 
items on scales; 2.) Items on scales were both positively and negatively worded to counter 
response set; 3.) Standardized measures with a strong reliability index were used to collect 
data. 
 
Practical and Clinical Implications 
This thesis provides results that have several implications for research and clinical practice. 
The studies presented in the thesis demonstrate an intricate relationship between psychosocial 
factors and diabetes mellitus. Psychosocial issues have been documented to affect quality of 
life in people with diabetes and the potential benefits of including skilled psychosocial support 
services in the multidisciplinary program of diabetes care have been suggested [34]. Thus, 
identification and treatment of psychological issues affecting people with diabetes seem 
warranted in order to improve the quality of life and outcomes of these patients. 
 
Identifying emotional problems in patients 
Chapter 3 through chapter 5 identified several psychosocial issues affecting people with 
diabetes. Among them were adaptation problems vis-à-vis managing diabetes, worrying about 
the future especially regarding adjusting in adult roles, such as job demands and finding 
romantic partners, worrying about low sugar reactions, worrying about the future and possible 
health complications, getting anxious when they got off track with diabetes management and 
feeling that diabetes was taking up too much of the mental and physical energy. Consequently, 
there is need to identify emotional problems that affect people with diabetes using reliable and 
valid measures. Chapter 4 and 5 demonstrated that the PAID and MDI were reliable measures. 




practitioners can use the PAID and MDI to assess diabetes-specific distress and depression in 
Zambia. These measures may be useful especially that evidence shows that only 25% of 
emotional stress is identified in clinical practice among people with diabetes [35]. Moreover, 
the America Diabetes Association global guidelines for T2DM recommend that an assessment 
of the patient’s psychological and social situation should be included as an ongoing part of the 
medical management of diabetes [36].  
 
Identifying psychosocial problems affecting people with diabetes require clinicians and other 
health care practitioners to be able to recognize such problems and attend to them. There is 
need to educate health care providers on recognizing and detecting psychosocial issues such as 
depression and emotional stress [37]. The effectiveness of educating healthcare providers to 
recognize depression for example was tested in a randomized trial and it was found that 
education was well received by participants (healthcare providers), 80% of whom thought it 
would change their management of patients with depression [48]. 
 
Treatment of diabetes-specific stress and depression 
There is evidence that Cognitive Behavioral Therapy (CBT) and antidepressants are effective 
in reducing levels of depression in people with diabetes [39-40]. After reviewing four published 
and completed randomized controlled trails testing psychosocial therapy for depression in 
diabetes, two controlled pilot studies of group CBT and two unpublished RCTS on CBT and 
additionally five systematic reviews/meta-analyses assessing the effectiveness of psychosocial 
treatment of depression in diabetes, the conclusion was that psychosocial interventions, 
particularly CBT, are effective in improving depression in patients with diabetes [40]. 
Additionally, results showed that psychosocial interventions were effective when used in 




psychosocial interventions, eight pharmacological studies and three collaborative care 
interventions, concluded that CBT and antidepressants (including serotonin re-uptake 
inhibitors–SSRIs, nortryptyline and buproprion) examined separately or in collaborative care 
approach are effective in treating depression in patients with diabetes [39]. Therefore, there is 
a need to train health care providers in CBT and combine CBT with other less costly 
community-based interventions such as peer support intervention. 
 
The effectiveness of current treatments for depression and diabetes-specific distress should not 
be overestimated, since a considerable percentage of depressed patients do not respond to 
treatment [37]. For instance, about 45% of the intervention group still had significant 
depression symptoms 12 months after the intervention and some had recurrence of depression 
[41]. In addition, most psychosocial intervention studies on depression have focused on adult 
populations; there is little evidence on their effectiveness in children and adolescents. Lastly 
the effectiveness and efficacy of these programs have hardly been tested in SSA context. 
Therefore, RCT should be employed to evaluate the effectiveness of such interventions in the 
Zambian context. Additionally, cultural appropriateness and contextual effectiveness of such 
interventions (especially given the constrained resources) need to be evaluated. More 
importantly, mental health services should be promoted and encouraged to patients with 
chronic illnesses in Zambia. Currently, mental health services are weak or non-available in 
most health institutions in Zambia with exception for those relating to HIV and AIDS and these 






Recommendation for Future research 
The thesis established a number of gaps that may require future research to advance the field 
of psychosocial functioning and diabetes in Zambia and elsewhere. In this section, 
recommendations for some areas that may require future research are suggested. 
 
Review of diabetes literature in SSA showed that epidemiological data on diabetes is lacking 
and sometimes inaccurate especially among children. In order to advance our understanding of 
the impact of and on psychosocial functioning, there is need for more epidemiological studies 
to establish the incidence and prevalence of diabetes and prospective studies on common 
psychosocial issues affecting people with diabetes especially children will be needed. At the 
time only two studies in Africa examined psychological problems specifically depression, in 
people with diabetes [8-9]. The dearth of epidemiological and psychosocial data on diabetes is 
a bottleneck to the provision of quality care for children affected with diabetes in Zambia and 
other similar settings. Therefore, in the future there is a need to invest in large-scale studies to 
provide an adequate evidence base for developing intervention programs for people living with 
diabetes in Zambia. 
 
Chapter four of the thesis demonstrated that the PAID had good psychometric properties for 
assessing diabetes-specific distress. This preliminary evaluation indicated the PAID provides 
an initial, useful measure for assessing diabetes-specific distress. However, there is a need to 
establish the latent structure of the PAID using confirmatory factor analysis in future studies. 
In addition, the PAID will need to be adapted and enriched to cover other diabetes specific-
emotional items such as worrying about finding romantic partners, worrying about being able 
to adapt and fit well at work or future occupations and other stigmatization associated with 




reported in the qualitative study in chapter 3. Further in chapter five, a self-report measure 
(MDI) showed that depression was common in patients with diabetes. As noted earlier, self-
report measures for depressive symptoms and structured interviews based on MDD diagnostic 
criteria tap into different constructs that have independent association with diabetes. Due to 
logistical reasons (e.g., time restrictions, financial resources and adequate access to clinicians 
who can carry out the clinical interview) I used a self-report questionnaire. Future studies 
should use both self-report and structured interviews to assess depression in patients with 
diabetes. Moreover, the gold standard for a research on depression is the structural clinical 
interview that uses the DSM IV criteria for illness [42]. In addition, using individual depressive 
symptoms was more effective than using composite scores of self-report measures when 
investigating the association between depression and diabetes self-care. Future research should 
examine this relationship using diagnostic clinical interviews. It will also be interesting to 
examine the relationship between individual depressive symptoms with other diabetes-specific 
areas such as fear for hypoglycemia and glycemic control. 
 
Test scores obtained in different cultural populations cannot be interpreted in the same way 
across studies [43]. Therefore, cross-cultural variations in the conceptualization of depression 
and other psychosocial issues will need further research in the future in order to draw valid 
conclusions and formulate effective treatment plans. Differences in sociocultural backgrounds 
between African nations and Western nations may influence the assessment of depression as 
we know it and measured by most questionnaires and interviews. For example, painful heart, 
fear of witchcraft, worry about poverty are all symptoms of depression in Zambian low SES 
communities which may differ in high SES communities and yet still for developed countries 
[50]. Furthermore, norms must be established for the measures that were used in the studies in 





Given the bidirectional relationship between diabetes and depression, policy makers, patients 
and family members can all play a role in minimizing the implications of this relationship. 
Zambian Policy makers should develop policies that encourage and prioritize screening and 
treatment of both diabetes and psychosocial issues especially depression affecting people with 
diabetes. This direction will over time have a trickledown effect on Zambian health care 
providers’ capacities and mandate to screen, treat and educate patients on the two disorders. If 
patients are educated about the two disorders and there is a deliberate policy to screen and then 
treat depression in diabetes patients, patients may put in more effort to buffer depression 
including other psychosocial issues affecting people with diabetes and improve self-care 
activities.  
 
Although the etiology and management of type 1 and 2 diabetes are different, there are no 
major differences in the way depression affects Zambian patients with diabetes whether they 
are young (adolescents) or old (adults). However, young patients seemed to have poorer self-
care scores compared to adults which in itself may increase symptoms of depression. Therefore 
clinicians should pay even more attention to young patients and females: the former seemed to 
score high on depression compare to male counterparts. Age and type of diabetes did not predict 
diabetes specific distress either although depression did predict diabetes-specific distress. This 
data has implications in clinical care of Zambian patients; all patients should be treated (young 
or older, with type 1 or type 2 diabetes) that are susceptible to depression particularly women 
who seemed to score even high scores than men. At the family level, there is need for increased 
family support regardless of age or type of diabetes although women and girls should be given 






The present thesis showed that diabetes is increasingly affecting a lot of people in Zambia and 
in SSA. Many people in Zambia with diabetes seem to register high levels of psychological 
problems especially depression and diabetes specific distress compared to other countries. 
Methodological issue in differences in socio-cultural expressions of depression may explain 
differences in the results observed in the thesis with those of the developed world. For instance, 
the study on depression in chapter 5 showed major differences in results with those reported in 
Denmark, USA and Nigeria because of different measurement tools (MDI vs Beck depression 
inventory for example) used for depression in the reported studies. Socioeconomic factors may 
also explain results in chapter 4 on diabetes-specific distress that differ with those of countries 
like USA, Sweden, Norway Netherland. These countries have strong economies, easy access 
to diabetes care, support from nurses, and easy access to oral medication, insulin and blood 
glucose measurement material, which may explain why Zambian patients reported high distress 
in comparison to the aforementioned countries. Health authorities and policy makers in 
developing countries face the challenge of improving health. In particular, clinicians and other 
stakeholders should concentrate on improving diagnosis, improve care and sensitizing the 
communities on prevention measures. Lack of health care resources, stress and stigmatization, 
poor health care and inadequate advice by family and friends, due to a lack of knowledge are 
common problems in Zambian adolescents with diabetes which health facilities should 
incorporate in care. Health care professionals must also be concerned with the mental health of 
diabetes patients’ particularly diabetes-specific emotional stress, depression and the potential 
negative effects of depression on medical outcomes and diabetes self-care. Clinicians need to 
register and treat individual depressive symptoms in patients with diabetes, especially in 
women, young people and patients from low SES. In addition to depression treatment, patients 




eating, physical activities, monitoring of blood sugar and compliance to medication, good 
problem solving skills, healthy coping skills and risk reduction behaviors. Mental health 
services, particularly problem-focused therapy, could help reduce levels of depression and 
improve the quality of life of patients. Therefore, interventions should simultaneously address 
depression symptoms, emotional problems and self-care skills to achieve optimal diabetes 
outcomes. In all, there is need to make treatment accessible and improve the quality of medical 
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There is an increase in the incidence of diabetes in Africa. A review of literature showed 
evidence of increased risk of several psychosocial problems including depression, anxiety and 
distress among others among individuals with diabetes (Chapter 2). Although there is abundant 
evidence in developed nations, little is known about the psychosocial issues affecting people 
with diabetes in Zambia. Therefore, the aim of this research was to examine psychosocial 
dynamics and functioning in individual with diabetes. 
 
Given the lack of research on diabetes in Zambia, it was important to understand diabetes in 
adolescents and how it affects their everyday experiences. Therefore, chapter 3, using 
structured interview explored stress, stress coping strategies, quality of care and life of 
adolescents with diabetes among 10 adolescents, 8 caregivers and 4 health practitioners. 
Results showed that diabetes had a huge impact on adolescents such that they had to make 
lifestyle adjustments in order not only manage the disease but also fit in with their healthy peers 
at school or at home. The adjustments they made include those involving diet and participating 
in activities they previously engaged in such as those requiring them to stay away from home 
for a long time. Adolescents experienced diabetes-related stress a result of the challenging 
routine of insulin administration, cost and access to required food and transport cost or 
laborious travel to the hospital. Others mentioned worrying about the future as the major 
stressor among adolescents with diabetes. Adolescents also mentioned experiencing stigma and 
discrimination in social context at home and at school. In addition to the aforementioned 
distressing issues, there was a common view among the participants that distance to hospitals, 
cost of food, medicine and other medical essentials were the major barriers to quality health 
care. In order to deal with these issues participants mentioned that adolescents employed 




indicate the need to improve diabetes care especially making health services available and 
easily accessible. There is also need to recognize and identify psychosocial issues and intervene 
in order to improve the quality of life of adolescents with diabetes. 
 
The aim of chapter 4 was to test the validity and reliability of the Problem Areas in Diabetes 
(PAID). A total of 157 Zambian people with diabetes completed the PAID and other self-report 
measures. Exploratory factor analysis showed that a one-factor solution was the best 
interpretable solution. Internal consistency of the Zambian version of the PAID was 0.90 and 
stable cross the types of diabetes. Diabetes-specific emotional problems were common, with 
problem endorsements ranging from 22% – 61% across PAID items. The PAID showed low to 
moderate associations with the Self-Care Inventory, Hypoglycemia Fear Survey and the Major 
Depression Inventory. Cognitive interviews showed that participants were able to comprehend 
question intent while a few participants faced some challenges with the meaning of words such 
as “anxious” and “physician” and with comprehension of some items. The Zambian version of 
the PAID is a reliable and valid measure to assess diabetes-specific distress. Zambian people 
with diabetes expressed high levels of diabetes-specific distress; yet some items may need to 
be simplified or clarified to enhance comprehensibility. Policy makers, clinicians, researchers 
and people with diabetes need to combine forces to find ways to reduce the high levels of 
diabetes-specific emotional distress in Zambians living with diabetes. 
 
The aim of chapter 5 was to explore how common depression is in individuals with diabetes 
and examine factors associated with depression in our sample. A total sample of 930 
participants comprising of 773 healthy controls and 157 individuals with diabetes completed a 
set of demographic questions and the Major Depression Inventory (MDI). Results revealed that 




females were more likely to report depression than males. Within individuals with diabetes, 
there was no significance difference between those with type 1 and type 2 diabetes. Thus, 
despite the different etiologies of the two types of diabetes, the observed differences in 
depression were not significant, suggesting a need to consider both types of diabetes prone to 
depression. The observed levels of diabetes in Zambia were often high compared to other 
nations in the West and in Africa particularly Nigeria. Gender and socioeconomic status were 
found to be associated with reported depression in our subjects. 
 
Finally, in chapter 6 we examined the association between depressive symptoms as measured 
by the MDI and self-care using the self-care inventory in individuals with diabetes. 157 people 
with diabetes completed the two measures. Out of 12 depressive symptoms from the MDI, we 
found that the symptoms “low in spirit or sad” and “feeling life was not worth living” were 
significantly associated with self-care. The symptom “lack of energy” was only marginally 
associated with self-care and did not remain significant after applying Bonferroni correction. 
However, much of the variance observed between the association of depression and self-care 
was accounted for by demographic characteristics such as the patient’s age, sex, socioeconomic 
status and diabetes type which were significantly associated with self-care. Clinicians should 
identify individual symptoms of depression most affecting patients especially among woman 
and patients from low SES and intervene in order to improve self-care behaviors and quality 
of life of the patients. 
 
In conclusion, the present thesis demonstrated that diabetes is a growing problem in Sub-
Saharan Africa, including Zambia. Pertinent problems affecting people with diabetes include 
comorbid conditions, such as HIV, malaria, macrovascular and microvascular complications. 
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